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ABSTRACT 
The 5-nitrothiazole, nitazoxanide, is a novel compound with a broad spectrum of activity; 
effective against anaerobic/microaerophilic intestinal protozoa and bacteria. The 
mechanism of nitazoxanide's anthelmintic activity is unknown. This study examined the 
mode of action of nitazoxanide and analogues against nematodes, trematodes and cestodes. 
Caenorhabditis elegans, a free living nematode, was used as a model. Nitazoxanide was 
found to exert a transient spastic paralytic effect, particularly at the posterior end of the 
nematode, with 50% effect at 4.62µM. This effect is similar to that of levamisole (a 
neuromuscular agent) specific for nicotinic receptors. An effect of nitazoxanide at nicotinic 
receptors was demonstrated using mutants of C. elegans and the specific neuroblockers, 
mecamylamine and pempidine. A neuromuscular effect was also seen in Ascaris suum at 
higher concentrations using electrophysiological technique. Nitazoxanide had no effect on 
L3 larvae of Nematodirus spathiger and Haemonchus contortus. 
Cestodes and trematodes in vitro showed high sensitivity to nitazoxanide with <3. tM 
causing rapid paralysis and tegumental damage in Hymenolepis diminuta and Schistosoma 
mansoni. This was accompanied by inhibition of a-bungarotoxin binding to nicotinic 
receptors in S. mansoni, further suggesting an effect on neurotransmission. Uptake of 
glucose by the schistosome was decreased, and tegumental damage was found, suggesting 
that nitazoxanide can impair worm nutrition. Analysis of physicochemical properties of 
nitazoxanide suggested it is a protonophoric uncoupler. Consistent with this, synthesis of 
ATP was inhibited significantly by 331tM nitazoxanide in C. elegans and S. mansoni. In 
mitochondria of H. diminuta an increase in oxygen uptake was observed comparable to that 
seen with known protonophores suggesting that uncoupling of oxidative phosphorylation 
was occurring. In conclusion, nitazoxanide is likely to affect helminths by a direct effect on 
neurotransmission and protonophoric uncoupling. Nematodes are less sensitive than 
trematodes and cestodes in vitro, possibly due to difficulty of drug adsorption through the 
cuticle. 
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CHAPTER 1- INTRODUCTION. 
1.1 Helminths. 
1.1.1 Back round. 
Helminthic disease remains one of the world's most prevalent and economically 
important parasitoses of man and his domesticated animals (WHO, 1998). The majority 
of helminth infections are light and cause little morbidity, nevertheless many are so 
widespread that the low percentage of patients who suffer severe clinical disease still 
represent a problem of great medical and economic importance (Muller, 2003). 
Helminthiasis flourishes especially in warm environments marked by inadequate 
sanitation, parasitized reservoirs and vectors, and contaminated food and water sources 
(Hardman & Limbird, 1996). This is particularly the case in developing countries where 
the systems for livestock production and the environmental and socio-economic 
conditions are highly conducive for the development, maintenance and transmission of 
infection (Chowdhury & Tada, 1994). The population of these developing countries, 
suffer not only as a direct result of these infections but also suffer co-morbidity caused 
by other factors such as anaemia, malnutrition and associated reduced immunity 
(Grover 2001). However, affluence does not protect against helminth infections and 
young or debilitated individuals are particularly vulnerable, regardless of socioeconomic 
status (Hardman & Limbird, 1996). 
Among the nematodes, it is estimated that Ascaris lumbricoides infects over 1.3 billion 
people with 250 million suffering from associated morbidity; the hookworms 
Ancylostoma duodenale and Necator americanus infect over 1.25 billion; Trichuris 
trichiura infects 1 billion with a high unmeasured morbidity (WHO, 1998). With regard 
to trematode infections, although several species may inhabit the intestinal tract of man, 
few are considered serious pathogens (Healy, 1970). One trematode infection of the 
blood however, schistosomiasis (i. e. bilharzia) is serious and widespread and one of the 
six diseases selected as especially significant in the World Health Organization's 
"Special Programme for Research and Training in Tropical Diseases, " (Basch, 1991). 
The total number of people infected with any of the three major or several minor forms 
23 
Chapter 1- Introduction. 
of schistosomiasis is not known (Basch 1991). It is estimated by the WHO that 200 
million people are infected, of which 120 million are symptomatic and 20 million have 
severe disease (WHO, 1994). Cestode infection is also important, though generally less 
than that of nematodes and trematodes (Vanden Bossche 1985). Taenia saginata and 
Taenia solium cause much economic loss amongst livestock with T. solium also causing 
the fatal disease, cysticercosis in humans (Kocicka, 1987). The estimated number of 
cestode infections is thought to be over 150 million globally with over 76 million 
infections with Taenia saginata alone (Peters & Pasvol, 1995), and although in the 
majority of cases, direct effects of the worms in the gut are not serious, side effects such 
as nausea and abdominal pain cause much discomfort (Kocigka, 1987). Though the vast 
majority of helminthic infections are carried by the populations of the developing 
countries of the world, Diphyllobothrium latum, Taenia saginata, Enterobius 
vermicularis and Trichinella spiralis still retain an impact in the developed or 
industrialised nations (Crompton, 1987). 
Despite the huge amount of infection present in humans and animals, there is still very 
little understanding of helminth biology and anthelmintic pharmacology (Geary et al, 
1999). Increased knowledge of biology and greater understanding of anthelmintic 
mechanisms would aid greatly in the control and prevention of infection. 
Nitazoxanide (NTZ) was first described in 1975 (Rossignol and Cavier, 1975), and has 
since been shown to have activity against a wide range of parasitic protozoans (e. g. 
Giardia intestinalis, Entamoeba histolytica, Trichomonas vaginalis) (Adagu et al, 2002) 
and anaerobic bacteria (e. g. Clostridium spp) (McVay & Rolfe, 2000; Dubreuil et al, 
1996). Its anthelmintic properties were described in 1984, and it demonstrated marked 
activity against Taenia saginata and Hymenolepis nana (Rossignol & Maisonneuve, 
1984). The mechanism of action of NTZ against helminths as yet has not been fully 
investigated. An understanding of this mechanism of action would greatly aid future 
chemotherapy of helminthic infection. In this thesis, in vitro activity of NTZ and its 
metabolites/derivatives was investigated against a wide range of helminths including the 
free-living Caenorhabditis elegans and helminths from both the main phyla e. g. 
Nematoda and Platyhelminthes causing disease in humans. 
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1.2 Classification. 
Helminth is a general term meaning worm. The helminths are invertebrates 
characterized by elongated, flat or round bodies and are biologically very different. 
There are 2 phyla of helminths, which are of medical importance; Nematoda 
(roundworms) and Platyhelminthes, which contains the two distinct classes, Trematoda 
(flukes) and Cestoda (tapeworms) (figure 1.1). The definitive classification is based on 
the external and internal morphology of egg, larval (juvenile), and adult stages (Castro, 
2003). This classification is helpful in planning chemotherapy, since members of a 
particular class are frequently susceptible to the same drug type (Rakel, 1997). 
Knowledge of the life cycle stages is also important and is the basis for understanding 
the epidemiology and pathogenesis of helminth diseases, as well as for the diagnosis 
and treatment of infected patients (Castro, 2003). 
Figure 1.1: General taxonomic tree of helminths. 
KINGDOM Animalia 
PHYLUM Nem4toda Platyhelminthes 
CLASS Secernentea Cestöda Trematoda 
1 
(sub class digenea) 
ORDER Ascaridida 
1 
Pseudophyllidea Strigeatoidea 
FAMILY Ascaridoidea 1 Hymenolepididae 1 Schistosomatidae 
GENUS Asc ris Hymenolepis 
1 Schistosoma 
SPECIES lumbricoides diminuta mansoni 
Fig 1.1: Classification of three helminths which can infect humans: One from each of the Classes 
Secernentea, Cestoda and Trematoda. 
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1.2.1 Phylum: Nematoda. 
The word nematode literally means `threadlike'. Nematodes are round worms and the 
oldest written record of nematodes is thought to be to the intestinal roundworm Ascaris 
in China 4,700 years ago (Maggenti, 1981). Nematodes constitute one of the largest 
animal phyla with some 20,000 species already classified, and can live as obligatory 
parasites of plants and animals, they can alternate a parasitic with a free living life style, 
or be strictly free-living (Broeks, 1997). All nematodes are morphologically, 
anatomically and developmentally very similar. The free- living nematodes occur in all 
aquatic and terrestrial habitats. 
Nematodes are pseudocoelomate bilateralia with flexible and living (though mostly 
inert) cuticles and have somatic longitudinal muscles for movement (Croll & Matthews, 
1977). They are usually called roundworms because they are round when viewed in 
cross section. They are however cylindrical in structure and taper towards their anterior 
and posterior ends. Nematodes have no appendages, but may have cuticular bristles or 
sensory setae. Their body tissues are believed to be permanently under pressure. 
Nematodes possess digestive, nervous, excretory, and reproductive systems, but lack a 
discrete circulatory or respiratory system. Nematodes have been characterized as a 
"tube within a tube" (Brusca et al, 2003); referring to the alimentary canal which 
extends from the mouth on the anterior end, to the anus located near the posterior end. 
This inner tube is located in a continuous body cavity surrounded by the longitudinal 
muscles of the body wall (Croll & Matthews, 1977). Their nervous system has sense 
organs of different modalities, central ganglia and neuromuscular junctions. Although 
organisation differs from the mammalian neuromuscular system, two established 
mammalian neurotransmitter pathways are thought to operate; acetylcholine functions 
as an excitatory transmitter and -t-aminobutyric acid (GABA) is inhibitory (James & 
Gilles, 1985). Neuromuscular function is basically similar in all nematodes but as yet, it 
is not completely understood (James & Gilles, 1985). This neuromuscular system is 
known to be a target site for a number of anthelmintics and a greater understanding 
would enable a more systematic search for agents that could modulate the degree of 
muscle function and aid expulsion of the worm from the infected man or animal. 
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The sexes of nematodes are typically separate, and eggs are laid which pass through 
four "larval" stages (Li- L4) before the adult stage is reached. Some nematodes 
however, can be hermaphroditic such as the free living Caenorhabditis elegans. The 
smallest adult species which is free-living is about 2501im long, and most species of 
soil, marine and freshwater forms are about 1mm long as adults (Croll & Matthews, 
1977). Nematodes which parasitize are found in all parts of the body but are most 
commonly found in the digestive and respiratory tracts and the circulatory system. 
Parasites of animals/mammals tend to be 1-10mm in length e. g. Trichostrongylus axei, 
but many are bigger. Ascaris lumbricoides is about 20-30 cm long and Dracunculus 
medinensis (guinea worm) and Dioctophyme renale (giant kidney worm) are up to one 
metre long (Cook, 1998). The biggest known nematode species is Placentonema 
gigantissima, found in the placenta of sperm whales, which is 8 metres long. 
There are a number of different groups of nematodes which infect humans. These 
include the geohelminths (e. g. Strongyloides sterocoralis, Ascaris lumbricoides, 
Trichuris trichiura and the hookworms), a group of intestinal nematodes, which, while 
not related zoologically, are all soil-transmitted and have great similarities in 
epidemiology and methods of control (Muller, 2003). One feature which is common to 
all these intestinal helminths, and distinguishes them from their hosts, is their ability to 
survive in an environment which is predominantly anaerobic. Here, their chief energy 
source carbohydrate, is metabolised by a biochemical pathway different from that 
utilized by the host's tissues (James & Gilles, 1985) and produces various end products 
depending on species e. g. 2-methylbutyrate for A. lumbricoides (Barrett, 1994). 
Another group consists of the tissue nematodes which includes Trichinella and the 
filarial nematodes, which invade the tissues of the host, including those of the intestine, 
and have a life cycle involving an intermediate host, which is either a vertebrate 
intermediate or an arthropod (Muller, 2003). Nematodes of the order Spirurida all have 
an arthropod as an intermediate host and include the filarial worms such as Wuchereria 
bancrofti which is a cause of lymphatic filariasis. 
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1.2.2 Transmission of nematodes. 
There are a number of different life cycles and hence different modes of transmission 
of nematodes. These life cycles are either direct (as for the geohelminths) with no 
intermediate host needed or they are indirect (as for the filarial worms), requiring an 
intermediate host (see figure 1.2 a and b). 
Figure 1.2 Outline of nematode lifecycles (adapted from Muller, 2003 p110). 
a) Direct cycle: no intermediate host. 
Egg contains Unembryonated egg 
rhabditiform larva in faeces 
on perianal skin I 
Larva develops in egg but does 
not hatch. (LI in Trichuris, L2 
in Ascaris). , 
Egg hatches in intestine when swallowed by humans 
Larva (LI) develops 
directly to adult in 
intesti e. 
Enterobius 
host 
Embryonated egg 
in faeces 
I 
Egg hatches on 
gr I ound 
Rhabditiform 
larvae develops to 
L3 with sheath in soil 
FI 
L3 ingested L3 penetrates 
Is 
in 
Rhabditiform larvae 
(AUTOMFECrioN)) 
a) Passed in faeces b) Remain in 
I intestinal tract 
Free-living generation 
with rhabditiform 
larvae in soil. 
I 
Some larvae develop to Larva develo 
infective L3 in soil. in intestinal to 
(others rema'n free-living) to L3 
I 
Invective L3 L3 penetrates 
penetr to skin intestinal tract 
Strongyloides 
Larva reaches 
intestine after 
entering blood and 
via lungs. 
I 
Trichuris Ascaris Ancylostoma Necator 
Mammomonogamus Ancylostoma 
Trichostrongylus 
Oesophagostomum 
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b) Indirect cycle: require intermediate host. 
Vertebrate host. 
Rhabditiform L, L, larva Microfilaria L, larva encysted 
larva in faeces in water (pre L, ) larva in blood in muscles 
To L3 in land To L2 in To L2 in To L3 in biting 
Snail or slug. 
I 
cyclopoid cyclopoid insect 
L3 ingested 
I 
L3 ingested L2 ingested L3 enters skin L, ingested 
and to L3 in and to L3 in 
fish, frog or snake, 
I 
intestine. 
L3 ingested. 
I 
Parastrongylus* Dracunculus Gnathostoma* Brugia, Loa Trichinella' 
Mansonella, Onchocerca 
Wuchereria. 
Humans are accidental or aberrant hosts. (For life ofAscaris sp see Appendix II a) 
1.2.3 Phylum Platyhelminthes: Class Trematoda. 
Trematodes or "flukes" are a large group of parasites, and some of those belonging to 
the sub-class Digenea infect man. These digenetic trematodes usually have oral and 
ventral suckers as holdfast organs and have an indirect and complex life cycle. Adult 
digenetic trematodes, with very rare exceptions are endoparasites occurring exclusively 
in vertebrate hosts. They should be differentiated from other subclasses of trematoda, 
such as the Monogenea which are usually ectoparasites of fish and occasionally 
endoparasites of fish and turtles, and the Aspidogastrea which are endoparasites of fish, 
turtles and molluscs. These show more complex holdfast organs and usually have a 
direct life cycle (Kumar, 1999). 
The digenetic trematodes include several parasites that have an enormous impact on 
human populations, such as the blood flukes that cause schistosomiasis and human liver 
flukes (Fasciola hepatica). Adult flukes are typically found in the major viscera such as 
the bile ducts, lungs and alimentary canal; the schistosomes occur exclusively in the 
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blood system (Smyth, 1966). The digenetic trematodes differ from other groups of 
parasitic worms in that the first larval stages of all species develop in intermediate hosts 
from the Phylum Mollusca. This relationship is difficult to account for and one 
hypothesis suggests that trematodes were originally parasites of molluscs and 
secondarily developed an association with vertebrate hosts (Smyth, 1966). Digenetic 
trematodes have developed a great variety of methods for transmission from one host to 
another, and for survival in each (Basch, 1991). 
Except for the blood flukes, trematodes are hermaphroditic. The male organ consists 
usually of two testes with accessory glands and ducts leading to a cirrus that extends 
into the common genital atrium. The female gonad consists of a single ovary with a 
seminal receptacle and vitellaria, or yolk glands, that connect with the oviduct as it 
expands into an ootype where a shell is secreted around the egg. The tubular uterus 
extends from the ootype and opens into the genital atrium. Both self- and cross- 
fertilization occur (Castro, 2003). 
Digenetic eggs usually exit the host with the faeces, but in some species eggs are found 
in the urine, sputum or elsewhere. In some species the eggs, when liberated in the 
environment, must be ingested by a snail, the first intermediate host. However, it is 
more common that the eggs hatch in the environment, releasing a swimming 
multicellular miracidium which locates and penetrates an appropriate mollusc in which 
it can develop (Basch, 1991). Within the tissues of this host the miracidium 
metamorphoses rapidly to a mother or primary sporocyst, Depending on species, 
sporocysts develop further into either a secondary, passive sporocyst or into rediae, 
which possess a mouth, pharynx and gut and move actively within the molluscan host. 
Eventually, tailed swimming larvae called cercariae are formed, which escape from the 
mollusc and, again depending on species, carry out a predetermined pattern of 
behaviour (Basch, 1991). Some, such as the liver fluke Fasciola, attach to aquatic 
vegetation (e. g. water cress), where they lose their tail and metamorphose slightly to 
become a metacercaria (metacercarial cyst). Some cercariae enter a specific second 
intermediate host e. g another snail or a fish where they develop into metacercariae. 
These metacercariae are either active or encysted according to species and they wait for 
the transitory host to be eaten by an acceptable definitive host where sexual maturity 
can ensue. A third pattern (followed by schistosomes), has the cercariae penetrate 
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directly through the skin into the body of the definitive vertebrate host (Basch, 1991) 
bypassing the metacercarial stage. Figure 1.3 shows the varying forms of transmission 
for different species. 
Figure 1.3 Modes of infection of trematodes of medical importance. 
Adapted from Muller. 2003 u8 
Cercaria liberated from snail 
II 
Active penetration of skin 
Encystment to give metacercaria, 
of definitive host. which 
is ingested by definitive 
host. 
Schistosoma 
Encystment on vegetation 2"d intermediate host required 
I 
Fasciolopsis, Fasciola. 
Fish Crustacean Snail Insect. 
IIII 
Clonorchis, Opisthorchis Paragonimus. Echinostoma. Dicrocoelium 
Heterophyes, Metagonimus. Plagiorchis. 
(for full life cycle of Schistosoma sp see Appendix II b). 
One of the most important features of trematodes is their tegument. The tegument is the 
host-parasite interface and is the outer body covering which overlays the entire 
parenchymal basal lamina of digenetic trematodes (Kumar, 1999). It differs from the 
tough and largely inert cuticle of nematodes in that it is metabolically active and has 
absorptive function. The tegument has been a focus of attention in recent years, because 
in the case of schistosomes, the tegument associated antigens have provided important 
clues in vaccination studies and in the case of Fasciola hepatica, the outer most 
covering of the tegument (glycocalyx), participates in evasion of the host's 
31 
Chapter 1- Introduction. 
inflammatory and immune assault (Kumar, 1999). The tegument also plays an important 
role in relation to chemotherapy. Due to its metabolic activity and ability to absorb 
nutrients, it may provide a good target for drug action or facilitate drug entry into the 
organism. For example, praziquantel damages the schistosome tegument affecting 
absorptive processes and possibly host evasion (De Silva et al, 1997). 
1.2.4 Phylum Platyhelminthes: Class Cestoda. 
The tapeworms are members of the class Cestoda. All adult members of this group are 
parasitic in the alimentary tracts, or associated ducts, of vertebrates (Vanden Bossche, 
1985). Cestodes can infect man both in their adult stage (tapeworm) and larval stages 
(Kocie, ka, 1987). Man is usually infected with a single tapeworm, but multiple or mixed 
infections (with e. g. T. solium) do occur. The bodies of tapeworms lack a body cavity or 
alimentary system, are usually flat and elongate, and divided into three major regions; 
the scolex, the neck and the body consisting of a segmented chain (strobila). The scolex 
bears various organs of attachment such as suckers or bothridia, which assist the worms 
in maintaining their position in the gut. Scolices of tapeworms that infect humans are 
either cap-like (acetabulate) or bear several suckers (bothriate) (Bogitsh, 1998). The 
neck is a short area behind the scolex and is an area of very active cell division (Vanden 
Bossche, 1985). The strobila consists of a series of proglottids or segments. Each 
proglottid is a complete unit in itself and has its own set of male and female 
reproductive organs. In the order Cyclophyllidea, to which most of the adult tapeworms 
of humans belong, the proglottids vary in sexual development along the length of the 
strobila so that they become mature as they move further from the neck (Muller, 2003). 
These successively maturing proglottids eventually become gravid, when they are filled 
with eggs. Cestodes are hermaphrodites and they reproduce by passing out eggs 
contained in a gravid proglottid which detaches from the strobila. The cattle tapeworm 
of man Taenia saginata can consist of 1000-2000 proglottids with gravid proglottids 
containing 0.8-1 x 105 eggs (Muller, 2003). Eggs are ingested by an intermediate host in 
order to maintain transmission. Almost all cestodes have at least one intermediate host 
in their life cycle. The cycles vary widely among species, but generally a metacestode 
matures in the intermediate host, which is in turn ingested by the definitive host. 
Intermediate hosts include insects, crustacea, amphibians, reptiles, fish, birds and 
mammals (for lifecycle of Hymenolepis diminuta, see Appendix II c). 
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Different tapeworm species vary widely in size, ranging from a few centimetres 
(Hymenolepis nana) to several metres (Taenia solium). The outer coating of the 
tapeworm is the syncytial tegument, which bears numerous small projections called 
microtriches. The dimensions of these projections vary according to species and 
locations on the strobila. They resemble microvilli, but unlike typical microvilli, each 
microthrix includes an electron dense apical tip separated from the more basal region by 
a multilaminar plate. When applied to the host's intestinal epithelium these tips provide 
resistance to the peristaltic movement of the intestine. They also agitate intestinal fluids 
with worm movement thus increasing accessibility of nutrients and flushing away of 
waste products (Bogitsh, 1998). Covering the entire surface of the tegument is the 
glycocalyx, which protects the parasite from host digestive enzymes, enhances nutrient 
absorption and maintains the parasite surface membrane (Bogitsh, 1998). Cestodes lack 
an alimentary system, and due to this, the function and permeability of the tegument 
play an important role in determining the activity of chemotherapeutic substances used 
to kill these parasites. 
1.2.5 Phylum Acanthocephala. 
One other group of worm-like parasites are the acanthocephalans. These organisms 
belong to the phylum Acanthocephela and show similarities in structure to both the 
nematodes and the platyhelminths (Muller, 2003). Members of this phylum are all 
parasitic and most species are under 1cm in length. Their lifecycle usually involves an 
insect or crustacean as an intermediate host. The principal diagnostic character is the 
presence of a proboscis armed with rows of hooks which gives rise to their being called 
the `thorny headed worms' (Muller, 2003). They usually parasitise such organisms as 
racoons, rats and fish but acanthocephalans from the genera Moniliformis (e. g 
Moniliformis moniliformis) and Macracanthorhynchus (e. g. Macracanthorhynchus 
ingens) are occasional parasites of humans. 
1.3 Symptoms of helminth infection. 
With over 200 species of parasitic helminth (with representatives from the Digenea, 
Cestoda, Nematoda and Acanthocephela) recorded as infections of man (Crompton, 
1987) there is a wide range of helminth pathology. However, in the majority of cases, 
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helminth infection does not result in disease. Most of the helminths that are 
predominately human parasites are pathogenic only when worm burdens are high and, 
as there is no multiplication within the body, light infections only become clinically 
important following reinfection (Muller, 2003). As previously mentioned, helminths 
develop through egg, larval, and adult stages and each of these various stages 
(depending on species) may contribute to different disease states and pathological 
changes in humans (see table 1.1). 
Table 1.1 Stages of helminths commonly responsible for pathologic changes 
in humans. 
Helminths Egg Larva Adult 
Flukes +++t +* + 
Tapeworms - +++ + 
Nematodes - ++ +** 
* Migrating and developing larval forms may cause transient 
pathologic responses in the host. 
** Adults ofAscaris and filarial nematodes e. g. Wuchereria can cause severe pathology. 
t In flukes, it is only in schistosomes where the eggs are responsible for pathology. 
+++ = severe pathology 
++ = moderate pathology 
+= light pathology 
Table 1.1 modified from Castro, 2003 
As seen from table 1.1 each stage of the helminth life cycle can be a cause of 
pathology. Flukes cause pathology in all stages of their life cycle, where in the case of 
schistosomiasis a substantial number of eggs are retained in the tissues where they can 
survive for around 3 weeks (WHO, 1994). It is these eggs which are responsible for 
inducing most of the pathological manifestations of disease such as granulomas and 
pseudopapillomas (WHO, 1994). With S. mansoni, the eggs can cause ulceration of the 
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colon and can result in blood loss of up to 12.5 ml day" as seen in Egyptian patients 
(Muller, 2003). Schistosome infection (especially S. japonicum) can also cause 
carcinomas of the large intestine and rectum associated with the chronic lesions caused 
by the presence of eggs (Matsuda et al, 1999). In the cestode, Taenia solium, which is 
the pork tapeworm of man, inappropriate development of the larva in the definitive host, 
man, causes cysticercosis. Cysts may be found in the brain, which may cause epilepsy 
and/or other symptoms (Cook, 1998). Another cestode infection, echinococcosis caused 
by e. g. Echinococcus multilocularis, has the human as an aberrant intermediate host. 
Normally after infection, a cyst develops in the definitive host (e. g foxes or voles), 
containing protoscolices which develop rapidly into adults (Stettler et al, 2003). In 
humans however, the cysts cannot develop further, and instead cause a fibrous host 
reaction. The parasite destroys the liver parenchyma, bile-ducts and blood-vessels, 
resulting in symptoms of biliary obstruction. The cysts often metastase via the 
bloodstream to form new cysts, particularly in the lungs and brain. E. multilocularis is 
considered the most dangerous helminth infection in humans (Muller, 2003). With 
regards to pathology caused by adult helminths, hookworms (e. g. the nematode 
Ancylostoma duodenale) feed on the blood of their host and thus sap its vitality. 
Roundworms such as A. lumbricoides show a tendency for migration and accumulation 
and when in large numbers may cause life-threatening bowel obstruction, or a single 
worm may block a vital duct (Vanden Bossche, 1985). Tissue dwelling filarial 
nematodes cause considerable pathogenesis. Most of the severe manifestations of 
Onchocerca volvulus infection are due to the presence of microfilariae, with the adults 
being of secondary importance. The microfilariae can reach the cornea of the eye, and 
on dying cause a punctuate keratitis which can be followed by sclerosing keratitis 
leading to blindness (hence `River blindness') (Muller, 2003). In contrast, in lymphatic 
filariasis, it is the adult worms which cause most of the pathology (Muller, 2003) e. g 
lymphoedema and elephantiasis. 
As well as the direct pathology from the helminths, there is also a problem with 
coinfection. This has been demonstrated with intestinal helminths which have been 
reported to increase the incidence of Plasmodium falciparum malaria attacks and during 
a P. falciparum malaria attack, helminth-infected patients were shown to be more likely 
to develop anaemia and carry gametocytes (Nacher, 2002). 
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One important aspect of helminth infection is, as mentioned with the schistosome 
eggs, the host response and degree of immunopathology stimulated. 
1.3.1 Immune reactions to helmintic infections. 
Infection with helminth parasites generates a strong Th2 type immune response in the 
host (Lynch, 1987) and a cytokine profile dominated by IL-4, IL-5, IL-6, IL-9, IL-10 
and IL13 (Holland & Kennedy, 2002). The characteristic features of this response 
include intestinal mastocytosis, eosinophilia and goblet cell hyperplasia (Chowdhury & 
Tada, 2001). The nature and degree of the immune response elicited by infection are not 
only dependent on the level and frequency of infection and the characteristics of the 
parasite concerned, but they are also influenced by the location of the parasite (Muller, 
2003). Helminths occupy a wide variety of habitats in the host's body, and the capacity 
of these to respond to infection and the nature of the response expressed can differ quite 
markedly. 
1.4 Diagnosis of helminth infection. 
For the laboratory diagnosis of helminth infection, the detection of eggs in the faeces 
or urine is still the most widely used method (Muller, 2003). Where eggs are less 
numerous, concentration methods such as Kato-Katz or sedimentation techniques can 
be used. Other methods include numerous immunological tests with ELISA and 
immunoblotting techniques. With filarial infection, routine diagnosis involves finding 
microfilariae, usually in stained thick blood films (Muller, 2003). Clinical diagnosis is 
mostly parasite-specific with certain symptoms characteristic to certain parasites. 
PCR is also used for diagnosis, and is very highly specific for identification of 
infection. However costs of equipment and the need of staff training and infrastructure 
make this a less utilisable form of diagnosis in develöping countries. 
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1.5 Chemotherapy of helminths. 
1.5.1 Economics. 
Eradication of helminthiasis is highly unlikely, due to its close association with 
human poverty. Although helminth infection is both common and cosmopolitan, its 
subtle clinical course generally encourages neglect until overt disease is obvious 
(Hardman & Limbird, 1996). Until effective vaccines become available, chemotherapy 
provides the single most efficient, practical, and relatively inexpensive strategy to 
control helminth infections (Hardman & Limbird, 1996). The selective toxicity of 
antiparasitic agents is based upon the parasite location, differences in host and parasite 
metabolic pathways, or upon the concentration of the drug reaching the parasites 
(Docampo, 2002). Parasite life cycle stages may have different drug susceptibilities. 
Antiparasitic drugs should ideally be safe, orally effective, curative in a single dose 
and inexpensive (Docampo, 2002). 
1.5.2 Selective toxicity. 
In contrast to viruses, bacteria, fungi and tumours, helminths parasitize (often 
simultaneously) virtually all host tissues, including blood (Dirofilaria immitis, 
Schistosoma spp), other tissues (Dictyocaulus viviparous (lung worm of cattle), 
Fasciola hepatica) and the gastrointestinal tract from stomach to anus (Ascaris 
lumbricoides, Enterobius vermicularis). Broad-spectrum anthelmintics must reach 
sufficient concentration in each of these compartments, preferably using a single 
delivery strategy (Geary, 1999). In the last 50 years specific, safe and effective 
anthelmintic drug therapies for various parasitic infestations have been developed. 
Earlier anthelmintic drugs suffered from serious drawbacks such as hepatotoxicity and 
required specific preparation of the patient before treatment. However, successive 
discoveries were born out of rational approach that contributed to the effective, more 
specific and more easily tolerated drugs (Grover 2001). 
S 
37 
Chapter 1- Introduction. 
1.5.3 Current anthelmintics. 
A wide range of clinically effective antihelmintics exists, creating a relatively 
satisfactory chemotherapeutic situation (Harder, 2002). Virtually all the important 
helminth infections of man can be treated with one of five main anthelmintics which are 
in use at the moment: albendazole, mebendazole, diethylcarbamazine (DEC), ivermectin 
and praziquantel. These drugs not only treat individual infections, but also aid in 
controlling the transmission of some of the more common infections (De Silva et al, 
1997). 
However, some helminthic diseases are still lacking effective chemotherapy such as 
fascioliasis and neurocysticercosis. There is also a severe lack of available anthelmintics 
which are able to target species from both of the two main phyla. The introduction of a 
new broad-spectrum anthelmintic which has activity against nematodes, trematodes and 
cestodes would greatly aid in prevention and control of infection. 
1.5.3.1 Intestinal nematodes. 
The treatment of intestinal nematode helminth infections, at both the individual and 
community levels is currently best served by the benzimidazoles (e. g. albendazole, 
mebendazole and thiabendazole) with alternative treatments using levamisole 
hydrochloride or pyrantel pamoate (WHO, 1987; Katz, 1977). The cure rate with these 
drugs is also high e. g. thiabendazole produces a cure-rate of 98% in cutaneous larva 
migrans while mebendazole gives cure rate of 76-95% in ascariasis, trichiuriasis and 
hookworm infestations (Grover, 2001). Piperazine salts though cheap, are only useful 
for ascariasis and enterobiasis. The efficacy of single dose therapy in the treatment of 
intestinal nematode infestations has made feasible mass treatment programmes targeted 
at school children, the age group with the highest prevalence. Such mass treatment has 
been advocated as a component of control measures to reduce the number of worms in 
individual children below pathogenic levels and has been shown to improve children's 
growth and physical fitness as well as academic performance (De Silva et al, 1997; 
Stephenson et al, 2000). 
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1.5.3.2 Filarial nematodes. 
Currently, diethylcarbamazine (DEC) and ivermectin are used in the treatment of 
filariasis. Albendazole is also used in combination with DEC (Kshisager et al, 2004; 
Rajendran et al, 2004). Mass treatment with an annual dose of ivermectin has now been 
established as the treatment of choice for onchocerciasis. This has been shown to be 
effective in controlling ocular lesions and in reducing transmission, and is safe enough 
to use in large scale control programmes. Long-term, low dose mass treatment through 
the substitution of normal salt with DEC-fortified table/cooking salt has also been 
useful in the control of lymphatic filariasis. This has been shown to reduce microfilariae 
by 99% for at least one year, when used for 9-12 months (De Silva et a1,1997). 
1.5.3.3 Cestodes. 
Praziquantel and niclosamide are accepted as very safe anticestodal drugs effective in 
clinical use (WHO 1987), and between them have good activity against most human 
cestode infections (Cook, 1998). Mebendazole is also used as an anticestodal drug, and 
inhibits the growth of E. multilocularis cysts and prevents the occurrence of metastases 
(Muller, 2003). 
1.5.3.4 Trematodes. 
Praziquantel is the best schistosomicidal agent available today. It is the one drug 
effective against all species infecting man and has a 96% cure rate. There is also 
oxamniquine for Schistosoma mansoni and metrifonate, used predominately in 
treatment of Schistosoma haematobium even though it has slight action against 
Schistosomajaponicum and Schistosoma mansoni (Jordan, 1993). Praziquantel also has 
activity against Chlonorchis sinensis and Paragonimus westermani (Terada et al, 1982). 
Praziquantel and albendazole are said to be of value in the treatment of 
neurocysticercosis, for which there was no effective chemotherapeutic agent until 1979 
(De Silva et al, 1997) and are also active against Echinococcus granulosus (Urrea- Paris 
et al, 2000). Until recently the only available compound for treating human fascioliasis 
caused by the trematode Fasciola hepatica, has been triclabendazole (Coles, 1986) 
which has only recently been introduced in Egypt (el-Karaksy et al, 1999). However 
this drug was shown to require repeated courses of treatment. 
39 
Chapter 1- Introduction. 
Table 1.2 Mode of action of the major groups of anthelmintics 
Examples Mode of Action 
Anthelmintic group 
Macrocyclic lactones Ivermectin Bind to glutamate 
(Macrolides) Eprinomectin chloride channels 
Doramectin causing paralysis. 
Moxidectin 
Milbemycin oxime 
Selamectin 
Benzimidazoles Thiabendazole Inhibition of 
Mebendazole polymerization of 
Fenbendazole microtubules 
Oxfenbendazole 
Oxibendazole 
Albendazole 
Pro- benzimidazoles Febantel Same as 
benzimidazoles 
Imidazothiazoles Levamisole Cholinergic agonists. 
Tetramisole 
Tetrahydropyrimidines Morantel Cholinergic agonists 
Pyrantel 
Organophosphates Dichlorvos Inhibitors of 
Haloxon cholinesterases 
Trichlorofon 
Piperazines Piperazine salts Anticholinergic action- 
block neuromuscular 
transmission. 
Uncouplers Niclosamide Uncouples 
(protonophores) mitochondrial 
respiration from energy 
production. 
Table modified from "Parasites and Parasitic Diseases of Domestic Animals" 
Dr. Colin Johnstone (principal author) 
Copyright ©1998 University of Pennsylvania (website http: //cal. vet. upenn. edu/menial/anthelmintics) 
1.6 Anthelmintic drug mechanisms. 
As presented in table 1.2, anthelmintics vary in their mechanism of action. Some show 
good activity against certain species of worms, yet have very poor activity against 
others. The general drugs for anthelmintic use are either cholinergic agonists, 
protonophores or anti-tubulin: 
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1.6.1 Anti-nematodal drugs. 
1.6.1.1 The cholinergic agonists. 
The cholinergic agonists e. g. levamisole, pyrantel (Martin, 1993; Martin et al, 1996), 
and morantel (Evans & Martin, 1996) are anthelmintics which target neurotransmitter- 
gated-ion-channels in the worms. These neurotransmitter-gated ion-channels provide 
the molecular basis for rapid signal transmission at chemical synapses. They are 
post-synaptic oligomeric transmembrane complexes that transiently form an ionic 
channel upon binding of a specific neurotransmitter (Stroud et al, 1990). 
A number of these neurotransmitter-gated receptors present in helminths include the 
nicotinic acetylcholine receptor (AchR), the muscarinic AchR and the gamma amino 
butyric acid (GABA) receptor. The motor neurons of invertebrates, are unmyelinated 
and are thus more susceptible to disturbances of nerve membranes caused by membrane 
active agents than are the myelinated somatic motor fibers of vertebrates (Docampo, 
2002). Acetylcholine receptors have different properties in different anatomical 
locations (Goldstein et al, 1974). In the neuromuscular junction or ganglia of the 
autonomic nervous system they are known as `nicotinic receptors' because they are 
stimulated by nicotine. In smooth muscle AchR's are known as `muscarinic' because 
they are stimulated by muscarine (Bacq, 1975). The nicotinic AchRs are ligand- gated 
ion channels that produce an increase in Na+ and K+ permeability, depolarisation and 
excitation upon activation (Haugland, 1998). Thus binding of a cholinergic agonist such 
as levamisole at the nicotinic receptor site would stimulate muscular contraction, 
causing spastic paralysis and resulting in expulsion of the worm from the host. Nicotinic 
receptors are selectively blocked by agents such as tubocurarine and muscarinic 
receptors are selectively blocked by agents such as atropine (James & Gilles, 1985). The 
GABA receptor is an inhibitory chloride channel receptor, which when stimulated by 
GABA (which acts as a transmitter substance of inhibitory neurons), prevents 
contraction by making the membrane of the muscle fibres permeable to chloride ions. 
This permeability increase reduces the effectiveness of the action of motor nerves and 
effectively inhibits contraction leading to flaccid paralysis of the worm (Bacq, 1975). 
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1.6.1.2 Levamisole. 
Levamisole is a potent nematocide (Richmond & Jorgensen, 1999), discovered along 
with tetramisole during a drug development programme in the early 1960's. Tetramisole 
is the parent compound and is a racemic mixture with the S(-) isomer, levamisole, 
containing all the biological activity. The spectrum of this drug against intestinal 
nematodes is narrower than that of the benzimidazoles (James & Gilles, 1985), though 
levamisole has very good activity against Ascaris. The neuromuscular mode of action of 
levamisole is similar to that of morantel and pyrantel, however, levamisole also has 
slight fumarate reductase inhibitory action, though this is considered too low to be 
operative in vivo with an anthelmintic dose regimen (James & Gilles, 1985). 
Figure 1.4 Structure of Levamisole. 
/I 
N 
Neuromuscular drugs with the same or similar mechanisms when used on nematodes 
can produce a number of effects. On exposure to levamisole in vitro, immature and 
adult worms of Ascaris lumbricoides show spastic contraction followed by tonic 
paralysis (Martin et al, 1997). The drug is immediately and almost completely absorbed 
via a trans-cuticular mechanism (Vanden Bossche, 1985). Studies on the mode of action 
of levamisole indicate it is a selective agonist at acetylcholine receptors present on the 
muscle cells of parasitic nematodes (Robertson & Martin, 1993). Levamisole, produces 
a characteristic depolarising type of neuromuscular blockade. This causes an excitatory, 
spastic effect on the worm, which closely resembles that of ganglionic stimulation in 
autonomically innervated mammalian systems (figure 1.5). 
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Figure 1.5 Schematic representation of ganglionic stimulation by neuromuscular 
agonist (levamisole). 
Effector 
Synaptic 
Post ganglionic nerve organ 
cleft 
Pre- ganglionic 
nerve Ganglion Neuroeffector 
junction 
LEVAMISOLE 
Cholinergic nerve (transmitter substance = acetylcholine (Ach) 
In figure 1.5 the presence of levan i. sole would stimulate the ganglionic nicotinic 
receptor leading to waves of depolarisation across the neuroeffector junction and 
would thus evoke a pharmacological response on the effector organ, the hehninth 
muscle, which would lead to a transient spastic paralysis of the worn. 
The excitatory effect of levamisole is similar to that of nicotine and is also abolished by 
the specific ganglionic-blocking agents pempidine and mecamylamine (Tornoe el al, 
1996). It is this observed effect which led to a ganglion-stimulating type of effect being 
proposed for the mechanism of levamisole and other anthelmintics including pyrantel 
and bephenium. Pyrantel is similar to levamisole in that it causes a neuromuscular 
blockade and induces a marked, persistent activation of the nicotinic receptor, which 
results in spastic paralysis of the worm (Hardman & Limbird, 1996). Pyrantel however, 
also inhibits cholinesterase and it can cause a slowly developing contracture of 
preparations of Ascaris at I% of the concentration of acetylcholine required to produce 
the same effect (Hardman & Limbird, 1996). 
Other receptors in helminths, which include the muscarinic and GABA receptors, are 
targets for a wide range of drugs. GABA receptors are targets for piperazine and 
ivermectin, and like GABA, piperazine activates chloride channels in the membrane. 
43 
Chapter 1- Introduction. 
The effect of piperazine on the nematode muscle thus resembles that of inhibitory 
nerves, which causes worm muscles to become flaccid and thus results in worm 
expulsion from the host (Bacq, 1975). 
1.6.1.3 Acetylcholinesterase inhibition. 
As mentioned, drugs such as levamisole cause paralysis by direct action on the 
neuromuscular receptor in the worm. However, some anthelmintics e. g. pyrantel 
(Hardman & Limbird, 1996), dichlorvos and metrifonate (Reiner, 1981) inhibit the 
enzyme acetylcholinesterase (AchE). Acetylcholinesterase is an enzyme found in the 
nerve tissue and is involved in the breakdown of the neurotransmitter acetylcholine 
(Bowman & Rand, 1990). The presence of two types of cholinesterases, acetyl- and 
butyryl-cholinesterases has been recognised in crude extracts and excretion-secretion 
products from different parasitic nematodes. These enzymes play an important role in 
the nematode neuromuscular system and in the host-parasite relationship and secreted 
AchE has been associated with the modulation of the following host mechanisms: 
gastrointestinal motility, cell membrane permeability, anti-coagulant processes, 
anthelmintic resistance, immune and inflammatory responses (Ros-Moreno et al, 2002). 
Drugs such as metrifonate and pyrantel, exert their effect by inhibiting the effect of 
helminth acetylcholinesterase and hence prevent the breakdown of acetylcholine, thus 
allowing a build up of acetylcholine which causes a depolarisation of the postsynaptic 
membrane (Bowman & Rand, 1990). Eventually the build up of acetylcholine exceeds a 
threshold level leading to propagated depolarisation (Goldstein et al, 1974), which 
causes paralysis and hence expulsion of the worm. The inhibition of helminth 
cholinesterases is likely to have an affect on the host-parasite relationship, though most 
of the reasons why the worm secretes cholinesterases have not yet been systemically 
investigated (Hussein et al, 1999). 
1.6.1.4 Benzimidazoles 
In 1964 it was discovered that thiabendazole (2-(4'-thiazolyl) benzimidazole) possessed 
a broad spectrum of activity against gastro-intestinal worms, and this opened up a new 
era in the treatment of parasitic diseases (De Silva et al, 1997). The benzamidazoles 
which include cambendazole, oxibendazole, albendazole and mebendazole are all 
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potent, orally active, broad-spectrum anthelmintics (McCracken et al, 1982). They have 
in common a bicyclic ring system in which benzene has been fused to the 4- and 5- 
position of the heterocycle (imidazole) (De Silva et al, 1997). 
Fig 1.6 Generalized structure of the Benzimidazoles. 
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Several thousand benzimidazoles have been screened for anthelmintic activity, but only 
mebendazole and albendazole are currently in wide clinical use, although thiabendazole, 
flubendazole and triclabendazole are in use but on a much smaller scale (De Silva et al, 
1997). 
1.6.1.5 Mode of action of benzimidazoles. 
The mode of action of the benzimidazole drugs has been extensively reviewed (Lacey, 
1990). Mebendazole selectively inhibits glucose uptake in nematodes and cestodes 
which leads to increased utilization of parasite glycogen, therefore depriving the 
parasite of its main energy source (James & Gilles, 1985). Mebendazole and other 
benzimidazole drugs have the ability to bind to tubulin (Bughio et al, 1994; Friedman & 
Platzer, 1980) and act on nematodes by preventing ß- tubulin polymerising into 
microtubules (Lacey et al, 1988; Barrowman et al, 1984). This effect induces the 
disappearance of cytoplasmic microtubules (important for intracellular transport) of the 
tegumental or intestinal cells of cestodes or nematodes causing degenerative changes in 
these cells (Vanden Bossche et al, 1985). This may lead to impaired coating of the 
membranes, followed by a decreased digestion and absorption of nutrients (Rahman and 
Bryant, 1977), eventually leading to death of the parasite. Mebendazole has no effect on 
blood glucose concentrations in humans, and examination of the intestine and other 
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organs of treated animals has shown an intact microtubular system and normal 
subcellular organelles. The presence of food in the digestive tract of the definitive host 
does not affect the action of the drug during treatment of intestinal helminthic infections 
(Rahman and Bryant, 1977). 
1.6.2 Anti-trematodal drugs. 
There are few drugs currently used to treat trematode infection. These drugs include 
triclabendazole, clorsulon and praziquantel, with the last being the drug of choice. 
1.6.2.1 Praziguantel. 
Praziquantel is a heterocyclic pyrazino-isoquinoline and was developed after this class 
of compound was discovered to have anthelmintic activity in 1972 (Hardman & 
Limbird, 1996). Praziquantel is the best schistosomicidal agent available today for the 
clinical management of schistosomiasis. It is highly effective against all species of 
schistosomes pathogenic to humans (Webbe & James, 1977). It has also been reported 
to be useful in combination with albendazole or alone in the treatment of other 
trematode infections, chlonorchiasis, paragonimiasis and fascioliasis (De Silva et al, 
1997), as well as the cestode infections, taeniasis and hymenolepiasis. Nematodes are 
unaffected (Hardman & Limbird, 1996). More than 80% of the drug is absorbed after 
oral administration and peak plasma levels are reached in 3-4 hours (De Silva et al, 
1997). Praziquantel crosses the blood-brain barrier, reaching CSF concentrations 
approximately 25% that of plasma levels. 
Figure 1.7: Structure of urazipuantel. 
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1.6.2.2 Mechanism of praziquantel. 
The mechanism of action of praziquantel remains unclear and is still under debate 
(Hardman & Limbird, 1996). The uptake of praziquantel is rapid and reversible 
(Hardman & Limbird, 1996) and effects of praziquantel on adult worms include 
vesiculation, vacuolisation and disintegration of the tegumental surface (Bricker et al, 
1983; Matsumoto, 2002). Firstly at low concentrations, praziquantel causes a muscle 
contraction in about ten minutes, followed by subsequent flaccid paralysis (Blair et al, 
1992). This would cause affected worms to detach from host tissues in vivo (Hardman 
& Limbird, 1996). The authors attributed this muscle contraction to a drug induced 
interference with the inorganic Mg 2+ ion mechanism of the parasite. At higher 
concentrations, praziquantel causes tegumental damage, which activates host defence 
mechanisms and results in destruction of the worms (Hardman & Limbird, 1996). In 
schistosomes praziquantel is shown to stimulate Ca 2+ influx (Kumar, 1999), which may 
cause muscle cells to contract (Coles, 1979). The drug then causes vacuolation of the 
syncytial tegument (blebbing), which is followed by disintegration of the surface of the 
tegument leading to parasite death (Kumar, 1999). 
1.6.3 Anti-cestodal drugs. 
Praziquantel is also the drug of choice for treatment of cestodes infection e. g. Taenia 
infections, Diphlylobothrium latum and Hymenolepis infections (Muller, 2003). 
However, niclosamide which has protonophoric (uncoupling) activity (Vanden Bossche 
et al, 1985) is also used. 
1.6.3.1 Protonophoric activity 
An uncoupler (protonophore) is a membrane- soluble small molecule with at least one 
weakly acidic group (-OH or >NH) which can readily release or bind a proton (Heytler, 
1979). As early as 1961, it was recognised that lipid-soluble weak acids can traverse a 
membrane both in protonated form (R-OH, R=NH) and as the anion (RO', R=N), 
thereby effectively translocating protons across the membrane (figure 1.8) ( Harold, 
1986). 
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Figure 1.8: Proton conducting uncoupler system. 
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When an uncoupler dissolves in the bacterial or mitochondrial inner membrane, it can 
ferry protons back along the proton gradient into the matrix, bypassing the ATP- 
synthetic machinery. This is the mechanism by which 2,4-dinitrophenol, niclosamide 
and other uncouplers dissociate the linkage between processes that generate the proton 
potential and those that consume it. Uncouplers cause the membrane to become 
specifically permeable to protons and to no longer be able to sustain a proton potential 
(Harold, 1986). The conversion of ADP to ATP is prevented and respiratory electron 
transport is effectively freed from dependence on ADP supply. This leads in many cases 
to an increase in oxygen uptake due to more rapid respiration uncontrolled by ADP 
availability. The effect can be monitored by examining phosphate exchanges in 
mitochondria and also oxygen exchanges between inorganic phosphate, water and ATP. 
One uncoupler which is in current use is niclosamide (2', 5-dichloro-4'- 
nitrosalicylanilide). This is an anti-tapeworm drug, which is hardly absorbed through 
the intestinal wall of the host (Vanden Bossche, 1985). 
1.7 Enzyme action. 
Enzyme inhibition is another mode of action displayed by some anthelmintic drugs e. g. 
inhibition of the Haemonchus contortus fumarate reductase system by thiabendazole 
(Prichard, 1970). The understanding of parasite enzymes holds much potential in the 
finding of new drugs, as a number of target enzymes exist that are found only in the 
parasites. One enzyme is pyruvate ferrodoxin oxidoreductase which is found in the 
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protozoa Trichomonas, Entamoeba and Giarda spp (Docampo, 2002). This enzyme, can 
achieve a very negative reduction potential, and can reduce the nitro group of 
metronidazole to form cytotoxic reduced products that bind to DNA and proteins 
(Docampo, 2002). Other enzymes that are important in the mode of action of anti- 
parasitic drugs include acetylcholinesterase (1.6.3), nitroreductase and fumarate 
reductase. 
1.7.1 Fumarate reductase. 
The fumarate reductase system functions in the respiratory chain in intestinal helminths 
(Prichard, 1973). In intestinal helminths living under relatively anaerobic conditions, 
there is a microaerophilic reducing system in the electron transport chain, which uses 
fumarate (redox potential approximately +0.025mV (millivolts)) as a hydrogen acceptor 
instead of oxygen (Kuramochi et al, 1995). Coenzyme Q (Cory) is a lipid soluble factor 
that transports electrons and protons across the inner mitochondrial membrane to 
maintain the proton gradient that drives ATP synthesis (Tatar et al, 2002). CoQ drives 
electron transport at complexes I and III (see figure 1.9). Worms endogenously 
synthesise the most prevalent Q9 isoform to obtain CoQ from a demethoxy-Q9 (DMQ9) 
intermediate (some worms i. e. C. elegans can also obtain CoQ from feeding on bacteria 
that synthesise Q8), they are also able to produce RQ9 (an alternative quinone) which is 
involved in anaerobic respiration rather than aerobic respiration (Tatar et al, 2002). This 
allows the worms to follow an alternative system where fumarate is reduced to 
succinate and allows phosphorylation of ADP (Barrett, 1994). 
The fumarate reductase system appears to be a particularly vulnerable point, in the 
metabolism of helminths, for chemotherapeutic interference (Prichard, 1973; 
Barrowman et al, 1984). This is due to the specificity of the system to the helminth in 
the host-parasite relationship. Many drugs have been tested for fumarate reductase 
inhibitory activity, cambendazole and 1-tetramisole inhibit the fumarate reductase 
system in Haemonchus contortus (Malkin et al, 1972, Vanden Bossche et al, 1969). The 
veterinary anthelminthic, thiobendazole, inhibits fumarate reductase in Haemonchus 
contortus, Fasciola hepatica and Hymenolepis diminuta (Coles, 1977). However, the 
role of fumarate reductase inhibition nowadays is not widely considered to be 
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important, though the further understanding of respiration in nematodes is still a major 
factor regarding chemotherapeutic targets (Barrett, 1994). 
Figure 1.9 The electron transport chain. 
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Figure 1.9: shows a diagram of the electron transport chain. Helminths are able to produce an RQ, 
alternate quinone which allows anaerobic respiration (blue arrow) instead of aerobic respiration (red 
arrow) allowing reduction of fumarate to succinate. 
1.8 Toxicity and side effects of anthelmintics. 
Few drugs are without side-effects though many of the main broad spectrum 
anthelmintics, such as mebendazole are very safe (Vanden Bossche, 1985). In some 
cases however, the drug itself has had to be removed from the market owing to severe 
complications. This was the case with the schistosomicidal drug, niridazole (Bassily ei 
al, 1979) which was found to be mutagenic, affecting reproductive systems and was 
carcinogenic in animals (Frohberg, 1989). From the toxicological point of view, 
praziquantel is the most promising drug, because it lacks systemic toxicity after 
repeated administration of daily doses of up to 100 or 180 mg/kg to rats and dogs, 
respectively. It does not affect reproduction, and is devoid of any mutagenic or 
carcinogenic potential (Frohberg, 1989). 
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1.9 Drug resistance. 
The efficacy of these anthelmintic drugs and their ability to cure disease and decrease 
morbidity have been well established. However in animals, where anthelmintics are 
used intensively, resistance is an increasing problem and has already been shown in 
some of the broad-spectrum anthelmintics. 
1.9.1 Drug resistance in animals. 
In the veterinary field, the number of reports on resistance against anthelmintics in 
nematodes has increased dramatically and resistance has been found in Fasciola, 
cyathostomes, ascarids, hookworms and strongyles (Conder and Campbell, 1995). In 
sheep, resistance was found in the trichostrongylids; Haemonchus contortus, 
Trichostrongylus colubriformis and Oesophagostomum circumcincta and demonstrated 
for all the benzimidazoles commercially available (Vanden Bossche, 1985). Recently 
resistance to macrocyclic lactone (ML) anthelmintics e. g. ivermectin for the control of 
trichostrongylid larvae has become a serious problem in sheep and goats (Prichard, 
2002). These parasites are prolific breeders, resulting in a huge population size within a 
farm. This huge population size and high reproduction rate are conducive to a high level 
of genetic diversity. As a result, repeated use of ML anthelmintics can select for rare 
individual nematodes able to survive the normal dose. These then reproduce and 
generate a new resistant strain of parasites (Prichard, 2002) 
Resistance in animal helminths has also been recorded with levamisole and morantel, 
drugs with a similar mode of action to each other (Sangster 1979). Recently ivermectin 
resistance has been seen to be on the rise in cattle helminths (Harder, 2002) and this 
demonstrates the urgent need in veterinary medicine for new anthelmintics with new 
modes of action (Harder, 2002). This emergence of anthelmintic resistance and 
associated economic problems in several animal industries has raised much concern, 
and highlights possible threats to the control of human parasites (Sangster, 1999). 
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1.9.2 Drug resistance in humans. 
To date there is no confirmed report of anthelmintic drug resistance in a soil- 
transmitted nematode infection in humans (De Silva et al, 1997). However, the 
detection of resistance is difficult, unless acute disease is a feature of the infestation, so 
most helminth resistance is likely to go unrecognised (Chowdhury & Tada, 1994). The 
widespread use of mebendazole and albendazole for treating intestinal nematode 
infections in human populations is raising concerns that careful monitoring procedures 
should be in place to identify any emergence of drug resistance (Bennett & Guyatt, 
2000). An example of these monitoring procedures which could aid in the delay or 
prevention of drug resistance emergence would be to treat only a proportion of the 
people in an infected community at most risk (e. g. targeting school children). This 
would ensure that some wild-type nematodes remain in the community and the genes of 
these survivors would dilute those of nematodes experiencing selection pressure. Other 
procedures could include giving treatment at intervals greater than the nematodes 
generation time or changing the drug of choice for a particular control programme (De 
Silva et al, 1997). An established protocol for detection of suspected drug resistance 
would also be very useful. 
Regarding other drugs such as the antischistosomals, no evidence of drug resistance to 
metrifonate has so far been reported. However, with oxamniquine and hycanthone, drug 
reistance has been located both in the field and the laboratory since the 1970's (De Silva 
et al, 1997). With Praziquantel, two recent developments have raised concerns. One 
report described low cure rates in infected patients in Senegal (Stelma et al, 1995), 
while another showed diminished susceptibility to praziquantel in a schistosome isolate 
from the same area in Senegal (Fallon et al 1995). 
The threat of drug resistance emerging is therefore ever-present and development of 
new anthelmintics to take the pressure off the main-stream anthelmintics is therefore a 
necessity. 
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1.10 The need for new anthelmintics. 
Effective agents are needed against systemic infections that respond inadequately to 
current drugs e. g. the filariases, echinococcosis, fascioliasis, dracunculiasis, trichinosis, 
toxocariasis and cysticercosis. The discovery of agents effective against all 
developmental stages of parasitic helminths, e. g. adult filarial worms, would constitute a 
major advance (Hardman & Limbird, 1996). 
Unfortunately, owing to the majority of helminth infections being non-life threatening 
there is sometimes a lack of interest in research to develop new drugs, with more money 
being put into the development of drugs for more life threatening disease (Geary, 1999). 
The development however, of new anthelmintic drugs is highly important. This fact 
arises not only with the increasing possibility of resistance occurring within the human 
population due to the usage of the same anthelmintics for many years, but also when 
viewing the extremely high figures of helminth infection present in the world. This 
situation is highlighted in the chemotherapy of filarial infections which is currently not 
satisfactory. There is an urgent need for a new macrofilaricidal drug with only slight 
side-effects (Harder, 2002). Presently the only way is the prophylactic control of 
Onchocerca volvulus infections and treating lymphatic filariasis with ivermectin, DEC, 
ivermectin / DEC or ivermectin/albendazole combinations (Harder, 2002). Helminth 
infection, can cause much suffering in the human population with diseases such as 
trichuriasis causing stunting and poor mental development due to malnutrition (Bell, 
1995). Helminth infections also cost the veterinary and food industries many millions of 
US dollars each year, and these facts stress the importance in the development of new 
anthelmintics. 
Recently the pharmaceutical industry has started to switch to mechanism-based, ultra 
high-throughput screening (UHTS) in the discovery of new drugs. Current 
understanding of the biochemistry of parasitic helminths and of the mechanisms of 
action of known anthelminthics identifies several targets that could be formatted for 
UHTS (Thompson et al, 1996). However, knowledge of helminth biology is presently 
very poor. Thus future investment in helminth biology is a necessity, as well as is the 
continuing development and understanding of novel compounds to combat worm 
infestation . 
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Efforts in this direction, have seen the emergence of a new anthelmintic, nitazoxanide 
(Stettler et al, 2003; Juan et al, 2002; Rossignol et al, 1998). This 5 nitrothiazole was 
originally designed and tested for toxicity towards anaerobic/microaerophilic protozoa 
and bacteria and was later found to have anthelmintic properties (Rossignol & 
Maisonneuve, 1984). The primary mechanism of nitazoxanide against protozoa and 
bacteria is thought to be similar to that of metronidazole. This idea was primarily 
circumstantial in that nitazoxanide affected a similar range of organisms to 
metronidazole and had a similar nitro-group. 
1.11 Metronidazole. 
Metronidazole [1-(ß-hydroxyethyl)-2-methyl-5-nitroimidazole] is the prototype for the 
nitroimidazole class of antimicrobials. Originally introduced over 25 years ago for the 
treatment of patients with Trichomonas vaginalis (Lamp, 1999) it has an extremely 
broad spectrum of activity against anaerobic and microaerophilic protozoa and bacteria 
which is used to clinical advantage. Metronidazole has particularly high activity in vitro 
and in vivo against the protozoa Entamoeba histolytica and Giardia intestinalis (Upcroft 
et al, 1999) as well as the bacteria Clostridium and Helicobacter sp (Hardman & 
Limbird, 1996). Sensitive isolates of T. vaginalis are killed on exposure to <0.05µg/ml 
of metronidazole under anaerobic conditions (Hardman & Limbird, 1996). 
Metronidazole has also been reported to produce a 60 % cure rate for Fasciolopsis 
buski, the largest trematode to infect man (Shah et al, 1973). 
Figure 1.10: Structure of metronidazole. 
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1.11.1 Mechanism of action of metronidazole. 
Metronidazole is reductively activated within microbial cells (Samuelson, 1999). 
Metronidazole has a low midpoint redox potential (Eo') of - 486mV (Wardman, 1985) 
and is selectively toxic for organisms capable of reducing its nitro group intracellularly 
to a toxic nitro free radical. This free radical would initially be a nitro anion and be 
produced by a one-electron reduction of the nitro group. 
R-N02 +e 10 R-N02'* EQUATION I 
The reduction of metronidazole in Helicobacter pylori is carried out by an oxygen- 
insensitive nitroreductase (Goodwin et al, 1998) and in Giardia intestinalis and 
Trichomonas vaginalis by pyruvate ferredoxin oxidoreductase (Upcroft et al, 1999). 
Inside the microorganism, the nitro radical, in the presence of minute concentrations of 
oxygen produces superoxide (Smith et al, 1995). The toxic effect inside the micro- 
organism is as follows: - 
R-N02 '+ O2 l R-NO2 + 02'* EQUATION 2 
In this process the parent drug is regenerated and this had led to the term "futile redox 
cycling". Hydrogen peroxide is then formed by dismutation of 2 superoxide radicals 
into oxygen and hydrogen peroxide by superoxide dismutase (SOD). 
(SOD) 
2O2 '+ 2H+ 0 H202 + 02 EQUATION 3 
Superoxide can stimulate the production of the highly toxic hydroxyl radical OH" by 
reducing ferric or cupric ions to ferrous or cuprous ions (a) which then undergo the 
Fenton Haber-Weiss reaction with hydrogen peroxide (b). In this diffusion controlled 
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reaction the production of the very toxic hydroxyl radical is shown in the following 
equation (Halliwell & Gutteridge, 1999). 
Fe3++020- -0 Fe 2+ +02 (a) 
Fe 2+ complex + H202 = OH* + OH" + Fe3 complex. (b) 
The hydrogen peroxide and oxygen products from equation 3 are broken down by the 
detoxification enzyme catalase to oxygen and water. 
2H202 catalase 0 2H20 + Oz EQUATION 4 
The highly reactive, short lived hydroxyl radical is likely to be a major toxic product 
from nitroimidazole drugs like metronidazole. It can cause major damage to the 
synthetic machinery and DNA of the microorganism. 2-electron reduction, 3-electron 
reduction and 4-electron reduction of metronidazole also occur, which lead to the 
production of mutagenic electrophiles like hydroxylamines. 
le- le- 2e- 2e- 
e'g' R-N02 -º R-NOS''º R-NO -º R-NHOH º R-NH2 
NITRO RADICAL H+ HYDROXYLAMINE H+ AMINE 
1.11.2. Metronidazole resistance. 
Resistance to nitroimidazoles is rare despite extensive use worldwide (Edwards, 1993) 
The first report of resistance was seen in T. vaginalis about two years after 
metronidazole was first introduced (Robinson, 1962). Resistance has also been reported 
in Bacteroides fragilis (Chardon, 1977) and Mobiluncus spp (Spiegal, 1987, Sprott, 
1983). In Trichomonas spp, resistance to metronidazole and other 5- nitroimidazoles is 
characterised by a tolerance to oxygen resulting in a decreased susceptibility under both 
anaerobic and aerobic conditions (Edwards, 1993), which suggests that the organism 
becomes more resistant to oxygen in the environment. 
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1.11.3 Metronidazole versus Nitazoxanide. 
Though metronidazole is active in anaerobes and microaerophiles, the activity of the 5- 
nitrothiazoles, nitazoxanide and its metabolite tizoxanide is rather wider. The possible 
reason for this useful property is that 5-nitrothiazole moiety of nitazoxanide (NTZ) (Eo' 
-estimated at 350mV) and tizoxanide (TIZ), is reduced by a wider range of anaerobic 
and microaerophilic organisms than metronidazole, leading to a broader spectrum of 
activity (D. C. Warhurst & D. J. Meyer (2000), unpublished data ). This redox potential 
of nitazoxanide and tizoxanide is similar to that of another 5-nitrothiazole, niridazole 
(Eo' of - 390mV) (Wardman, 1985; Bassily et al, 1979) which also has a wide range of 
activity against parasites, however while niridazole is a mutagen, NTZ and TIZ are not 
(Romark Laboratories (1999) "Pharmaco-Toxicological expert report). NTZ is effective 
against Helicobacter pylori (Megraud et al, 1998) (which can cause peptic ulcer and 
lymphomas). H. pylori is able to reduce metronidazole because it has an oxygen- 
insensitive nitroreductase rdxA (Sisson et al, 2002). However, H. pylori possesses a 
PFOR which is incapable of reducing metronidazole and resistance to this drug is due to 
a defect in rdxA which renders the nitroreductase enzyme inactive and therefore stops 
reduction of metronidazole. However, strains resistant to metronidazole retain 
sensitivity to nitazoxanide (Sisson et al, 2002). This lack of reduction of metronidazole 
when the rdxA system is inactive is due to the redox potential of metronidazole being 
too negative and hence it cannot be reduced by H. pylori PFOR. The redox potential of 
nitazoxanide however is less negative and it therefore becomes likely that the H. pylori 
PFOR may be involved in the reduction of nitazoxanide (Sisson et al, 2002). This easier 
reduction of nitazoxanide and tizoxanide compared with metronidazole is supported by 
a comparison of calculated heats of formation of the reduced drugs, where the 
difference involved was estimated as 13 kcal/mol. When comparing niridazole and 
tizoxanide, this was estimated to be 3 kcal/mol (D. C. Warhurst 2000, unpublished). 
Furthermore, another differing factor of nitazoxanide and metronidazole is that the 
reduction products from nitazoxanide, although equally toxic for parasites, are not so 
indiscriminately mutagenic as those from metronidazole. The test for mutagenicity was 
carried out using the Ames test. This test using Salmonella typhimurium showed that 
nitazoxanide did not cause mutagenesis as seen with metronidazole (Romark, 
Pharmaco-Toxicological report, 1999; Sisson et al, 2002). 
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1.12 Nitazoxanide and its derivatives. 
Nitazoxanide (NTZ) is 2-acetyloxy-N-(5-nitrothiazol-2-yl) benzamide and was first 
described in 1975 by Rossignol & Cavier. Derivatives of nitazoxanide include the 
metabolite tizoxanide (TIZ), denitro-nitazoxanide (DNNTZ), denitro-tizoxanide 
(DNTIZ), the excretory metabolite tizoxanide glucuronide (TIZg) and 2-benzamido-5- 
nitrothiazole (BZNT). Experimentally DNNTZ and DNTIZ are used to investigate the 
role of the nitro group. 
* For structures of DNNTZ, DNTIZ and BZNT see Appendix III 
Figure 1.11: Structures of nitazoxanide, tizoxanide and tizoxanide glucuronide. 
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Nitazoxanide is metabolised rapidly to tizoxanide, which is itself a potent antibacterial 
and antiparasitic agent (Dubriel et al, 1996). Further metabolism of tizoxanide leads to 
the formation of the glucuronide conjugate (Rossignol & Stachulski, 1999). 
1.12.1 Pharmacokinetics. 
Nitazoxanide is only partially absorbed from the gastro-intestinal tract, and 65% of the 
metabolised drug is excreted in the faeces (Broeckhuysen et al, 2000). At least 32 % of 
a 500mg oral dose is absorbed, much of which is secreted as the metabolite, tizoxanide 
glucuronide, in the bile. (see fig 1.12). Upon absorption, the acetyloxy group of 
nitazoxanide is rapidly hydrolysed to its first metabolite, tizoxanide, which is highly 
active against the same range of organisms as nitazoxanide (see figure 1.11). The final 
metabolite, a glucuronide conjugate (tizoxanide glucuronide), is less active, and is 
found in the plasma and urine and at high concentrations in the bile (Broeckhuysen et 
al, 2000). No trace of nitazoxanide can be found in either plasma or urine after the 
single dose oral administration (Stockis et al, 1996). This pattern of absorption shows 
that nitazoxanide could have antiparasitic effect both systemically and locally 
throughout the gastro-intestinal tract. 
The metabolism of nitazoxanide has been investigated in vitro, in laboratory animals 
and in man, by studying the fate of radio-labelled drug and by cold analytical techniques 
including mass spectrometry and HPLC (Broeckhuysen et al, 2000). The de- acetylation 
occurs spontaneously over time in aqueous solution and is pH and temperature 
dependent, with more rapid de- acetylation at lower pH and higher temperature. In 1M 
HCI, 50 % of NTZ hydrolyzes to TIZ in 30 minutes and complete hydrolysis is 
observed after 8 hours. At 0.1M HCl (pH 1- stomach) less than 10% of NTZ hydrolyzes 
to TIZ. It is therefore not likely that NTZ hydrolyzes significantly in the stomach due to 
acid (D. J. Meyer 2000, unpublished data). The de-acetylation, probably occurs much 
more rapidly by the action of simple esterase enzymes, which are widely distributed in 
many mammalian tissues and intestinal secretions, as well in the microorganisms of the 
gut flora. The enzymatic de-acetylation is a very rapid process which probably accounts 
for the absence of detectable intact nitazoxanide from plasma and excreta (Romark, 
Pharmaco-Toxicological report, 1999; Stockis et al, 1996). 
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Figure 1.12: Absorption of nitazoxanide. 
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Fig 1.12: After absorption of a 500mg dose of nitazoxanide, the drug rapidly hydrolyses in the body 
to form its primary metabolite tizoxanide, which has a reactive hydroxyl group. This hydroxyl group 
facilitates glucuronidation and excretion in the urine and faeces (Broekhuysen et al, 2000). The fact 
that tizoxanide can form a glucuronide may account for the lack of significant toxicity to the host 
and explains why the drug is best suited for activity in the intestinal tract. 
1.12.2 Physiochemical properties. 
X-ray study of yellow crystals of tizoxanide carried out by Dr. John Lisgarten and Prof 
Rex Palmer of Birkbeck College London (unpublished observation), shows that the two 
rings are completely coplanar, and linked by an H-bond between >N-H and the phenolic 
-OH, which effectively gives a three ring structure (see Appendix 
III). At pH 4.0 
solutions of tizoxanide are colourless with an absorbance peak of approximately 350nm. 
At pH 7.0 the tizoxanide solution is yellow with a peak absorbance of approximately 
409nm. This indicates that the yellow species is the anion. At pH 4.0 tizoxanide is non- 
planar. At pH 7.0 however tizoxanide loses a proton and becomes a planar anion. Since 
the pKa of NTZ and TIZ is slightly acidic at 5.9 and 5.25 (see table 1.3) respectively, 
both are proton donors at around pH 5.0. One interesting characteristic of NTZ/TIZ is 
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their high plasma protein binding and studies using ultrafiltration found less than 1% 
NTZ and TIZ unbound in plasma (Romark laboratories investigation brochure, 1999). 
This would cause a significant depression of NTZ/TIZ availability in the blood stream. 
NTZ at excitation 350nm, emission 480nm shows a high relative fluorescence (91 
RFU) compared to TIZ and TIZg (see table 1.3). This fluorescence is lowered when the 
wavelength is increased to 414nm, emission 500nm. DNNTZ and DNTIZ demonstrate 
very high fluorescence at 350nm, emission 480nm, which is significantly decreased 
with an increase in wavelength. 
Table 1.3 Physiochemical properties of NTZ and related drugs 
(D. J. Meyer. unpublished. 2000). 
NTZ TIZ TIZg DenitroNTZ DenitroTlZ 
pKa' 5.9 5.25 7.1 6.1; 9.1 6.0; 7.3 
P 18.0 19.6 
E01(mV)3 --350 --350 --350 
Fluorescence 91 44 51 167 5400 
Fluorescence 38 10 10 13 14 
'Measured by scanning spectrophotometry. 
2 Partition coefficient between phosphate- buffered saline (pH 7.0) and 1- octanol at 37°C. 3 Estimated using spinach NADPH ferredoxin reductase and ferredoxin to reduce various 
nitro- compounds (including those of known Ea) and following oxygen uptake (hence 
superoxide formation) in a 0.5m1 Rank oxygen- electrode cell. 
4 Relative fluorescence units using Spectramax Gemini plate-reader to obtain optimal 
wavelengths, then make fixed- wavelength readings: excitation 350nm, emission 480nm. 
5 As above, excitation 414nm, emission 500nm. 
NTZ and TIZ are weakly lipophilic with calculated log P, (P= distribution ratio 
between octanol and water at equilibrium) values of 1.8 and 2.02 respectively (see 
table 1.4). These log P values are high enough to allow absorption through the cuticle 
of a nematode, though levamisole and ivermectin which have higher log P values 
would be more readily able to cross nematode cuticles. The lower log P value of NTZ 
and TIZ suggests that any possible drug effect on nematodes would be delayed 
compared with that of LEV and ivermectin. In order for NTZ and TIZ to be 
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protonophores, they would need to be readily lipophilic to dissolve in the 
mitochondrial membrane and have a pKa around 5.0. 
Table 1.4 Lipophilic values (Los P) and other features of anthelmintic drugs. 
Log P (calc) Log P 
measured 
Proton acceptor Proton donor 
Nitazoxanide 1.8 1.67 7 1 
Tizoxanide 2.02 2.10 5 2 
Mebendazole 2.52 2.71 5 2 
Prazi uantel 2.16 4 0 
Ivermectin A 5.60 10 2 
Levamisole 2.79 2.87 2 0 
Niclosamide 3.51 4.56 4 2 
CCCP 3.15 3.38 1 1 
A high number proton acceptor shows that the compound is more hydrophilic. 
1.13 Clinical usage. 
In the United States nitazoxanide has been used as an investigational new drug for the 
treatment of diarrhoea caused by Cryptosporidium parvum and microsporidia in patients 
with AIDS. The anticryptosporidial activity of NTZ was first reported by Doumbo et al, 
in 1997. The results of a double blind, placebo- controlled study of NTZ in 66 Mexican 
AIDS patients with cryptosporidiosis demonstrated the efficacy of the drug. A 500mg 
dose twice a day for 14 consecutive days or a 100mg dose twice a day for 14 
consecutive days had a cure rate of 63% and 67% respectively. These groups differed 
statistically compared to placebo with P values of 0.016 and 0.013 respectively. 
Diarrhoea was also resolved in 90% of the patients who exhibited eradication of the 
cryptosporidium infection in this trial. (Rossignol et al, 1998). Soave, 2002 reported the 
results of a study carried out in the United States, in 30 AIDS patients with 
cryptosporidial diarrhoea who did not respond to other potential treatments. Ten of the 
twelve with CD4 count below 54cells/mm3 (83%) who completed at least 12 weeks of 
treatment with NTZ eradicated the parasite (Soave and Davis 2002). A double blind 
placebo controlled study of NTZ in 50 adults and 50 children in Egypt showed clinical 
and parasitological response of 80% and 67% respectively (p<0.0001 for the entire 
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population) and this was the first trial to study treatment of cryptosporidiosis in 
immunocompetent individuals (Rossignol et al, 2001). However recent clinical trials in 
Zambia have shown treatment with NTZ produces cure rates of 52% of 
Cryptosporidium in HIV- seronegative children, whereas HIV-seropositive children did 
not benefit from NTZ treatment. (Amadi et al, 2002). 
In November 2002, nitazoxanide was Romark's first product to reach the market in the 
United States and is marketed as AliniaTM. Alinia was approved by the Food and Drug 
Administration (FDA) as an oral suspension for the treatment of diarrhoea caused by 
Cryptosporidium parvum or Giardia intestinalis in children from 12 months to 11 years 
of age. (Romark Labs, 2001). Romark is currently pursuing FDA approval to market 
Alinia tablets in the United States for the treatment of diarrhoea caused by 
Cryptosporidium parvum and Giardia intestinalis, including Cryptosporidium-induced 
diarrhoea in patients with AIDS. 
In Latin America nitazoxanide 500mg film-coated tablets, 200mg dispersible tablets 
and a 100mg/5m1 paediatric suspension are marketed. These are used for the treatment 
of a broad spectrum of parasitic diseases that are common in the developing world and 
also for treatment of diarrhoea caused by C. parvum and microsporidia in AIDS patients 
(Romark Labs, 2001). 
1.14 NTZ activity against anaerobic protozoa and microaerophilic bacteria. 
Nitazoxanide has activity against the organisms described earlier for metronidazole 
e. g. Giardia intestinalis, Entamoeba histolytica, and the Bacteroides fragilis group 
(Dubreuil et al, 1996). Nitazoxanide also kills other species including 
Propionibacterium spp, and Bifidobacterium spp (Dubreuil, 1996), Clostridium dicile 
(McVay, 2000) Cryptosporidium parvum (Gargala et al, 2000), Blastocystis hominis 
and Isospora belli (Romero Cabello, 1997). 
In vitro nitazoxanide and tizoxanide have shown very ° good activity against E. 
histolytica (strain HM1) with concentrations of 0.06 µg/ml* inhibiting 100% growth of 
the parasite. This compares favourably to metronidazole, which only gave 100% 
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inhibition at 0.12gg/ml (Adagu et al, 2002). With G. intestinalis tizoxanide was 8 times 
as active as MTZ and is twice as active as MTZ in a resistant strain. Nitazoxanide and 
tizoxanide have also been demonstrated to be effective against 16 metronidazole- 
resistant clinical isolates of T. vaginalis cultured in aerobic and anaerobic conditions. In 
aerobic conditions all strains were resistant to metronidazole with MLC50 of 100µg/ml. 
NTZ and TIZ were effective against all strains with MLC5os of 1.6 and 0.8µg/ml 
respectively. In anaerobic conditions all strains had decreased sensitivity to 
metronidazole with a MLC50 of 12.5µg/ml. NTZ and TIZ were effective with MLC50's 
of 1.6 and 0.4µg/ml respectively (Adagu et al, 2002). 
(* For conversions of µg/m1 to µM for NTZ and related compounds, see Appendix IV). 
One important finding with regards to nitazoxanide is its activity against C. parvum. C. 
parvum was cultured in vitro using the MDBK cell line, selectively cloned to make 
them susceptible to the parasite. After 48 hours of incubation the cultures were read 
using an immuno-fluorescent technique, and it was seen that nitazoxanide reduced the 
percentage of cells infected compared to the controls by 93% and 44% for 
concentrations of 10µg/ml and 1 gg/ml respectively (Theodos et al, 1998). In vivo 
nitazoxanide reduced the number of oocysts in ICR female mice by 57.7% and 95.7% 
for 100 and 150mg/kg respectively when compared to the control animals (Romark 
Pharmaco Toxicological Report, 1999). This activity against C. parvum, shows the 
benefits of nitazoxanide over metronidazole which has no effect against this parasite. 
1.15 Nitazoxanide and helminths. 
Nitazoxanide has a broad action against helminths and in clinical trials, it has 
demonstrated promising cure rates (Davila-Gutierrez et al, 2002). A 3-day treatment 
course was reported to be effective in treating helminth infections caused by Ascaris 
lumbricoides, hookworms, Trichuris trichiura, Taenia saginata, and Hymenolepis nana 
(Rossignol et al, 2001; Davila-Gutierrez et al, 2002) (see table 1.5). The fact that 
nitazoxanide affects the same anaerobic species as metronidazole as well as having 
activity against helminths suggests that it may have a similar mode of action but with 
important differences. 
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Recent clinical trials of a standard 3-day course of NTZ against helminths have shown 
cure rates comparable to the standard single 400mg dose of albendazole in the treatment 
of ascariasis, to praziquantel (25mg/kg) in the treatment of hymenolepiasis and a higher 
cure rate than a single 400 mg dose of albendazole in the treatment of trichuriasis (Ortiz 
et al, 2002). Nitazoxanide compares well with praziquantel and albendazole, with all 
three drugs producing egg reduction rates in excess of 98% in ascariasis, trichuriasis 
and hymenolepiasis (Juan et al, 2002). 
Table 1.5 Efficacy of nitazoxanide against helminths. 
Species/level of infection Dose % Cure 
A. lumbricoides (Nematode) 
Light 45mg/kg dose 96% 
Moderate divided into 6 doses 82/ 
over 3 day period 
Heavy 
(7.5mg/kg twice/day) 48% 
T. trichiura (Nematode) 
Light 45mg/kg dose 80% 
divided into 6 doses 
Moderate over 3 day period 56% 
Hookworms (Nematode) As above 96% 
Hymenolepis nana (Cestode) 
Light As above 93% 
Moderate 84% 
Taenia saginata (Cestode) 30mg/kg dose divided 95% 
into 6 doses over 3 
days 
F. hepatica (Trematode) 7.5mg/kg twice/day 87% 
for 7 days 
(Unpublished Romark data, 1999) 
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Apart from a heavy infestation with A. lumbricoides (48% cure) or a moderate infection 
with T. trichiura (56% cure), the efficacy of nitazoxanide meets the World Health 
Organisation standard for an antiparasitic drug by having a cure rate above 60% (WHO, 
1990). Cestodes are particularly susceptible with cure rates of 93% and 95% for H. 
nana and T. saginata respectively. 
1.15.1 In vitro activity of NTZ against helminths. 
With the trematode Fasciola hepatica, nitazoxanide at 32µM in vitro caused rapid 
contraction, ventral curling and eventually death (Romark laboratories & Malone, Final 
Report, 1995). Tizoxanide was as effective but over a longer period of time. At the 
lower concentration of 3µM, NTZ was still toxic, but death of the fluke could take up to 
3 days. 
In vitro studies using Echinococcus multilocularis, showed vacuolisation of the 
germinal layer of the metacestode, damage to the microtriches and separation of the 
laminated and germinal layer when exposed to 32µM NTZ (Stettler et al, 2003). 
1.16 Toxicity of NTZ. 
At therapeutic doses, NTZ has low toxicity when given orally. Toxic manifestations at 
high doses include loose stools, emesis (observed in dogs) and anaemia (Romark, 
Pharmaco-Toxicological report, 1999). Studies carried out by Romark (unpublished, 
data) show that NTZ is not teratogenic and does not affect fertility nor impair peri- and 
post-natal development. 
1.17 Possible Mechanism of action of NTZ. 
Although it is almost two decades since the introduction of nitazoxanide, it has only 
been recent work which has demonstrated the broad- spectrum anti-parasitic properties 
of the drug. The mode of action of nitazoxanide and its derivatives is as yet not 
completely known but preliminary tests have shown a number of possibilities. One 
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possibility, is that nitazoxanide undergoes a one electron reduction in a similar way to 
metronidazole. This has been demonstrated using spinach NADPH ferredoxin reductase 
(D. J. Meyer 2000, Unpublished data). Another possibility is that nitazoxanide acts as a 
protonophore (D. C. Warhurst 2000, Unpublished data). 
1.17.1 Possible mechanism of action of NTZ against anaerobic protozoa/ 
microaerophilic bacteria: Effect of the nitro group. 
As described earlier (section 1.11), the reduction of the nitro-group of metronidazole 
yields very reactive metabolites and hence very good activity against anaerobic 
intestinal parasites. Nitazoxanide and tizoxanide (see Fig 1.11) also have a nitro-group, 
which could undergo one electron reduction and recycling like metronidazole to yield 
significant amounts of superoxide radical anion (D. J. Meyer 2000, unpublished data), 
and hence become toxic to the anaerobic protozoa and microaerophilic bacteria. 
Comparing NTZ/TIZ to DNTIZ, the latter shows very poor activity against E. 
histolytica, G. intestinalis and T. vaginalis suggesting that the nitro-group is essential 
for anti-protozoal activity (Adagu et al, 2002). 
TIZg the glucuronide metabolite of TIZ has a weaker in vitro antiparasitic activity, 
possibly because of its reduced cellular uptake (see figure 1.13) (Adagu et al, 2002). 
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Figure 1.13. Comparison of inhibitory effects of TIZ, DNTIZ and TIZ2 
on E. histolytica, G. and T. naginalis. 
ICso 
µM 
Data from AdaQu ei a!, 2002 
Figure 1.13: TIZ shows good activity against E. hisiolvtica, G. intestinalis and T. 
vaginalis. DNNTZ and TIZg show a much weaker activity. 
1.18 Possible mechanism of action of NTZ against helminths. 
Nitazoxanide is active against nematodes, cestodes and trematodes. The mechanism of 
its anthelmintic activity is not fully understood, but there are a number of possibilities. 
While the nitro-reducing capabilities of parasites are an essential requirement for its 
action against anaerobic protozoa, this does not aid the explanation of the mechanism of 
NTZ in helminths, which are incapable of reducing metronidazole. 
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1.18.1 Drue reduction in helminths. 
Nitazoxanide as stated is thought to work against protozoa by reduction of the nitro- 
group and hence produce a free radical toxic to the parasite. However, the pyruvate 
ferredoxin oxidoreductases which reduce metronidazole and NTZ are not present in 
helminths. Drug reduction could still be a factor, as members of the oxygen-insensitive 
nitroreductases (Bryant & DeLuca, 1991) have been identified in the Caenorhabditis 
elegans genome. These nitroreductases strongly resemble the FMN linked 
nitroreductase from Enterobacter cloacae which utilises NAD(P)H. (Bryant & DeLuca, 
1991 see Appendix V) The E. cloacae reduces nitroaromatic compounds e. g. 
nitrofurans and nitrobenzenes to mutagenic metabolites (Bryant et al, 1991) and a 
similar FrxA (qv) from Helicobacter, will reduce nitazoxanide (Sisson et al, 2002). If 
this enzyme occurs in other helminths it could provide a mechanism for reducing 
nitazoxanide and thereby provide an anthelmintic effect. 
1.18.2 NTZ as a protonophore. 
Analysis of the structure, spectral properties and partition coefficients of (nitazoxanide 
and) tizoxanide would suggest the drug could be a protonophore. Both an NH group 
and OH group are present (see fig 1.14) in a relationship seen in the known uncoupler 
niclosamide. The pKas of TIZ and NTZ and partition coefficients between PBS and 
octanol (see table 1.3) also suggest that NTZ and TIZ are uncouplers (D. J. Meyer 2000, 
unpublished). Both TIZ and NIC have a weakly acidic >NH group attached to an 
aromatic ring, The nitro group withdraws electrons from >NH which reduces proton 
attraction and the pKa value of proton release to around 4-8. The more easily 
dissociated is the proton from >NH, the higher will be the uncoupling power. Another 
major feature of the molecule is lipophilicity. The higher the log P value, the higher will 
be the uncoupling power. This is because uncouplers need to carry H+ through the 
mitochondrial inner membrane. TIZ and niclosamide have high log P values and the 
potential to donate protons, thus making them good uncouplers Structural comparison 
with levamisole suggest that this drug could not donate a proton, and although the log P 
value is high, levamisole would not have any uncoupling properties. 
69 
Chapter 1 1»iroduclion 
Figure 1.14. Structures of tizoxanide and niclosamide showing possible 
protonophoric groups. 
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Possible protonophore groups. 
The potential protonophoric activity of NTZ and TIZ were (hence) examined and 
confirmed by uncoupling respiration of cultivated human Caco-2 intestinal cells and 
proton-leakage in Giardia (table 1.6) (D. J. Meyer 2000, unpublished). 
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Table 1.6 Table showing arotonoahoric action of NTZ. TIZ, TIZ2 and NIC on 
cultivated human intestinal Caco-2 cells. 
Compound U50' (µM) U50 (µM) 
With 1% BSA 
Concentration (AM) causing 50% 
increased Caco-2 cell respiration. 
NTZ 1.0 6.5 35 
TIZ 0.3 6.5 10 
TIZg >20 >60 No detectable effect 
Niclosamide 0.05 4 3 
1 concentration causing 50% uncoupling, i. e 50% conversion of state IV rate to state 
III rate of oxygen uptake in liver mitochondria. 
Table 1.6: shows protonophoric activity of NTZ and TIZ with clear uncoupling evident with mouse liver 
mitochondria. TIZg shows much lower protonophoric activity and this agrees with the lower anti- 
protozoal potency of this compound. In the presence of 1% bovine serum albumin (BSA) the activity of 
both NTZ, TIZ and niclosamide was diminished showing that the binding of serum albumin to these 
drugs dramatically lowers their potency. 
The role of protonophoric activity with regards to the anti-protozoal action of NTZ has 
previously been examined by comparison with the effects of other protonophores (D. J. 
Meyer 2000, unpublished). Growth of both G. intestinalis and T. vaginalis were 
sensitive to NTZ and TIZ as well as to protonophoric uncouplers lacking a nitro-group 
(CCCP or FCCP) (see table 1.7) showing that this property of NTZ/TIZ could 
contribute to its anti-protozoal activity. The protonophoric anthelmintic agent 
niclosamide also inhibited the growth of T. vaginalis. If an uncoupling effect of 
nitazoxanide could be demonstrated in helminths, it would suggest that NTZ/TIZ may 
have a similar mode of action as niclosamide. 
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Table 1.7 Inhibition of `anaerobic' protozoal growth by nrotonophores' 
Compound E. histolytica HMI(s) G. intestinalis EBE (s) T. vaginaliS ATCC50143 (r) 
150 (µM) 
FCCP - 12 1.3 
CCCP >80 - 1.4 
Niclosamide - - 3 
TIZ 11 2.3 3 
MTZ2 18s 52r* 6s 15r * 3.9s* 59.6r 
1 1. S. Adagu, D. J. Meyer, unpublished. 
2 Metronidazole (MTZ) (not a protonophore) comparative values (Adagu et at, 2002); 
s= MTZ- sensitive strain; r= MTZ- resistant strain. 
* MTZ resistant strain of a) E. histolytica = HK9C2; b) G. intestinalis = JKM 1. 
MTZ sensitive strain of T. vaginalis = PER 0 13/EPM. 
1.18.3 Potential neuromuscular activity of NTZ. 
Selective neuromuscular toxicity against helminths may also be a mode of action of 
NTZ. Drugs like levamisole and pyrantel, utilise this mode of action against helminths. 
Both drugs are agonists for nicotinic acetylcholine receptors (nicotinic AchRs) (Martin 
et al, 1997) and after treatment, cause expulsion of the worm from the host. In vivo trials 
of nitazoxanide have demonstrated, that after drug treatment, the worm is expelled from 
the host (Romark 1999, unpublished data), an action consistent with a neuromuscular 
agent. This expulsion of parasites due to treatment with nitazoxanide could suggest a 
neuromuscular effect on the worm, similar to that of a known neuromuscular agonist. 
However expulsion can also result due to worm death or the worm ceasing movement. 
1.18.4 Possible enzyme effect. 
Another possible mode of action of nitazoxanide is the possible inhibition of essential 
parasite enzymes. Drugs like pyrantel, inhibit parasite acetylcholinesterase, causing an 
accumulation of acetylcholine leading to an excessive effect at the neurotransmitter. It is 
a possibility that NTZ action on the helminth may involve this mode of action. 
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The inhibition of fumarate reductase has also been proposed as a potential mechanism 
of NTZ by Kuramochi et al, 1995. Inhibition of this enzyme would inactivate a cycle 
within the helminth essential for anaerobic metabolism. Another possibility is (as 
mentioned) that helminths possess a nitroreductase type enzyme, which would be able 
to reduce the nitro-group of nitazoxanide in a similar mechanism to that of 
metronidazole i. e a drug-activation process by a parasite enzyme and not the inhibition 
of an enzyme. 
1.18.5 Anti tubulin activity of NTZ. 
Another mechanism of action proposed for NTZ is that NTZ could act like a 
benzimidazole drug and prevent ß-tubulin polymerising into microtubules. This 
mechanism has been investigated by D. J. Meyer using bovine brain tubulin (Sigma, 
UK). The results showed, as expected a significant inhibition of tubulin polymerisation 
by 34µM mebendazole (120% of control) and a good inhibition of tubulin by 83µM 
thiabendazole (58% of control). DMSO, 65µM NTZ and 57µM TIZg showed no tubulin 
inhibition. However, 38µM TIZ gave a slight reduction in bovine tubulin (79% of 
control), but this was found later to be due to the drugs insolubility at this concentration 
(D. J. Meyer 2000, unpublished data). This data would suggest that NTZ produced no 
inhibition of the bovine brain tubulin polymerisation. Further investigation is necessary 
as to confirm this observation. 
1.19 Selection of helminths to study NTZ activity/mechanisms. 
In order to study the anthelmintic drug mechanism of NTZ etc, the free-living 
Caenorhabditis elegans was chosen as a nematode model. Effects were compared to 
effects of known anthelmintics. Further investigation was then carried out to compare 
drug effects observed with Celegans to those with parasitic nematodes, and with 
helminths from the Classes Cestoda and Trematoda. 
73 
Chapter 1- Introduction. 
1.19.1 Caenorhabditis ele ans. 
Caenorhabditis elegans is a small, free-living soil nematode that has been reported 
from many parts of the world (Wood 1988). It primarily feeds on bacteria and 
reproduces with a life cycle of about 3 days under optimal conditions, consisting of four 
larval stages (L1-L4) and the adult stage. There are two sexes of C. elegans, males and 
hermaphrodites. Each of these sexes, about lmm in length as adults, differ slightly in 
appearance (see figure 1.15). 
Figure 1.15 Major anatomical features of a) hermaphrodite and 
b) male C. eleFans. (Wood, 1988). 
a) 
b) 
spicules 
ray% 
Hermaphrodites produce both oocytes and sperm and can reproduce by self- 
fertilization. Males which are only found at a low frequency in the population - 0.2%, 
can fertilize hermaphrodites; hermaphrodites cannot fertilize each other. 
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A hermaphrodite that has not mated lays about 300 eggs during its reproductive life span 
(Wood, 1988). Juvenile worms hatch and develop through four larval stages (see figure 
1.16), punctuated by moults with no metamorphosis. The mature adult emerging from the 
fourth moult is fertile for about 4 days and then lives for an additional 10-15 days. Upon 
starvation and overcrowding, an alternative third developmental stage, the clatter stage, 
accumulates in a population. Dauer larvae are arrested in development and can survive 
for several months (Broeks, 1997). In recent studies, this non-feeding dauer larvae stage 
has been shown to have an increased reliance on anaerobic respiration for energy 
production (Tartar & Rand, 2002). 
Figure 1.16 Life cycle of C. elegans. 
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Figure 1.16 taken from http: -/ t w2. nrcgill. ca biology labs "0v l ecvcle. htm 
Figure 1.16 represents the liiecycle of C. elegans at 25°C. As the temperature decreases. the length oi'each 
stage increases. 
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1.19.2 C. elegans as an organism for molecular research. 
C. elegans has many qualities that are advantageous for molecular biological research 
(Broeks, 1997) It is a simple organism both anatomically and genetically (Wood, 1988) 
and has a very short life cycle (Burglin et al, 1998). The adult hermaphrodite has only 
959 somatic nuclei, and the adult male has only 1031. The haploid genome size is 8x107 
nucleotide pairs, about eight times that of the yeast Saccharomyces or one-half that of 
the fruit fly Drosophila (C. elegans sequencing consortium, 1988). 
C. elegans is easily maintained in the laboratory, where it can be grown on agar plates 
with Escherichia cola as food source, or axenically in complex liquid media. Individual 
animals are conveniently observed and manipulated with the aid of a dissecting 
microscope, and large numbers can be grown in mass culture. The use of C. elegans in 
an experimental drug assay is very convenient, owing to the fact that the worms are 
transparent throughout their life cycle and that their development can be followed at the 
cellular level in living preparations by light microscopy. Mutants are readily obtained 
following chemical mutagenesis or exposure to ionizing radiation (Wood, 1988). 
Uncoordinated mutants have helped identify a large number of molecules which 
function in the nervous system (Richmond & Jorgensen, 1999). 
1.19.3 C. elegans as an experimental organism for study of anthelminthics: 
Advantages and disadvantages. 
Cultures of C. elegans were originally proposed to have utility in anthelminthic 
screening almost 20 years ago (Simpkin & Coles, 1981). Free-living nematodes such as 
C. elegans can provide a biochemical standard for comparison with their many parasitic 
cousins (Rothstein, 1974) and represent a good source of biological material for 
research. While discovery of new anthelmintic templates using a primary C. elegans 
screen has not been notably successful, this organism has provided an exceptionally 
valuable model for research on the basic pharmacology of anthelmintic drugs (Rand & 
Johnson, 1995). 
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The use of free-living nematodes as experimental animals for biochemical 
investigations offers several distinct advantages (Rothstein, 1974). The most important 
of these is that the organisms can be grown in axenic media, which removes the 
presence of secondary organisms which could complicate experimental results. 
It is moderately easy to detect drug effects in cultures of C. elegans by monitoring the 
behaviour, survival and/or reproduction of the worm. Drugs that reduce motility or 
survival, such as levamisole and the AM (avermectins and milbemycins) class, can be 
detected in these cultures at low concentrations, and their potency against C. elegans is 
a reasonable predictor of potency against parasitic nematodes in culture. Nicotinic 
receptor agonists have specific and easily assayed effects on several aspects of C. 
elegans behaviour including locomotion, feeding and egg-laying (Waggoner et al, 
2000). However, in vitro testing is not comparable to in vivo results. Furthermore, the 
tetrahydropyrimidines, morantel and pyrantel, which act with similar potency to 
levamisole at parasitic nematode nicotinic receptors (Martin, 1997) are in vitro 50 to100 
fold less potent respectively than levamisole against C. elegans (Simpkin and Coles, 
1981). Differences in vivo between the tetrahydropyrimidines and levamisole are much 
less marked. In addition, the benzimidazoles (anti tubulin drugs) e. g. mebendazole, 
typically show low potency and slow onset of activity against C. elegans compared to 
their effect on parasitic helminths (Geary 1999). Finally, closantel, a salicylanilide 
similar to niclosamide with potent activity against H. contortus in vivo (Rothwell, & 
Sangster, 1993), is only weakly active against C. elegans. 
Perhaps the most important disadvantage of the use of C. elegans as a model to 
estimate intrinsic potency of anthelmintics against parasitic nematodes are the large 
differences that are present in the life styles. The conditions that can be tolerated by a 
free-living nematode in culture compared to a parasite adapted to various host 
environments will in all likelihood show many differences. For example, a parasite in 
the host, will be affected in varying degrees to temperature, availability of nutrients, 
host immunity, threat of digestive enzymes etc, whereas a worm in culture will most 
likely be tested in ideal conditions. Subtle drug-induced alterations which result in 
expulsion of worms from a host, may be difficult to detect in culture. Geary, (1999) 
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points out that although the in vitro system can usually be manipulated to detect known 
anthelmintics, it is poorly suited to characterize the intrinsic potency of new compounds 
with unknown mechanisms of action. 
1.19.4 C. elegans end ome. 
The C. elegans genome project was the first animal genome to be completed, around 
Christmas 1998. From the genome sequence, 19099 genes have been identified and 
novel features of gene organisation and chromosomal structure discovered (Blaxter, 
2003). The cDNA data obtained from mRNA is used in the prediction of genes from the 
genome sequence along with database searches on the genomic sequence for similarities 
to genes of other organisms (such as parasitic worms and even humans) (Blaxter, 2003). 
C. elegans has proved to be an invaluable tool for the understanding of vertebrate 
neuronal growth and pathfinding, apoptosis and intra- and inter-cellular signalling 
pathways. It is also proving to be a powerful model for studying host-pathogen 
interactions. 
1.19.5 Use of cultured parasites for drug testing. 
Parasitic nematodes cannot yet be raised in continuous culture, though maturation of 
larvae to egg laying adults has been obtained (Stringfellow, 1986) e. g with 
Nippostrongylus brasiliensis. However other adult nematodes such as Ascaris 
lumbricoides can only be studied for brief periods outside of the host, due to unsuitable 
conditions for prolonged in vitro culture. It would be of enormous benefit to helminth 
research if parasitic worms could be raised in the laboratory throughout their lifecycle 
as this would enable a greater potential to study their biology and observe the effect of 
drugs. Systems for maintaining adult stages in culture, following isolation from the host, 
are plagued by a continuous drop in viability, complicating the interpretation of most 
drug toxicity tests (Geary, 1999), with the exception of neuromuscular "rapid onset, " 
drugs. Variation in culture success is seen with some species e. g, Trichostrongylus 
colubriformis and Nippostrongylus brasiliensis, which are more robust in culture than 
Haemonchus contortus. 
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Recently it has been possible to use in vitro cultures of Schistosoma mansoni, S. 
japonicum, Hymenolepis diminuta and Rodentolepis (Hymenolepis) microstoma to carry 
out drug testing (Behnke, 2000). The entire life cycle cannot be maintained in vitro, but 
certain stages of the life cycle (e. g. schistosomulum or cysticercoid) can be maintained 
for a period of time long enough to test drug activity. Short-term in vitro cultures of 
schistosomes and cestodes are generally found useful in drug screening. 
79 
Aims of Project. 
Currently the situation of chemotherapy in human disease due to helminths is reported 
as satisfactory (Harder, 2002). However owing to a lack of interest, there are relatively 
few new anthelmintics becoming available (Geary, 1999). In the veterinary field, this is 
a problem owing to an increase in resistance (Prichard, 2002; Conder and Campbell, 
1995) and there remains a potential risk of resistance occurring in humans. A new 
broad-spectrum anthelmintic would have many advantages, not only in easing treatment 
of helminth infections in the veterinary field but would also help ease the increasing 
pressure in humans. 
As mentioned, the 5-nitrothiazole, nitazoxanide is active against a wide range of 
protozoan parasites (e. g. E. histolytica, G. intestinalis, T. vaginalis, H. pylori and C. 
parvum) and bacteria. NTZ however, has also demonstrated good activity against 
helminths with good cure rates being demonstrated with A. lumbricoides, T. saginata 
and F. hepatica. However, the activity of this drug against helminths is not yet fully 
understood. This study was therefore designed to investigate the in vitro anthelmintic 
mechanism of nitazoxanide, its metabolites tizoxanide and tizoxanide glucuronide and 
the derivatives, denitro-nitazoxanide, denitro-tizoxanide and 2-benzamido-5- 
nitrothiazole. 
To achieve this objective the design aimed at: 
1) Developing an in vitro assay to examine acute activity of NTZ and related drugs in 
helminths using Caenorhabditis elegans as a model. Then from initial findings to 
develop hypotheses which could be followed up. 
2) Using information derived from the model to investigate the mechanism(s) of the 
anthelmintic effect of the drugs in the parasitic nematodes Ascaris suum and the 
trichostrongylids Nematodirus spathiger and Haemonchus contortus. 
3) To extend the investigation into other Classes of helminths using Hymenolepis 
diminuta and Hymenolepis microstoma from the Cestoda and Schistosoma mansoni 
and Schistosoma japonicum from the Trematoda. A comparison of NTZ mode of 
effect between the three classes of worms could then be made. 
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2.1 Introduction. 
To investigate the mechanism of action of nitazoxanide (NTZ) and related compounds 
against helminths, various nematode, trematode and cestode worms were studied. Drug 
effect on individual classes was examined and these effects were then compared with 
effects on the other classes. Animal work for the supply of parasitic nematodes was 
kindly carried out by Keith Hunt (VLA laboratories, Weybridge), for trematodes by 
Quentin Bickle and Yaobi Zhang of LSHTM and for cestodes by Jerzy Behnke and Jill 
Brown of Nottingham University. 
2.1.1 Caenorhabditis eleeans culture. 
2.1.1.1 Plate culture. 
Bristol strain (N2) wild type C. elegans used in this study was kindly provided by G. 
Joshua of the LSHTM. Cultures were initially maintained in 9cm flat-bottomed petri- 
dishes (Sterilin) containing NGM (Nematode Growth Medium) agar (NaCl 3g (BDH 
AnalaR), agar 17g (Sigma), peptone 2.5g (Sigma), cholesterol (5mg/ml EtOH) lml 
(BDH), distilled H2O 975ml, supplemented after autoclaving with lml sterile CaC12 1M, 
lml sterile MgSO4 1M and 25m1 sterile potassium phosphate pH 6.0 iM (BDH 
AnalaR)) (Wood, 1988). Plates were seeded with 10011l of Escherichia coli OP50, a 
leaky uracil-requiring strain (Brenner, 1974) grown in LB (Luria-Bertani) medium (lOg 
tryptone, 5g yeast extract (Oxoid), lOg NaCl: made up to a litre with distilled water and 
autoclaved) (Wood, 1988). The plates were then inoculated with a few adult worms 
using a flame-sterilized platinum wire pick and allowed to develop for a seven days in a 
20°C incubator. 
2.1.1.2 Liquid axenic nematode culture. 
The nematodes were washed from the plates with 7 ml M9 axenising buffer (KH2PO4 
3g, Na2HPO4 6g, NaCI 5g, 1M MgSO4 lml (BDH AnalaR): made up to a litre with 
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distilled water) (Wood, 1988) to which was added a mixture of 1.4 ml 4M NaOH 
(BDH) and 2. lml NaOCI (70%) (Aldrich). The nematodes were then washed 3 times 
with the M9 buffer by centrifugation at 144 g for 30 seconds. The pellet, containing 
eggs (Wood, 1988) was transferred into polystyrene, filter-cap tissue culture flasks 
(Nunc) in liquid medium, containing 3% yeast extract, 1.5% peptone, 1.5% glucose and 
0.5mg of haemoglobin/ml (Sigma) [a stock solution of 5% (w/v) haemoglobin in 0.1M 
KOH was autoclaved for 10 min to generate a sterile water-soluble growth-promoting 
peptide mixture] (Vanfleteren et al, 1990). Axenic liquid cultures were stored in a 20°C 
incubator and allowed to develop for 2-3 weeks. 
2.1.2 Isolation of Dauer larvae. 
For initial assays with NTZ and related drugs, the dauer larval stage of the C. elegans 
life-cycle was chosen as it was easier for this stage to be standardised. Dauer larvae 
were isolated from starved liquid cultures by differential density sedimentation. Liquid 
cultures of the larvae were allowed to grow under gentle agitation for 12-14 days at 
20°C. 0.5 ml of the culture was then layered on top of Iml of 15% (w/v) Ficoll PM 400 
(Amersham) in 0.1M NaCl. Dauer larvae settle in the lower solution within 5 minutes, 
whereas other stages remain at the interface (Golden & Riddle, 1982). 
2.1.3 Cryopreservation of C. elegans. 
To prepare frozen stocks, two plates containing predominately starving Ll and L2 
larvae (i. e. one day after bacteria are exhausted) were used. Worms were washed off 
into lml M9 buffer and equal volume of freezing solution (5.85g NaCl, 6.8g KH2PO49 
300g glycerol, 5.6m1 NaOH 1M and H2O to 1 litre). The suspension in 0.5 ml aliquots, 
was mixed and transferred to freezing vials and placed in a styrofoam box at -70°C 
cooling at -1°C/min. Vials were then transferred to a liquid nitrogen container. To 
recover C. elegans from liquid nitrogen, cryo-preserved vials were allowed to thaw until 
solution melted. Then the contents were gently tipped onto one side of a bacteria-seeded 
9cm plate (Wood, 1988). 
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2.2 Motility assay of C. eleJans. 
Adult and L3 larvae of C. elegans were assayed for susceptibility to nitazoxanide 
(NTZ), tizoxanide (TIZ), denitro-nitazoxanide (DNNTZ), denitro-tizoxanide (DNTIZ), 
tizoxanide glucuronide (TIZg) and 2-benzamido-5-nitrothiazole (BZNT) supplied by 
Romark. A negative control, metronidazole (anti-protozoal) and positive controls, 
mebendazole, fenbendazole, niclosamide, FCCP, CCCP (to examine effect of 
protonophores) ivermectin and levamisole, were assayed in parallel for comparative 
pharmacological effects. Stocks of the drugs were prepared in DMSO to give 0.1,1,10 
and 50 mg/ml solutions and stored at -20°C. Worms were exposed to drugs in a 
concentration range of 0. lµg/ml (0.32µM) to 1OOpg/ml (320µM) (for NTZ). 
Concentrations of DMSO equal to that in the drug solutions were tested as solvent 
controls. 
C. elegans is actively motile in liquid medium. Drug assay end point was taken to be 
reduced motility, or paralysis. Paralysis could be mild or severe and transient (worms 
recovering after a period of time) or continuous. Paralytic effect could be tonic (total), 
spastic (jerking) or flaccid (limp). 
Twenty four well flat bottom culture plates (Invitrogen) were used for the assay. Drug 
dilutions for each drug were made in growth medium to concentrations of 100µg/ml, 
50µg/ml, 20. tg/ml, 10µg/ml, 5pg/ml, 2.5µg/ml, lµg/ml 0.8gg/ml, 0.5pg/ml and 
0.1µg/ml. Each well contained 2m1 axenic culture medium and drug or DMSO control 
and inoculated with 10 worms (either adults or L3 stage). Worms were staged at L3 by 
starvation to produce dauer larvae (see 2.1.2) (Golden and Riddle, 1982) and drug 
assays were carried out in triplicate. Drug effects were monitored under 20x 
magnification using an inverted microscope (Reichert-Jung, Microstar). Continual 
microscopic observation was maintained for 4 hours post worm inoculation. Then, half- 
hourly checks were made for a further 2 hours. A dose response curve was obtained 
from which the concentration of drug causing motility inhibition in 50% of the worms 
in 1 hour (M150) was calculated. The MI50 values were calculated from fitting to a 
sigmoidal log curve of [drug concentration] versus `response' using Sigmaplot 2000. 
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2.2.1 Growth of development assay of C. elegans. 
The effect of Romark compounds (NTZ and TIZ) on the development of C. elegans 
from egg to adult was also investigated. In preliminary experiments, a 1-20pg/ml 
solution of each drug in DMSO was added to the E. coil OP50 strain under sterile 
conditions with a final DMSO concentration equal to 0.1%. DMSO (0.1% w/v) was 
used separately as a negative control. Plates were then streaked with 100gl of E. cola 
and incubated at 20°C for 24 hours. Eggs from axenised culture medium were then 
added to the plates and effect on hatching and development was examined 
microscopically every 30 minutes during the day for seven days using an inverted 
microscope at 20x magnification. 
For more accurate results, axenised eggs were also injected into liquid medium 
containing 1-20µg/ml NTZ, TIZ or DMSO (0.1%) and the effect of the drugs on egg 
hatching and development again observed every 30 minutes during the day for seven 
days using an inverted microscope. 
2.3 NTZ as an agonist or antagonist of acetylcholine (Ach) receptors. 
This assay was carried out to investigate the agonistic/antagonistic effect of NTZ/TIZ 
on the nicotinic or muscarinic (Ach) receptor of C. elegans. Experiments using the 
specific ganglion blockers, pempidine and mecamylamine (Sigma-Aldrich), which 
block the nicotinic receptors in nematodes (James & Gilles, 1985) were carried out. 
Similarly, atropine (Sigma) which antagonises muscarinic action, was also used to test 
whether NTZ/TIZ were acting as muscarinic agonists or antagonists. Pempidine was 
dissolved in 1M HCl and then water to give a stock solution of 1M. Mecamylamine was 
prepared in water to give a stock concentration of SmM. Atropine was dissolved in 
DMSO to give a stock solution of 10mg/ml. 
Using the same motility assay technique as described in section 2.2, C. elegans at the 
L3 stage were pre-treated with either 10µM pempidine or 10µM mecamylamine for 20 
minutes, before the addition of NTZ/TIZ 10µg/ml (33/38µM). Worms were monitored 
continuously under an inverted microscope for 2 hours. Reverse experimentation was 
carried out by first exposing the worms to NTZ/TIZ 10µg/ml (33/38µM) for 20 minutes 
and then 10µM pempidine or 10µM mecamylamine was added. This experiment was 
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repeated using 10-30gM atropine. Worm motility was assessed in comparison to DMSO 
solvent controls. 
2.3.1 Nicotinic receptor mutant C. elegns. 
Mutants of C. elegans were obtained from the Caenorhabditis Genetics Centre 
(University of Minnesota), courtesy of Theresa Stiernagle. The mutants used were strain 
904 (unc38) (S. Brenner) a nicotinic receptor mutant and levamisole resistant. The 
second strain used was 1072 (unc29) (J. Lewis) a nicotinic receptor mutant and 
levamisole resistant (weak kinker), and thirdly strain 211 (1ev 1) (S. Brenner), also a 
nicotinic receptor mutant and levamisole resistant. Also used was strain 407 (unc49) (S. 
Brenner) a GABA mutant (uncoordinated, shrinker). 
Using the same culture techniques and drug assay conditions described in section 2.2, 
the C. elegans wild type and 4 mutants: unc29, unc381ev 1 and unc 49 were exposed to 
NTZ/TIZ at final concentrations of 1-20pg/ml. Controls of the drug diluent DMSO and 
levamisole 1-20µg/ml (Sigma) were tested in parallel. 
2.4 NTZ: Effect on acetvlcholinesterase. 
Acetylcholinesterase (AChase) from Electrophorus electricus (Sigma) activity was 
determined using 1mM acetylthiocholine iodide as a substrate in the presence of 
Ellman's reagent, 1mM 5.5' dithiobis (2-nitrobenzoic acid) in 100mM sodium 
phosphate, pH 7.0, at 20°C (Hussein et al, 1999, Ellman et al, 1961). The reaction was 
continuously monitored by measuring absorbance at 412nm, using a Perkin-Elmer 
Lambda 5 spectrophotometer and the hydrolysis of ACh was calculated from the 
extinction coefficient (E = 14000 M'lcm 1) of the coloured product, 2-nitrobenzoic acid. 
One unit of AChase is defined as 11tM of substrate hydrolysed per min at 20°C. 
Concentrations of NTZ ranging from 1-20µg/ml were included to test for inhibition of 
AChase. The positive control drug metrifonate (a known AChase inhibitor) was used at 
concentrations ranging from 1-20µg/ml. DMSO was used as a negative control. 
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2.5 Effect of NTZ on the muscle of Ascaris suum. 
2.5.1 Source and maintenance of worms. 
Adult A. suum were obtained from the University of Southampton courtesy of Lindy 
Holden-Dye. Worms were originally obtained from an abattoir and stored at 37°C in 
artificial perienteric fluid (APF) buffer (NaC1 27g, MgC12 16g, CaC12 3g, KC1 3g, Tris 
5g and sodium acetate 5.49g, made up to 1 litre using distilled water). The APF was 
then made pH 7.6 with ethanoic acid and 4g of glucose was added. A. suum can be 
maintained for up to 4 days in vitro changing the APF twice daily. 
2.5.1.1 Effect of NTZ on the motility of adult A. suum. 
Adult worms were individually placed into glass beakers containing 60m1 of APF at 
37°C. NTZ was added containing 10µg/ml to 100gg/ml of the drug. The assay was 
carried out for 48 hours and observations were recorded after 10min, 30min, lhour, 2 
hours, 5 hours, 10 hours, 24 hours and 48 hours. Equal concentrations of the drug 
diluent DMSO were used as comparative controls. 
2.5.2 Worm muscle-strip preparation. 
Muscle-strip was prepared as described by Maule et al, 2001. A female worm 
(characterised by turgidity, pinkish colour and well defined with reddish lateral lines) 
was chosen because they are larger and more amenable to dissection and physiological 
analysis. The gonopore was located, which is situated about one-third of the worm's 
length from the head. A transverse incision was made approximately 2mm below the 
gonopore and another approximately 2cm above. A cylindrical segment of the worm 
was then able to be removed and placed in a dissecting dish containing APF. The 
segment was then opened up by cutting longitudinally along the length of one of the 
lateral lines and pinning down the edges of the segment, outer face downward. This 
exposed the intestine, visible as a soft brown-green tube-like structure situated in the 
centre of the body-wall segment. The intestine was then gently pulled away from the 
segment. A second cut was then made along the length of the remaining lateral line 
effectively separating the muscle into dorsal and ventral muscle- strip preparations, of 
which the latter included the gonopore. A needle and thread were then used to make 
loops with which to attach the muscle- strip to the organ bath holdfast and transducer. 
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The needle was inserted midway between the cut lateral lines and 3mm from the 
anterior and posterior end of one of the muscle segments. Using the loops, the segment 
was transferred to the organ bath containing APF buffer at 37°C and attached to a 
stationary holdfast (in the organ bath) and a force transducer (Fig 2.1). The recorded 
voltage on the transducer machine was calibrated by using a1g weight on the thread. 
Figure 2.1: Schematic diagram of muscle tension recording 
apparatus (organ bath). 
Wren 
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Fig 2.1: Muscle strip is suspended by thread in organ-bath containing 15ml of APF. Drugs at varying 
concentrations are added via the top of the organ bath. 
Diagram from Maule et al, 2001 
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A syringe containing APF buffer was attached to the side of the apparatus towards the 
base and when pressed caused agitation inside the organ bath, which assisted rapid 
distribution and mixing of test compounds. Any movement generated by the muscle was 
amplified and recorded on a chart recorder. The muscle strip was left for 15min to 
equilibrate and establish regular spontaneous contractions. 
2.5.3 Effect of NTZ/TIZ and acetylcholine on muscle-strip. 
2.5.3.1 Effect on nicotinic receptors. 
Once the muscle-strip had equilibrated, compounds (ACh, lev, NTZ/ TIZ and DMSO) 
were tested in turn. Graded concentrations of each compound (10µM to 80µM for Ach 
and levamisole, 10µM to 600µM for NTZ and 10µM to 100µM for TIZ) were added 
and the resulting effect was measured on the chart recorder. Equal concentrations of 
DMSO to those used with the drugs were used as a negative control. Drugs were 
injected into the organ-bath just below the surface of the APF buffer and 20 minutes 
contact time allowed before the drug was washed off the muscle-strip by rinsing for 30 
seconds with fresh buffer. The bath was then refilled and the experiment repeated with 
the addition of another dose of the drug. 
2.5.3.2 NTZ/TIZ effect on chloride-gated ion channels. 
The experimental set up described in 2.5.3.1 was used to examine NTZ/TIZ effect on 
chloride-gated ion channels. A range of 10µM-600µM NTZ or 10µM-100µM TIZ was 
used and the drug was added to the bath immediately after addition of 30µM levamisole 
or 30µM Ach. This experiment was carried out to examine whether rapid relaxation and 
cessation of contraction occurred. NTZ/TIZ cessation of contraction would suggest the 
drugs were targeting chloride channels in the worm as has been previously 
demonstrated for GABA by Maule et al, (2001). 
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2.6 Assay for fumarate reductase using H. contortus. 
Kuramochi et al (1995) suggested that inhibition of nematode fumarate reductase may 
be a factor in the mechanism of action of nitazoxanide. This was investigated using 
adult Haemonchus contortus as described below. 
2.6.1 Isolation of H. contortus. 
Adult H. contortus CVL strain were obtained from Keith Hunt (VLA Weybridge). 
Worms were collected from a lamb's abomasum post mortem. The abomasum was cut 
up and worms gently washed off into Earle's Balanced Salt Solution (EBSS) at 30°C 
(116.4mM NaCl, 5.4mM KCI, 1.8mM CaC12,0.4mM MgSO4,0.9mM NaH2PO4, 
11.9mM NaHCO3,50mM MOPS. The medium was then adjusted to pH 7.2 with 5M 
NaOH). The worms were then washed 5 times in EBSS to clean them from gut flora etc. 
2.6.1.1 Effect of NTZ on H. contortus motility. 
Ten adult worms were assayed in triplicate for NTZ effect on motility in a 24 well 
culture plate containing 1.5m1 of EBSS at 37°C. NTZ was added to 10µg/ml and effect 
on worm motility and morphology monitored microscopically (magnification 20x) with 
an inverted microscope for 8 hours. Monitoring was initially every ten minutes for the 
first two hours, followed by half-hourly checks for the remainder of the assay. An equal 
concentration of drug solvent (DMSO) was used as a comparative control. 
2.6.2 Preparation of H. contortus mitochondria. 
Adult H. contortus mitochondria were prepared essentially as described by Prichard, 
1970. The nematodes were homogenised at 4°C in a 1.5m1 Dounce homogeniser in 
mitochondrial medium (1: 2, w/v) containing 0.25M sucrose, 0.01M Hepes/KOH pH 
7.4,0.1 mM EGTA and 0.1 % bovine serum albumin (fraction V). The homogenate was 
then centrifuged at 1000 g for 15min at 4°C. The pellet was discarded and the 
supernatant containing the mitochondria was then centrifuged at 9500 g for 15min at 
4°C. The mitochondrial pellet obtained was then resuspended in 5m1 of mitochondrial 
medium and further centrifuged at 16000 g for 15min. The pellet was thereafter 
resuspended in 5ml 0.1M Hepes/KOH buffer pH 7.4 and stored on ice until required. 
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2.6.3. Fumarate reductase assay. 
Methods described previously by Prichard, (1973) and Bryant & Bennet, (1983) were 
employed in the fumarate reductase assay. For the assay a lambda-5-spectrophotometer 
was used (Perkin-Elmer). The spectrophotometer waterbath was maintained at 37°C and 
a solution of 1mM K-phosphate buffer (pH 7.0) was warmed to the same temperature 
prior to use. Absorption of the co-factor (NAD-NADH) was measured at 340nm. 
Determinations of the rate of NADH oxidation were conducted under ambient air in a 
final volume of 1. Oml containing 1mM buffer, mitochondrial suspension (0.1mg 
protein) 1 0µM MgC12 and 0.3µM NADH. 
The reaction was started by the addition of sodium fumarate (final concentration 
10µM) and the rate measured. After the reaction had started, varying drugs were added 
to observe for inhibition. Effects of NTZ and TIZ were examined in a concentration 
range of 1 to 20µg/ml (3-65µM). Rotenone a known fumarate reductase inhibitor 
(Bryant & Bennet, 1983) was used as a positive control in the same concentration range. 
DMSO at comparable concentrations was used as a negative control. 
Fumarate reductase activity was calculated by subtracting the rate seen with NADH, 
drug and Hepes buffer (instead of fumarate) from the rate observed with NADH, drug 
and fumarate. Statistical analysis was performed using a Student t-test where P<0.05 
was considered significant. 
2.7 Larval migration inhibition assay for determination of susceptibility of 
parasitic L3 larvae to NTZ and related drugs. 
Stage L3 infective larvae of Nematodirus spathiger (CVL strain) and Haemonchus 
contortus (CVL strain) were provided courtesy of Keith Hunt and Ralph Marshall from 
VLA Weybridge. Lambs were infected by initially keeping in worm-free conditions 
from birth until the lamb was old enough for infection. An infective dose was given 
orally in water, 8,000 larvae for H. contortus and 20,000 larvae for N. spathiger. 
Infections became patent about 24 days after ingestion. The larvae were obtained by 
fitting a harness and collection bag to a lamb and collecting faeces. The bag was 
emptied every 24 hours and the nematode eggs cultured to third stage larvae by 
incubation in enamel trays for 7 days at 27°C. Coarse faecal material was removed 
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using a sieve and then larvae were harvested from the faeces by adding warm water 
(22°C) and using a `Baermann funnel technique'. This consisted of a high wet-strength 
filter paper, held over a plastic cylinder and fixed in place with an elastic band. The 
liquid-larval suspension was poured through the filter paper, temporarily restraining the 
larvae on the filter. The filter and holder were then immersed in warm tapwater (22°C) 
allowing larvae to migrate through the filter into the cylinder (Jackson et al, 2001). 
Larvae were then washed and stored in water. L3 H. contortus could be maintained in 
vitro in water at 10°C for 6 months and L3 N. spathiger at 5°C for 1 year in water (1500 
larvae/ml) in flat culture flasks. 
2.7.1 Design of larval filter apparatus. 
A larval filter apparatus was made to a similar design to that used by Jackson et al, 
2001 (figure 2.2). A filter of Nytal mesh with pore size of 25µm (Lockertex), was cut to 
40mm x 40mm and held in place in a polythene cylinder cut from a 2ml pastette, by 
using an inner collar from a polypropylene plastic pipette tip (Grenier) trimmed to size. 
Individual filters were then placed into separate wells of a 24 well plate. 
Figure 2.2 Schematic representation of larval migration filter apparatus. 
Nytal mesh Inner collar larvae 
Larvae migrate into well. 
Outer collar 
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Larvae ( still sheathed) were placed into 1.5m1 eppendorf tubes, centrifuged for 2 min 
at 100 g and then washed three times with 0.85% NaCI solution. Larvae were 
quantitated by taking 1001il samples and counting on a slide using an inverted 
microscope at 100x magnification. Then larval density was adjusted to retain 100 larvae 
per 1001i1 of sample. Motility was measured by the ability of larvae to penetrate the 
mesh and migrate into the well. Control larva suspensions contained concentrations of 
DMSO equal to the drug-containing solutions and the migration of larvae from this 
solution was compared to that from drug treated solutions. Differences in migration 
were taken to be indicative of a drug effect on larval motility. 
2.7.2 Assay of larval motility with selected drugs. 
The larval motility assay was modified from those of Jackson et al, 2001 and Douch et 
al, 1993. L3 larvae of N. spathiger and H. contortus (triplicates) were exposed to each 
Romark compound (see section 2.2) at concentrations ranging from 0.1 to 30pg/ml (0.3- 
10011M). Controls included levamisole (positive control), DMSO and 0.85% NaCl 
(negative controls). Other drugs assayed were niclosamide, mebendazole, CCCP and 
FCCP. Firstly 200µl of 0.85% NaCl solution (containing approximately 200 larvae) was 
placed into 1.5m1 eppendorf tubes containing 1.3 ml of 0.85% NaCl and the appropriate 
drug solution. The larvae were then spun down for 15 seconds in a microfuge and the 
supernatant removed. lml of 0.85% NaCl containing an equal drug concentration as 
before was added and the larvae incubated at 37°C for either 2,4 or 8 hours. The 
suspension was then centrifuged and the volume reduced to 200µ1.1.8m1 of 0.85% 
NaCl containing each drug concentration was added to individual wells of a 24 well 
culture plate (Nunc) and the filter meshes placed into each well, ensuring that the mesh 
was fully submerged to avoid trapped air bubbles. The larval suspension was mixed 
thoroughly and the larvae in 200µl of the same concentration of drug as in the well, 
were added to each filter by gently pipetting down the inner collar. A cover was placed 
over the plates and larval migration through the filter was allowed to proceed for 2 
hours at 37°C. The filters were carefully removed and any remaining larvae on the 
upper surface, washed into individually labelled petri dishes and stained with a few 
drops of helminthological iodine/ potassium iodide (Lugol's solution). A few drops of 
Lugol's solution was also added to each well on the culture plate. The number of larvae 
in each well and each corresponding petri dish were counted using an inverted 
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microscope at x40 magnification and percentage migration was calculated for each 
concentration as indicated below. 
migration = (Nm) 
(Nm + Nr) 
Where: N., = number of larvae migrating through mesh (in well). 
N, = number of larvae retained by mesh (washed off). 
A plot of drug concentration against percentage migration was used to determine the 
IMg50 value (concentration at which 50% of larvae fail to migrate) by using Sigmaplot 
2000. 
2.7.3 Exsheathment of third stage larvae. 
To examine the importance of the larval sheath, larvae were exsheathed and the above 
assay repeated. For exsheathment, larvae of H. contortus or N. spathiger were placed 
into 1.5m1 eppendorf tubes and 80µl of 70% sodium hypochlorite solution (Sigma- 
Aldrich) was added per ml of larval suspension. After 2 min (time needed for all larvae 
to exsheath) the larvae were centrifuged for 2 min at 100 g and then washed three times 
with 0.85% NaCl. 
2.8 Assay for nitroreductase activity in C. elegans. 
In this assay, C. elegans was used in order to examine whether any nitroreductase 
activity is present in the worm as suggested by the findings of Bryant & Deluca, 1991. 
The positive control drug nitrofurazone (NF) used in this assay, is reduced by the 
nitroreductase of E. cloacae and the activity of NTZ/TIZ was measured in comparison 
to that of NF. 
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C. elegans plates were grown (as described in section 2.1.1.1) and after seven days, 
washed 4 times in M9 buffer to remove E. cola as described in section 2.9.1. C. elegans 
were made into a final suspension of 2m1 axenic medium with glucose, centrifuged at 
100 g for 1 minute and the pellet homogenised on ice in a Dounce homogeniser using 
buffer containing 0.25M sucrose, 0.01M Hepes/KOH pH 7.4,0.1mM EGTA. 
Nitrofurazone stock solution 10mM was prepared in DMSO, NADPH and NADH 
stocks were 100mM in water. 
The assay was carried out spectrophotometrically at 37°C at 375nm with nitrofurazone 
and at 375,390,400 and 412nm for NTZ and TIZ. 1 ml of reaction buffer (50mM MES, 
100mM Tris, pH adjusted to 7.0 using acetic acid) was added to a cuvette to which was 
added an enzyme system required for recycling of the nicotinamide nucleotide cofactor. 
This enzyme system consisted of either: NADPH 0.3mM, glucose 6 phosphate 
(I0µmole) and 1 unit of glucose 6 phosphate dehydrogenase (Sigma), or NADH 
0.3mM, 1 unit of alcohol dehydrogenase (Sigma) and 10µl of ethanol. On addition of 
the enzyme system, the reduced nucleotide absorbance level initially rose and then 
stabilised. 1,10 and 20pg/ml nitrofurazone or NTZ or TIZ or the DMSO negative 
control was then added, causing the absorbance to increase and then level off again. 
Various volumes of C. elegans extract (0.1-0.3mg/ml protein) were then added and any 
change in absorbance recorded. Protein content of C. elegans extract was calculated as 
described in section 2.9.4. 
2.9 ATP inhibition assay. 
The method of Ronner et al (1999) was modified for the ATP inhibition assay (see 
2.9.2). This is a luciferin/luciferase assay system conducted using primarily C. elegans 
and then S. mansoni. 
2.9.1. Preparation of worms. 
C. elegans were grown in 9cm petri-dishes. After inoculation, worms were allowed to 
develop for two weeks. They were then washed off the plates into 50m1 culture tubes 
with M9 buffer, and then washed to remove bacteria as described by Araüjo et al, 1999 
by adding 20m1 of M9 and spinning at 100 g for 1 minute to produce a pellet. The 
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supernatant was removed and washing repeated four times. After the final wash 5m1 of 
axenic media containing glucose was added to the pellet producing a suspension of 
bacteria-free C. elegans. Individual 50m1 culture tubes were used for the assay and 
drugs at concentrations ranging from 1 to 20µg/ml were added. Drugs tested were NTZ, 
TIZ, DNNTZ, DNTIZ, FCCP, CCCP and LEV. DMSO (0.2% w/v) and axenic medium 
were used as a negative controls. Worms were exposed to each drug concentration for 1 
hour at room temperature. After this time the tubes were again briefly centrifuged at 100 
g to produce a pellet. The drug solution was removed and 2 ml of solubilising reagent: 
0.1M NaOH/ 0.5mM EDTA was added. The tubes were then incubated at 60°C for 2 
hours to solubilise the worms. Solubilised extracts were then transferred to - 20°C 
storage and left overnight. 
2.9.2 Measurement of ATP inhibition. 
A stock solution of ATP assay buffer: 250mM glycylglycine, 2mM EGTA, 2mM 
MgC12 and 0.4g BSA per litre made to pH 7.4 with IM NaOH was prepared and stored 
in portions at -20°C until required. Upon thawing, a portion of stock solution was made 
7.5mM in dithiothreitol. Luciferin (Sigma) and luciferase (Sigma) were added to 15µM 
and 10µg/ml respectively. The solution was then allowed to stand at room temperature 
for 2 hours before use. The NaOH/ EDTA worm solutions were thawed and 0.5,1,1.5, 
2,3,3.5,4 and 5µl were each added to 0.2m1 of 0.2M NaOH/ EDTA. 
A stock solution of 1OµM ATP was made in water and ATP at different concentrations 
was used as a standard. To make this, 0.1,0.2,0.4,0.8,1.25,1.8,2.2 and 2.8141 of ATP 
stock solution were added to 0.2m1 0.2M NaOH/ EDTA as per the worm solutions. 3O1il 
of each soluble extract and each ATP concentration were then added to a white flat- 
bottomed 96 well plate (Wallac) and 1061i1 of the luciferin/ luciferase solution added to 
start the reaction. The reaction was measured in a 1450 Microbeta® Scintillation- ß 
counter (Perkin-Elmer, UK) with the machine configured to read luminescence at 10 
second intervals. 
From the Scintillation- ß counter, using Sigmaplot 2000, the ATP standard allowed a 
curve to be plotted, showing the amount of relative luminescence per each concentration 
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of ATP. An example of a standard curve is shown below. A separate standard curve was 
obtained for each experiment. 
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A curve was also obtained for each solubilised C. elegans extract, showing amount of 
luminescence per sample. Counts of luminescence from the ATP standard were then 
compared with the C. elegans samples in order to find the concentration of ATP in each 
C. elegans extract. A protein control using BSA was then calculated using methods as 
described in section 2.9.4 to find the amount of ATP/mg of protein in each extract. 
Inhibition of ATP in the presence of drug compared to the DMSO or medium only 
negative controls was then examined. Statistical analysis was performed using a Student 
t-test and difference in mean levels of ATP, where P <_0.05 considered significant. 
Controls were also carried out using all concentrations of drug and DMSO with known 
concentrations of ATP to control for direct effect on ATP. 
2.9.3 Preparation of protein reagent. 
Coomassie Brilliant Blue (G) 250 was used to prepare the protein standard according to 
Bradford, (1976). 10mg of reagent was dissolved in 5m195% ethanol. To this solution 
10ml 85% phosphoric acid (w/v) was added and the resulting solution was diluted to a 
final solution of 100ml and filtered, then stored in a dark, tightly sealed bottle. 
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2.9.4 Protein assay. 
Several dilutions of standard were prepared containing from 1 to 25µg/ml BSA 
(lmg/ml stock solution). A standard curve was obtained each time the assay was 
performed. 
0.8m1 of standards and appropriately diluted samples were placed in clean dry test 
tubes. 0.8 ml sample buffer or mQ water was placed in "blank" test tube. 0.2ml of Dye 
Reagent Concentrate was added and vortexed several times. After lhour, the OD595 was 
measured on a spectrophotometer versus reagent blank. The OD595 versus concentration 
of standards was plotted and the unknown samples read from the standard curve. 
Usually six standards of BSA lmg/ml were added to the 0.8m1 mQ each with 
2µW6µU10µU14µ /18µU21µ1. For unknowns 2µl (duplicates), 4µi, 8µi l0µ1 14µl and 
18µl were added. The reading was then recorded. An example of a standard protein 
curve is shown below. A separate standard was used for each experiment. 
Protein graph for BSA 
o. 
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0. 
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2.9.5 Luciferin/luciferase assay for ATP inhibition with S. mansoni. 
The same assay was carried out as above with adult S. mansoni. In this case the worms 
were incubated for 30 minutes at 37°C instead of room temperature and the assay was 
carried out in medium 169 (Appendix I). For the assay; 4 worm pairs were used in 
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1.5m1 of medium 169. Praziquantel was used as a control. After freezing/thawing, worm 
extract was added to a white flat-bottomed 96 well plate and luminescence read as 
described above. Again a protein assay was performed as described in section 2.9.4 to 
find concentration of ATP per mg of protein and statistical analyses carried out to 
examine drug induced differences in ATP levels. 
2.10 Trematode susceptibility to NTZ and related drugs. 
Since Fasciola hepatica was unavailable to study, Schistosoma mansoni (and when 
available, Schistosoma japonicum) was used as a model to examine NTZ activity and 
mode of action in trematodes. Schistosomes were prepared at various stages of the life 
cycle including miracidia, cercariae, schistosomula and adults. 
2.10.1 Culturing of schistosomes. 
Schistosomula and adults of a Puerto Rican strain of Schistosoma mansoni were 
obtained from Quentin Bickle of the LSHTM. They were maintained in medium 169 
without phenol red (see appendix I) in a6 well culture plate (Greiner) at 37°C in an 
incubator with 5% C022 95% air. 
2.10.2 Isolation of Adults. 
The adult worms were obtained from infected CD I mice, 20-25g obtained from 
accredited suppliers and maintained in Category 2 animal facility. For infection, mice 
were anaesthetized with sodium pentobarbitone and infected percutaneously via a 
shaved portion of the mouse with 100 S. mansoni cercariae freshly shed from 
Biomphalaria glabrata (see section 2.10.5). The cercarial exposure was for 20 mins. On 
day 49 post-infection, mice were killed with an overdose of sodium pentobarbitone. 
Thoracic and peritoneal cavities were then opened and 25m1 of perfusion fluid (8.9g 
NaCl, 15g trisodium citrate, 2000 units heparin, 0.2g merthiolate/ litre water) was 
injected into the right ventricle and the perfusate emerging from an incision in the 
hepatic portal vein was drained into a plastic 50m1 centrifuge tube (Orange Scientific). 
After allowing parasites to settle, excess solution was removed and erythrocytes in the 
remaining 1- 1.5m1 of fluid were lysed with a few drops of 2.5% saponin (w/v) solution 
(Doenhoff et al, 1978). Worms were then washed 5 times with medium 169 and 
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transferred to the 6 well plate. Adult Schistosoma japonicum (Anhui strain) were 
provided by Yaobi Zhang, LSHTM using the same procedure (cercariae obtained from 
Oncomelania hupensis) and maintained in the same way. 
2.10.3 Collection of S. mansoni eggs. 
To obtain S. mansoni eggs, the liver is removed from the mice after perfusion of the 
adult worms. Using double strength saline as a wash, the liver was crushed through a 
sieve with a pestle into a long glass bottle. The crushed liver was then stored at 3-5°C 
and debris allowed to settle for 20-30 minutes. The saline was replaced, and the settling 
step repeated. After 20-30min the saline was again removed and cold distilled water 
added. The remaining liver tissue was placed into a glass Petri dish and eggs identified 
using light microscopy. Eggs of schistosomes were kept in distilled water at 5°C in the 
dark until required. 
2.10.4 Maintenance of Biomphalaria glabrata snails. 
B. glabrata snails were provided by Quentin Bickle and Lauren Rattray of LSHTM. 
Snails were maintained in tanks at 26°C. 5m1 of snail salts* was added every 10-14 
days. Snails were fed with 3 pellets of food (Special Diets Services) per tank each day. 
*(100g calcium carbonate, lOg magnesium carbonate, lOg sodium chloride and 2g 
potassium chloride suspended/dissolved in 3 litres of fresh water). 
2.10.5 Hatching of eggs and infection of snails. 
In order to hatch the miracidia from the eggs, light (60 watt bulb) was shone directly 
onto the petri dish. After 10-20min the schistosome eggs within the liver began to hatch 
and release the miracidia into the water. To infect the snails (0. hupensis for S. 
japonicum and B. glabrata for S. mansoni), approximately 60 uninfected snails were 
placed into a tank and miracidia added at approximately 20 per snail. After 
approximately 4 weeks, when the miracidia within the snail would have matured, the 
snails were kept in the dark for 1 week prior to cercarial shedding. After about 5 weeks 
after miracidial infection, it was time to shed the snails. 
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2.10.6 Shedding of cercaria from snails. 
The snails of both species were kept in dechlorinated tap water at 24-26°C. Cercariae 
were shed in a beaker containing a minimum volume of dechlorinated water warmed to 
28°C. Shedding was carried out under direct illumination for 30 minutes - lhour. 
2.10.7 Preparation of schistosomula. 
Schistosomula were prepared with the assistance of Nuha Mansour (LSHTM) as 
follows: After shedding the cercariae from the snails as described above, cercariae were 
mechanically transformed by tail-shedding into schistosomula. This method of 
transformation of schistosomula from S. mansoni cercariae was modified from methods 
previously described by Ramalho-Pinto et al, (1974); Basch (1981); James and Taylor 
(1976). Cercariae were collected and concentrated in dechlorinated water. 10ml aliquots 
of the cercarial suspension were then pipetted into 15m1 glass conical centrifuge tubes 
and cooled in an ice bath for 10 minutes to reduce motility of the organisms and 
facilitate concentration of cercariae (Ramalho-Pinto et al, 1974). These were 
centrifuged at 400 g for 30 to 60 seconds at 4°C and the upper 90% of water was 
carefully removed leaving behind packed cercariae (Basch 1981). They were then 
resuspended in 2m1 cold E/LAC (Earle's/Lactalbumin) medium (as shown in Appendix 
I) per tube, and pooled from all the glass tubes into a conical-based plastic `Universal' 
tube. E/LAC was supplemented with 300U/ml Penicillin, 300µg/ml Streptomycin and 
160pg/m1 Gentamycin (Sigma). 
Mechanical transformation of cercariae into schistosomula, was done by disruption of 
cercarial heads from tails by the `Syringe method' (James & Taylor, 1976). Briefly, 
cercariae suspended in E/LAC were forced through a 21-guage needle attached to a 
Luer Lock Syringe a total of 20-22 times. The cercarial heads were left to settle by 
sedimentation at 37°C under 5% CO2 and 95% air and then the tail-rich supernatant was 
carefully removed. Using this technique, the isolated cercarial heads were washed 3 
times in 7m1 of E/LAC after which they were ` washed another 2 times with 
schistosomula culture medium 169 supplemented with antibiotics but lacking foetal calf 
serum (FCS). Schistosomula were then incubated in medium 169 at 37°C and 5% CO2. 
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Transformation and washing were done at room temperature and under sterile 
conditions. 
2.11 Motility and mortality assay of schistosomes exposed to Romark compounds 
and known schistosomicidals. 
Schistosomula (3-10 days old) and paired adult schistosomes (7 weeks) of S. mansoni 
and S. japonicum were assayed for susceptibility to the same range of drug 
concentration and control drugs as used for C. elegans (section 2.2). Praziquantel was 
used as a positive control in the same concentration range. Other known 
schistosomicidal compounds were also tested for comparison of effect with NTZ/TIZ, 
e. g. lucanthone, hycanthone, oxamniquine, metrifonate and niridazole as well as 
compounds with unknown effect (e. g. the uncouplers CCCP, FCCP and proguanil). 
Other drugs tested included the artemisinin derivatives (artemether, artesunate and 
dihydroartemisinin), antimycin A, thiabendazole, mebendazole and levamisole. All 
drugs were in 100% DMSO and stock solutions were made of 10mg/ml, 1mg/ml and 
0.1mg/ml. Aqueous drug solutions were kept at -20°C in the dark. The drug diluent 
DMSO (0.2%) and medium 169 only were used as negative controls. 
2.11.1 Assay of adult schistosome activity with NTZ/TIZ and control drugs. 
Using sterile technique, adult schistosomes were gently washed 3 times by 
sedimentation in medium 169 and placed (4 males and 4 females) into wells of a 24 well 
plate containing 1.5m1 medium 169 (in the presence or absence of 10% FCS) and then 
drug solution added to give required concentration between 0.1 µg/ml and 20µg/ml. 
Each drug was tested in triplicate wells and the plates were maintained at 37°C in 5% 
CO2 / 95% air during the assay. The effects of the drugs were recorded for both 
concentration and effect over time, and examined using an inverted microscope (20x 
magnification) at regular intervals from 10mins to 120hr. Drug effects were evidenced 
by motility disturbances (e. g. increased activity or paralysis), morphologic changes (e. g. 
relaxation, shrinkage; curling) and tegumental effect (disruption, darkening, granulation 
and blebbing). Death was assumed if no movement (gut or body) was observed during a 
2 minute period. Negative control . wells contained medium 169 alone or medium 169 
with 0.1 and 0.2% DMSO. The pH of the medium was monitored for each assay using 
a Coming pH meter and was unaffected by any of the drugs added. The assay conditions 
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used were the same for S. japonicum as for S. mansoni. LD50's (in the presence or 
absence of 10% FCS), showing the concentration of drug that killed 50% of the worms 
after 120 hrs were calculated using Sigmaplot 2000. 
Four week old juveniles were also subjected to NTZ, TIZ, TIZg and PRAZ in medium 
169. Conditions were the same as described above and motility and morphologic 
changes were similar to those in the adult worms. 
2.11.2 Assay of schistosomula activity. 
Using sterile technique, the schistosomula were gently washed 3 times in medium 169 
and approximately 50 larvae were placed into individual wells of a 96 well flat- 
bottomed culture plate (Nunc) containing l00µ1 medium 169 (again in the presence or 
absence of 10% FCS) and exposed to each of the Romark compounds. PRAZ and NIC 
were used in comparison as positive controls. Drugs were added to the same 
concentration range (initially in a blinded trial) as for the adults and the effects of the 
drugs again observed microscopically, for both concentration and effect over time, 
initially 10min to 1 hour at 37°C in 5% C02/ 95% air, then for a further 23 hours at 
regular intervals. Each assay was carried out in triplicate. Drug effects were again 
evidenced by motility disturbances, morphological changes and tegumental effect. 
2.11.3 Test of NTZ/TIZ drug reversibility. 
The same assay, was carried out as above, except that after the adults had been exposed 
to the NTZ/TIZ for 4 hours (2 hours for schistosomula), worms were removed from the 
drug, and placed into fresh medium. Incubation was continued with regular monitoring 
for the remainder of the time (120 hours for adults, 24 hours for schistosomula). 
2.11.4 Assay of NTZ and praziguantel on egg hatching and miracidial motility. 
100µ1 of water containing approximately 100 eggs were placed into separate wells of a 
96 well flat-bottomed culture plate (Nunc) and pre-exposed to NTZ, TIZ, DNTIZ and 
PRAZ at concentrations of l ug/ml and 101tg/ml for 30 minutes before illumination 
allowed. The assay was then carried out under illumination at room temperature and 
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constantly monitored using the 20x objective of an inverted microscope (Reichert-Jung, 
Microstar) for 2 hours. Drug effects on egg hatching and miracidial motility was 
monitored. DMSO was used as a solvent control at the same concentration as in the 
drugged wells. 
2.11.5 Assay of NTZ and praziquantel on cercarial motility. 
Fifty cercariae in dechlorinated water were placed into separate wells of a 96 well 
culture plate and exposed to NTZ, TIZ, PRAZ , NIC or DNNTZ at concentrations of 1 
or IOgg/ml The assay was again carried out at room temperature and effects on cercarial 
motility constantly monitored under the 20x magnification of an inverted microscope 
for 2 hours. 
2.12 Tests of drug effects at nicotinic and muscarinic receptors in schistosomes. 
The effect of Romark compounds and control drugs on the neuromuscular systems of 
schistosomes were examined. 
2.12.1 Test of neuro-receptor antagonists on S. mansoni adults. 
Adult S. mansoni were placed into 96 well culture plates containing 100µ1 of medium 
169 and pre- or post-treated with mecamylamine, pempidine or atropine and 10µg/m1 
NTZ as described for C. elegans in section 2.3. 
2.12.2 Test of effect at nicotinic receptor in schistosomes usine a-Bunearotoxin. 
A stock solution of a-bungarotoxin (125µM) (BTX) (Calbiochem) a specific nicotinic 
receptor agonist (Haughland, 1998) was prepared in medium 169. Adult S. mansoni 
were then exposed to 10-40µM BTX (as described for NTZ in section 2.11) and the 
effect of BTX on worm motility was observed over 24 hours. BTX was also used in 
combination with NTZ or TIZ to check for possible antagonistic effect and hence 
reduction of drug activity. 
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2.12.2.1 Visual examination of NTZ/TIZ interaction at nicotinic receptors in 
S. mansoni and S. japonicum using rhBTX. 
In order to visualise nicotinic receptors in schistosomes (adults and schistosomula), 
fluorescent tetra-methylrhodamine labelled a-bungarotoxin (rhBTX) (Molecular 
Probes) was used (200µM stock solution in medium 169). NTZ, DNNTZ and BENZ 
were added separately before and after addition of rhBTX to view drug interaction at the 
receptor and hence examine potential inhibition of binding of a-bungarotoxin. The 
fluorophore was examined in the fluorescent microscope using an excitation wavelength 
of 553nm and an emission wavelength of 577nm. 
2.12.2.2 Examination of possible NTZ/TIZ induced inhibition of 
rhBTX binding in schistosomula. 
Schistosomula of Schistosoma mansoni (3 days in culture) were placed into a 96 well 
microtitre plate (Nunc) in 45µl medium 169 (without FCS) and 5µl rhBTX (20µM final 
concentration). The plate was incubated for 20 min at 37°C in 5% C02/ 95% air. O. 15µ1 
NTZ (30µM final concentration) was then added and incubation was carried out for a 
further 2 hours. The experiment was also carried out with schistosomula exposed to 
30µM NTZ for 20 minutes, followed by 2 hours incubation with 20µM rhBTX. Varying 
concentrations of NTZ were used, ranging from 1-20gg/ml (3µM to 60µM). Controls of 
NTZ alone, rhBTX alone and DMSO alone were also tested with the schistosomula. 
After incubation, worms were washed in medium 169 as follows: - medium 169 (100µl) 
was added to the well and the top 100µl of this solution was then removed leaving 
schistosomula at the bottom of the well and the process repeated 5/6 times to remove 
the unbound rhBTX. The schistosomula were then fixed with l00µ1 of 4% 
paraformaldehyde in phosphate buffered saline (PBS) for 30 min. Most of the fixing 
solution was then removed using a pipette and 200µl of 45% glycerol in 1x PBS (7.3 g 
NaCl, 2.36g Na2HPO4,1.31g NaH2PO4.2H20 and H2O to I litre (pH 7.0-7.2)) (Wood, 
1988) was added. Sµl of solution containing schistosomula was then transferred onto 
wells of a immuno-fluorescence multi-well microscope slide (Scientific laboratory 
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supplies) with cover slip. The slide was examined using a fluorescent microscope 
(mercury lamp and filter) and confocal fluorescent microscope (Zeiss) (excitation 
543nm (green), emission 565nm (red)) with the assistance of Courtney Meier. 
2.12.2.3 Examination of possible NTZ/TIZ induced inhibition of rhBTX binding in 
adult S. mansoni and S. japonicum. 
Effects of drug interaction with rhBTX was also examined using adult S. japonicum 
and S. mansoni. Again the protocol was carried out as for the schistosomula with either 
20 minute pre- or post drug incubation. The known protonophore CCCP was also tested 
with adult worms for comparison with NTZ effect. Controls of NTZ alone, rhBTX 
alone and DMSO alone at the relevant concentrations were also tested with the adult 
schistosomes. 
The BTX and rhBTX experiments were also carried out with C. elegans with slight 
modifications. The stocks of BTX and rhBTX were prepared in axenic media. Drug 
concentrations were as with the schistosomes but incubation was at 20°C. After 
incubation, M9 buffer was used for washing away any unbound rhBTX. 
2.12.3 Drug effect on muscarinic receptors in schistosomes. 
A stock solution of pirenzepine Bodipy Red (fw 805) (BoP) (1.3mM) (excitation 560 
nm, emission 569nm) was made in DMSO. The same protocol was used for pirenzepine 
Bodipy Red as for rhBTX with slight modifications as follows: - Adult S. mansoni were 
placed in a 96 well plate containing 98.7µl medium 169 and lµ1 Bodipy (6.5µM final 
concentration) and incubated for 20 min. NTZ 0.32µ1 (final concentration l01tg/ml) was 
then added and the S. mansoni were incubated as with the rhBTX for 2hrs at 37°C. The 
worms were then washed in medium 169, fixed and put on a microscope slide as 
described earlier. Similarly 10µg/ml NTZ was added to S. mansoni 20 minutes prior to 
addition of 6.5µM BoP, followed by 2 hours incubation. S. mansoni with NTZ alone, 
BoP alone and diluent concentration of DMSO alone were used as controls. 
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2.12.4 Spectroscopic test for quenching of rhBTX. and pirenzepine bodipy Red 
fluorescence by NTZ. 
NTZ quenching effects on rhBTX and BoP were tested in the absence of worms. 
Solutions were prepared in a 96 well flat bottom plate and tested for fluorescence as 
follows: The solutions were 1) Medium 169 and DMSO; 2) Medium 169 and 45µM 
NTZ; 3) Medium 169,20µM BTX and DMSO; 4) Medium 169,20µM Bodipy and 
DMSO; 5) Medium 169,20µM of BTX and 45µM NTZ; 6) Medium 169,20µM of BoP 
and 45µM NTZ. The relative fluorescence of these solutions was quantitated using the 
Spectra Max Gemini fluorescent plate reader (Molecular Devices). Excitation was at 
553nm, emission 577nm for rhBTX and excitation 560nm, emission 569nm for BoP, 
with a cut off for both at 565nm. 
2.12.5 Qualitative quenching test for NTZ. 
The above solutions 1-6 were also examined qualitatively using a Leica fluorescent 
microscope, (excitation 543nm (green), emission 565nm (red)). A 5µI sample of each 
of these solutions was transferred to a clean slide and examined under the lOx 
magnification of a fluorescent microscope and the relative fluorescence qualitatively 
assessed by eye. 
2.13 Assay for nitroreductase in S. mansoni. 
As described for C. elegans in section 2.8 adult S. mansoni were tested for possible 
nitroreductase activity using a method previously adopted by Tracy et al, 1983. 
2.13.1 Homogenisation of S. mansoni. 
Adult S. mansoni were homogenised using a glass Dounce homogeniser on ice in Tris- 
HCI buffer containing 0.3M sucrose at pH 7.5. Homogenate was then centrifuged at 
4°C for 15min at 2000 g. The supernatant was assayed for nitroreductase activity. 
Protein levels were measured as described in section 2.9.4. 
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2.13.2 Nitroreductase assay with S. mansoni. 
The spectrophotometric assay for schistosomal nitroreductase activity, was carried out 
under anaerobic conditions in the presence of an oxygen-scavenging enzymatic system 
in quartz cuvettes at 37°C. The cuvette contained lml of 0.15 mM potassium phosphate 
buffer (pH 7.5), 0.5mg of schistosome protein and either 0.1,0.5,1,2 or 5 µl of NTZ or 
niridazole (10mg/ml stock solution) added. DMSO was used as a negative control. 10µl 
of glucose-6-phosphate dehydrogenase (Sigma), 0.06 units of glucose oxidase (Sigma) 
and 1100 units catalase (Sigma) were then added to scavenge oxygen upon glucose 
addition. The contents of the cuvette were then gassed with Argon to remove oxygen 
and the cuvette covered with a rubber septum lid. 50µ1 of 0.3M D-glucose solution 
(Sigma) was then added to the cuvette (via a syringe) and the purging cycle repeated. 
After maintaining equilibrium for 5 minutes the reaction was initiated by adding 1.5µM 
NADH and 15µM D-glucose (purged with argon for 2 minutes), through the lid and 
measuring' the decrease in absorbance, (412nm for NTZ, or 400nm for niridazole) 
continuously for 3 minutes using a Perkin-Elmer Lambda 5 spectrophotometer. A 
control mixture lacking NADH and glucose-6-phosphate was used as a reference. One 
unit of nitroreductase activity was to be defined as the amount of enzyme which 
catalyzed the disappearance of approximately 16 picomol of substrate per minute. 
2.14 Assessment of drug effect on S. mansoni tegument by 
Scanning Electron Microscopy. 
Freshly isolated adult worm pairs of S. mansoni were placed into individual wells of a 
24 well culture plate (Nunc) containing 1.5m1 of medium 169 and exposed to 10µg/ml 
of either NTZ, DNNTZ, BZNT or DMSO (0.2% w/v) for 1 hour at 37°C. 
Thiocarbohydrazide 1% (1.5µ1) (Sigma) was also added to the well in order to increase 
tegumental definition (Malida, 1975). 
2.14.1 Preparation of SEM specimens. 
After drug incubation, worms were carefully fixed for 2 hours with 3% glutaraldehyde 
in 0.2M sodium cacodylate buffer pH 7.4. Fixative was then removed by washing 4 
times in 0.2M sucrose, 0.075M sodium cacodylate buffer pH 7.4. Worms were then 
placed in 1% osmium tetroxide for 1 hour at room temperature and then washed again 
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with 0.2M sucrose, 0.075M sodium cacodylate buffer pH 7.4 at 4°C and then stored in 
the same buffer until further processing. SEM was carried out by Maria McCrossan 
(LSHTM) as follows: Worms were washed in several changes of mQ water and then 
dehydrated through a series of ethanol dilutions - 20 minutes each in 30%, 40%, 60%, 
70% and 90% (w/v) dilutions, and finally 90 minutes in 100% ethanol. The specimens 
were then subjected to critical point drying in an EMScope CPD750 using liquid carbon 
dioxide. This was followed by sputter coating in an Edwards S 15 OB fitted with a Au/Pd 
target. 
2.14.2. Specimen examination under SEM. 
The specimens were mounted on an aluminium stub and then viewed using a Jeol 
JSM25S Scanning Electron Microscope. Photographs were taken using Kodak 
Technical PAN roll film TP 120 ISO 25/15 (black and white). The films were 
subsequently developed in Kodak D19 developing solution and prints of the negatives 
were enlarged and printed using Agfa multigrade paper and chemistry. 
2.15 Examination of inhibition of glucose uptake in S. mansoni on exposure to 
NTZ and related drugs. 
2.15.1 Assay of glucose uptake inhibition in S. mansoni schistosomula. 
Three day old schistosomula of S. mansoni were obtained by tail-shedding of cercariae 
(see section 2.10.7) and transferred to 24 well plates (Nunc) in medium 169 and allowed 
to develop for 3 days in a 37°C incubator in 5% C02/ 95% air. After 3 days 50 
schistosomula were placed into individual wells of a 96 well plate containing l00µ1 of 
medium 169. Drugs (triplicates) which included NTZ, TIZ, PRAZ, DNNTZ, BZNT and 
NIC were then added to concentrations of 5,10 and 20µg/ml. Samples and solvent 
controls were then incubated for 30 minn at 37°C. After the incubation 21Al of [3H] 2- 
deoxyglucose (Amersham Biosciences) containing 2iCi was added to each well and the 
plate incubated at 37°C for a further 20 mins. A protein assay was carried out as 
described in section 2.9.4 to determine the protein content of 50 schistosomula. 
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2.15.2 Harvesting of schistosomula. 
[3H] labelled schistosomula were harvested using a 96 well harvester (Tomtec, USA). 
Excess [3H] 2-deoxyglucose was removed by washing the schistosomula gently through 
the machine at 1 PSI (pounds per square inch) pressure, 3 times with lx PBS onto a 
glass fibre filter mat (Perkin- Elmer, UK). The mat was then microwaved to dry at 300 
Watts. A Meltilex (Wallac) containing solid scintillant in the form of wax was then 
placed onto the mat and the mat placed in a 60°C oven for two minutes to allow the 
Meltilex to melt. The filter mat was placed in a polystyrene sample bag and heat sealed. 
The tritium count in wells in the sealed bag were then assayed in a Wallac 1450 
Microbeta® Scintillation- ß counter (Perkin-Elmer, UK) using 2 minute cycles. The 
data were analysed for drug-related effects on glucose uptake using the Student t-test. 
2.15.3 Assay of glucose uptake inhibition in adult paired S. mansoni. 
Glucose uptake was also assayed in adult paired S. mansoni as follows: 2 pairs of adult 
worms were placed into separate wells of a 96 well plate containing l00µ1 of medium 
169. NTZ, TIZ, PRAZ, DNNTZ and NIC were added to concentrations of 5 and 
10µg/ml and incubated as described above. [3H] 2-Deoxyglucose was then added again 
as described above. After 20 min incubation, the worms were washed 3 times with Ix 
PBS and after the final wash PBS removed and replaced with 100141 of Wallac Betaplate 
liquid scintillation fluid (Perkin-Elmer, UK) and [3H] 2-Deoxyglucose uptake 
determined by a fl-Scintillation counter. Data was again analysed using the Student t- 
test. Protein concentration for each well was calculated after the reading using the 
protein assay described in section 2.9.4 
2.16 H. diminuta and H. microstoma. 
2.16.1 Isolation of adult worms. 
To obtain adult worms, 6-8 cysticercoids of H. diminuta or H. microstoma were 
inoculated orally by intubation into the host animal using Wistar rats for H. diminuta 
and CDI mice for H. microstoma. Three weeks later adult tapeworms were obtained 
from the animal's intestine by dissection. Intestines of infected rats/mice were removed 
and syringed with Earle's balanced salt `solution (EBSS) at 37°C, thus displacing any 
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worms present in the gut. Worms were maintained in EBSS for approximately 48 hours 
at 37°C. 
2.16.2 Tribolium confusum (Wild Type colony. 
T. confusum "flour beetles", obtained from Jill Brown (University of Nottingham) were 
maintained at 22 - 26°C under a fairly dry atmosphere (usually a storage room) in 
culture medium containing stone ground brown wheat flour, plain white wheat flour 
(100g: 100g) and 5g of brewers' yeast powder. After mixing, about 3cms of flour mix 
was placed in the base of a glass culture jar (10: 10: 20 cm, width/breath/height). 
Circulation of the air within the jar was maintained via small holes in the jar's plastic 
lid. The beetle culture was placed into the jar, and a cone-shaped piece of filter paper 
added to allow the beetles to escape from the flour. The beetles lay their eggs in the 
flour and upon hatching, the larvae grow shedding their skins several times until they 
pupate and emerge as adult beetles. 
2.16.3 Infection of beetles and in vitro culture of cysticercoids. 
Adult beetles were fed with eggs present in the gravid segments of the adult worm. 
The segments were excised and ground in a glass dish to make a pulp. The pulp was 
then fed to beetles that had been left to starve for 5 days in a glass petri-dish layered 
with filter paper. The pulp was placed on the filter paper allowing the beetles to feed on 
it. The pulp was left as the only source of food for 2-3 days to ensure it was completely 
eaten. Cysticercoids could thereafter be obtained from the infected beetles after 21 days. 
Beetles were maintained by removal of any new larvae. This was done every 2-3 weeks 
to ensure that the new beetles did not replace the infected ones as they died. 
2.16.4 Preparation of cysticercoids. 
Healthy looking T. confusum beetles previously infected with cysticercoids of H. 
diminuta and H. microstoma were selected to ensure presence of living cysticercoids. 
Two to 3 ml of filter-sterilised insect Ringer's solution (6.5g NaCl, 0.14g KCI, 0.12g 
CaC12,0.1 g NaHCO3, O. Olg Na2HPO4: Made up to l litre with de-ionised water) was 
placed into a solid watch glass (radius =2cm). 
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Using fine-forceps a beetle was transferred to the watch-glass. Under a dissecting 
microscope the beetle's head was removed by gently pulling with the forceps resulting 
in the release of the haemocoel content into the insect Ringer's solution. Once dissected 
the cysticercoids (usually between 5-10 per beetle) were readily apparent within the 
haemocoel fluid. The cysticercoids were then transferred to another watch-glass 
containing filter-sterilised Hanks saline (8. Og NaCl, 0.4g KCI, 0.14g CaC12,0.19 
MgSO4.7H20,0.1g MgC12.6H20,0.06g Na2HPO4.2H20,0.06g KH2PO4) l. Og glucose, 
0.35g NaHCO3 and 100mg phenol red indicator: Made up to 1 litre with de-ionised 
water) and the process repeated until approximately 100 cysticercoids were collected. 
2.16.5 Hatching, of cysticercoids. 
Cysticercoids were hatched according to a method described by Behnke, (2001). Five 
solutions A-E were prepared as follows: A, 2g of pepsin (Sigma) in 100ml of 0.85% 
NaCl; B, 1. Oml conc. HCL in 100 ml of 0.85% NaCl; C, lg of trypsin (Sigma) in 
100ml of Tyrode's saline; D, lg of sodium tauroglycocholate (Sigma) in 100ml of 
Tyrode's saline, and E, Tyrode's saline (8. Og NaCl, 0.20g KCI, 0.20g CaC12,0.10g 
MgC12,0.05g NaH2PO4,1. Og glucose, 1. Og NaHCO3 /litre). 
10ml of 1% pepsin in acid 0.85% NaCI was prepared by adding 5m1 of solution A to 
5m1 of solution B in a small Petri dish (acid pepsin solution). 10ml of 0.5% sodium 
tauroglycocholate was also prepared by mixing 5m1 of solution C and 5ml of solution D 
in a separate Petri dish (Tyrode's tauroglycocholate-trypsin solution). These mixtures 
were then warmed to 37°C in a waterbath. 
The 100 isolated cysticercoids were transferred to a fresh watch glass containing 2m1 of 
Hank's saline. Cysticercoids in groups of 20 were selected and each placed in separate 
watch-glasses. Excess fluid was removed using a Pasteur pipette until minimal Hank's 
saline remained containing the cysticercoids. 2m1 of the pre-warmed acid pepsin 
solution was then added, the watch glass was then sealed with parafilm and incubated at 
37°C in a waterbath for 5-10 minutes. The acid pepsin solution was then removed and 
the cysticercoids washed 4 times in Tyrode's (solution E). After the Tyrode's was 
removed, 2ml of Tyrode's tauroglycocholate- trypsin solution was added. The 
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watchglass was then recovered in parafilm and placed back into the waterbath for up to 
30min until all cysticercoids were hatched. 
2.16.6 Test of effects of NTZ and related drugs on newly excysted cysticercoids 
of H. diminuta and H. microstoma. 
Ten cysticercoids (newly hatched) were placed into separate wells of a 96 well plate 
containing 1001il of Dulbecco's Modified Eagle's medium (DMEM). Initially, drug 
concentrations of lµg/ml to 10µg/ml were added to wells. Drugs included Romark 
compounds, niclosamide, FCCP, CCCP, PRAZ and DMSO as a solvent control. The 
plate was kept in a 37°C incubator (5% C02/ 95 % air) and monitored at ambient 
temperature using an inverted microscope (magnification 20x) every 10 minutes for one 
hour followed by half-hourly checks for a further 3 hours. Effects on cysticercoids were 
also examined at 12 hours and 24 hours post drug addition. Drug effects were evidenced 
by changes in motility, sucker movement and morphology, characterised by scolex 
damage. MI50's were found for each drug by making 2 fold dilutions from 10µg/ml and 
calculated using Sigmaplot 2000. 
Similarly compounds were added to cysticercoids in medium containing 10% FCS. in 
order to observe effect of serum on drug effect. 
2.16.7 Effect of NTZ on motility of adult H. diminuta. 
Adult H. diminuta were individually placed in plastic 9cm Petri dishes (Sterilin) 
containing 15 ml of EBSS containing 1 or 10µg/ml of either NTZ, TIZ, DNNTZ, 
BZNT, NIC or 0.2% DMSO. The worms were monitored continually for a period of 4 
hours using a bench dissecting microscope (Nikon). Drug effects were evidenced by 
motility disturbances (e. g. increased activity or paralysis), morphologic changes (e. g. 
relaxation, shrinkage, curling), tegumental effect (disruption, darkening, granulation and 
blebbing) and scolex damage. Death was assumed if worms demonstrated no movement 
within a2 minute period. 
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2.17 Effect of NTZ and selected 'uncouplers' on the oxygen 
uptake of H. diminuta. 
2.17.1 Isolation of mitochondria. 
Adult H. diminuta were obtained from Wistar rats by manual removal from the 
intestine and maintained in Tyrode's balanced salt solution. 5g of worms (wet weight) 
were transferred to 25m1 isolation medium (5m1 of medium per g wet weight of worms) 
at pH 7.4*. The parasites were cut up finely with scissors and then homogenised with a 
Dounce homogeniser at 0°C. The homogenate was centrifuged at 1000 g for 15min at 
4°C. The supernatant was taken and centrifuged at 9500 g for a further 15min. The 
resulting crude mitochondrial pellet was resuspended in 5ml of isolation medium 
lacking BSA then centrifuged at 16000 g for 15min. After washing gently in isolation 
medium minus BSA the final mitochondrial pellet was resuspended in reaction medium 
containing 0.15M sucrose, 10mM Tris, 20mM KH2PO4,30mM KCl and 5mM MgC12 
pH 7.4. 
* Isolation medium [0.25 M sucrose, 25mM Tris, 1 mM EGTA and 1% defatted bovine 
serum albumin]. 
2.17.2 Protein assay. 
A mitochondrial sample of H. diminuta was assayed for protein content using BSA as 
described in section 2.9.4. 
2.17.3 Measurement of oxygen uptake. 
Oxygen uptake was measured at 37°C using a Dual Digital Model 20 oxygen electrode 
(Rank Brothers LTD) in a similar method as described by Yorke & Turton, (1974). A 
0.2m1 mitochondrial suspension in reaction medium containing 0.24 mg of protein was 
added to 0.8ml of reaction medium. Succinate and ADP substrates were added from 
stock solutions of 160mM and 100mM respectively. After stabilization of oxygen levels 
for 5 minutes, 6.7mM succinate was added followed by 200µM ADP. The respiratory 
control ratio was calculated as the ratio of oxygen uptake following and prior to, the 
addition of ADP. The rate of 02 uptake was calculated in ng-atom/min/mg protein. NTZ 
or TIZ were added, to see whether coupled respiration and ATP synthesis by the 
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mitochondrial respiratory chain system was inhibited. NTZ and TIZ (1mg/ml stock 
solutions) were added to the reaction mixture after addition of ADP. The final 
concentration range of drug added was between 1 and 20µg/ml. NIC, CCCP and FCCP 
were used as positive controls and levamisole and DMSO (0.2% w/v) were used as 
negative controls. All experimental drugs and control drugs were added to the same 
final concentrations. 
2.18 H. diminuta tegument preparation for SEM. 
Adult H. diminuta were exposed as in 2.16.7 to 101tg/ml NTZ, DNNTZ, BZNT, or 
DMSO. Drug exposure was for 30 min and incubation was at 37°C. After 30 minutes 
drug-incubation the worms were immediately fixed with 3% glutaraldehyde in 0.2M 
sodium cacodylate buffer pH 7.4 and a lcm2 section of proglottid removed 
approximately 2cm below the neck of the worm. The specimens were then prepared for 
SEM using the same techniques described in section 2.14.1 Specimens were examined 
under SEM and photographed as described in section 2.14.2. 
2.19 NTZ as a molluscicidal agent. 
Dreyfuss et al, (1996) and Rondelaud & Dreyfuss, (1996) have previously described the 
antimolluscal properties of niclosamide and BZNT. In a modification of the assay used, 
NTZ and TIZ were examined for potential molluscicidal properties. 
2.19.1 Comparative assay of NTZ and niclosamide for molluscicidal activity 
against B. glabrata. 
In order to examine molluscicidal drug toxicity, NTZ, TIZ and Bayluscide (70% WP 
niclosamide) were assayed against B. glabrata for effects on snail motility, morphology 
and viability. For each assay, 10 snails (average size of about 1.5cm in diameter) were 
placed into separate conical flasks containing one litre of water and the appropriate drug 
concentration (0.5mg/L or lmg/L). Each concentration was tested in triplicate. 
Molluscicide stock solutions were made to 0.25mg/L'1 in snail water. 25ml of the stock 
solution was then diluted with 225ml of snail water to give a working drug 
concentration of 0.025mg/ml. The assay was carried out for 48 hours, with snails 
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initially exposed to drug and monitored every 30 minutes for 6 hours. Temperature was 
monitored periodically and maintained at 26°C for this time After this initial exposure, 
snails were then washed in fresh snail water, transferred to a recovery container and 
monitored for a further 42 hours. Food was provided for the surviving snails when they 
were transferred to the recovery container after 6 hours. DMSO (0.1%) was used in 
comparison as a solvent control. 
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3.1 Introduction. 
In order to investigate the effects of nitazoxanide (NTZ) on helminths, NTZ and its 
metabolites (tizoxanide, TIZ and tizoxanide glucuronide, TIZg) and derivatives (denitro- 
nitazoxanide, DNNTZ, denitro-tizoxanide, DNTIZ, 2-benzamido-5-nitrothiazole, BZNT) 
were tested on C. elegans, a free-living nematode which is simple to culture and which has 
a fully characterised genome (Wood, 1998). The assay, which included microscopic 
analysis of the worms in liquid medium was used to examine drug effects on worm motility 
and behaviour. Using initial findings from C. elegans, studies were extended to examine 
effects on other nematodes: Trichostrongylid sheep parasites, Nematodirus spathiger and 
Haemonchus contortus and also Ascaris suum, a parasite of pigs. 
3.2 Effect of NTZ/ TIZ on C. eleoans. 
L3 (Dauer) stage larvae, and adult worms of C. elegans were assayed to examine NTZ/ TIZ 
effect on worm motility and viability. Varying concentrations of drug were added to wells 
of a 24 well plate containing 10 worms (triplicates) in 2 ml of axenic medium at ambient 
temperature. Effects were monitored microscopically at regular intervals. 
Initially worms were exposed to 10µg/m1 NTZ (33µM) or TIZ (38µM). At this 
concentration approximately 90% of adults and L3 larval stages of C. elegans exhibited 
paralysis. Paralysis was characterised by loss of the normal `S' shaped movement of the 
worm and an increase in rigidity producing jerky or spastic movement. It was most marked 
in the posterior part of the worm. The effect developed over 20 min and lasted for up to 2 
hours. The effect was comparable to the "transient spastic paralysis, " caused by the 
anthelmintic compound levamisole (Hardman, 1996). Equivalent concentrations of the drug 
solvent DMSO produced no observable effect on C. elegans motility or viability. 
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The observed paralytic effect of NTZ/TIZ was concentration dependent with regard to both 
the proportion becoming paralysed and the rapidity of its induction. At 2011g/ml paralysis 
was observed in 100% of worms and at 0.1 gg/ml no motility effect and hence no paralysis 
was observed. For those worms demonstrating a paralytic effect, no significant variation in 
speed of onset (approximately 20 minn) was detected between concentrations of 10 and 
100µg/ml. 
3.2.1 Effect of other Romark compounds on C. elegans. 
No observable effect on C. elegans was produced by TIZg, DNNTZ, DNTIZ or BZNT at 
concentrations which produced 100% paralysis for NTZ and TIZ. These compounds were 
also tested at 30µg/ml, but they still failed to visibly affect the worms. 
3.2.2 Effect of other anthelmintic drubs on C. elegans. 
The effects of the known anthelmintics levamisole, ivermectin, mebendazole, 
fenbendazole, praziquantel and niclosamide were examined for comparison of the effect 
observed with NTZ and TIZ. The anti-protozoal compound metronidazole, and the 
protonophores (uncouplers) Carbonylcyanide m-chlorophenylhydrazone (CCCP) and 
Carbonyl cyanide p-(trifluoromethoxy) phenyl-hydrazone (FCCP) were also tested. 
Levamisole, which causes transient spastic paralysis, was selected as a positive control. At 
lOpg/ml, levamisole produced complete paralysis in 100% of worms within 5-10 minutes 
but, unlike with NTZ and TIZ, no worm recovery was observed for the duration of the 
assay. At 1 pg/ml, 100% paralysis still developed, though speed of paralysis was less rapid, 
occurring in 10-15 minutes. Of the other drugs tested, metronidazole (MTZ) an anti- 
protozoal reductively activated nitroimidazole drug, showed no effect within 6 hours. The 
other anthelmintic drugs, mebendazole, fenbendazole, praziquantel and niclosamide also 
showed no effect during the 6 hour test. Addition of lOpg/ml and 1 Vg/ml ivermectin caused 
rapid paralysis within 5 minutes. Unlike the paralysis observed with NTZ, ivermectin- 
induced paralysis was tonic evidenced by a complete lack of worm movement. Again no 
worm recovery was observed. Ivermectin however, was poorly soluble in DMSO and 
precipitated in axenic medium, hence results were difficult to interpret as worms would 
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become entangled in the resulting precipitate. Also exact concentrations to induce paralytic 
effect were unable to be calculated due to this precipitation. Addition of 10µg/ml FCCP or 
lOgg/ml CCCP caused rapid paralysis (<10 minutes) in 100% of exposed C. elegans. The 
drug-effect was similar to that of ivermectin, in that it resulted in a complete and tonic 
paralysis of the worm with no movement evident. No recovery was seen in these worms 
within 6 hours. At lower concentrations (Ipg/ml), FCCP had no effect on worm movement 
with no paralysis evident. Interestingly addition of 1 gg/ml and 0.1 gg/ml CCCP caused the 
same rapid and tonic paralysis as observed with the 10µg/ml concentration. 
3.2.3 Dose response of NTZ/TIZ in C . elegans. 
Dose response curves were obtained for NTZ and TIZ for L3 larvae (figure 3.1) and MIso 
values (concentration of drug to causing motility inhibition in 50% of worms after 60 
minutes) were calculated for these positive Romark compounds using Sigmaplot 2000 
(Table 3.1). 
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Figure 3.1 Determination of MI. m of NTZ and TIZ with C. e%ans. 
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Paralysis of worms exposed to NTZ (a) or TIZ (b) for 60 minutes in axenic 
medium. Sigmoid inhibition curves were fitted using Sigmaplot 2000. 
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Table 3.1: Effect of Romark compounds and control drugs on 
C. eleoans motility. 
Compound MI 50* ± S. E. (µg/m1) 
Nitazoxanide 1.4± 0.2 
Tizoxanide 2.9 ± 0.5 
Denitro- Nitazoxanide N. E. 
Denitro- Tizoxanide N. E. 
Tizoxanide- glucuronide N. E. 
2 Benzamido- 5- Nitrothiazole N. E. 
Mebendazole N. E. 
Levamisole > 0.1 < 1.0 
Niclosamide N. E. 
Ivermectin > 0.1 <1 
FCCP >1< 10 
CCCP < 0.1 
Metronidazole N. E 
Fenbendazole N. E 
MI 50 =- Concentration of drug which results in the motility inhibition in 
50% of the worm population in 60 minutes. 
N. E. = No Effect: Inhibition of motility not detected up to 30µg/m1. 
* for concentration calculations from µg/ml to µM see Appendix IV. 
Table 3.1: The sensitivity of C. elegans motility to NTZ and TIZ was measured as a percentage 
of L3 larvae affected at 60 min in a range of drug concentrations. 
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3.2.4 Assessment of effects of NTZ/TIZ on egg hatching and larval development. 
3.2.4.1 Culture on solid medium. 
Petri dishes containing NGM agar were streaked with 100µl E. cola liquid culture which 
contained from 1 to 20gg/ml NTZ or TIZ. The next day eggs of C. elegans were placed onto 
the bacterial lawn and hatching of eggs observed by regular monitoring every 30 minutes 
using an inverted microscope at 20x magnification. At no concentration of either drug was 
egg hatching affected and worms developed normally compared to the solvent controls. 
3.2.4.2 Axenic cultures. 
In case the lack of effect upon hatching was due to metabolism of drugs by E. coli prior to 
addition of eggs, hatching was also tested in liquid axenic medium. NTZ or TIZ (1-20gg/ml) 
were added to axenic media containing eggs, and cultures were monitored every 30 minutes 
using an inverted microscope at 20x magnification. At no concentration did the presence of 
NTZ or TIZ prevent egg hatching and larval development was normal compared to the 
solvent controls. 
3.3 Test of acetyicholinesterase inhibition by NTZ. 
The initial observations of paralysis of C. elegans by NTZ suggested a neurological 
response in the nematodes. This could be due to build up of acetylcholine as a result of 
inhibition of acetylcholinesterase as described for an anthelmintic mechanism of pyrantel 
(Hardman & Limbird, 1996). Paralysis could also be due to a direct effect on specific neuro- 
receptors, which is considered to be the anthelmintic mechanism of levamisole (Martin et al, 
1997) and ivermectin (Vanden Bossche et al, 1985). 
Possible inhibition of acetylcholinesterase (Achase) by NTZ was therefore tested using the 
type VI-S acetylcholinesterase from Electrophorus electricus, which is commercially 
available and sensitive to inhibition by metrifonate. The enzyme hydrolyzes other 
alkylacetates, including acetylthiocholine (ASch), which can be observed 
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spectrophotometrically, in the presence of Ellman's reagent (Hussein, 1999), due to the 
formation of the yellow 5-thio-2-nitrobenzoate at 412nm. 
Addition of from 0.1-20µg/ml (0.32µM to 64µ. M) NTZ in DMSO to E. electricus 
acetylcholinesterase, showed no significant inhibition of rate of ASch hydrolysis over a 30 
minute period (see figure 3.2). TIZ similarly showed no effect on the rate. The positive 
control drug metrifonate (MET) at 10µg/ml clearly inhibited the rate of hydrolysis after a 
delay of about 15 minutes. This inhibition was dependent on concentration. DMSO only 
caused no effect in rate of hydrolysis. 
Fig 3.2 Test of inhibition of Achase by NTZ. 
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Fig 3.2: Achase of E. electricus was assayed spectrophotometrically in 1 ml cuvettes with acetyl thiocholine as 
substrate by monitoring the formation of 5-thio-2-nitrobenzoate by increased absorbance at 412nm. Test of 
inhibition of Achase was monitored in the presence of the DMSO solvent control (a), NTZ, 10µg/ml (b) or 
metrifonate 10µg/m] (c). Metrifonate showed reduction in the rate of hydrolysis of ASch (30%, 47% and 50% 
reduction after 15-20,20-25 and 25-30 minutes respectively) and therefore was inhibiting the activity of the E. 
e/ectricus Achase. NTZ and DMSO had no effect on the rate of hydrolysis of ASch and hence no Achase 
inhibitor}, activity. Chart rate was at 2mm/min. 
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It was then necessary to test if NTZ caused paralysis in C. elegans by direct action on a 
neuromuscular receptor. 
3.4 Testing nicotinic receptor antagonists, pempidine and mecamvlamine and the 
muscarinic receptor antagonist, atropine as blockers of NTZ action on C. eleEans. 
C. elegans has been thoroughly characterised with respect to its neuromuscular receptors 
and how they are affected by anthelmintics (Martin et al, 1997), so the effects of NTZ/TIZ 
on these systems were investigated. 
3.4.1 Nicotinic antaizo nists. 
The characteristic depolarizing, neuromuscular blockade on the nicotinic receptor, seen with 
levamisole (Martin et al, 1997) is blocked by the specific nicotinic, ganglionic- blocking 
agents pempidine or mecamylamine (James & Gilles, 1985). Therefore, to test whether NTZ 
was affecting a nicotinic receptor in C. elegans, these compounds were tested as blockers of 
its paralytic effect. 
Treatment of C. elegans L3 larvae or adults with pempidine (2014M) or mecamylamine 
(20µM), 20 min before addition of 10µg/ml NTZ (a concentration causing paralysis in 90% 
of the worms), resulted in no onset in worm paralysis for 40 minutes post NTZ addition and 
normal `S' shaped movement was observed. After this time the antagonism began to wear 
off and worms began to show characteristic paralysis due to NTZ. 
If worms were exposed to 10µg/ml NTZ and pempidine or mecamylamine (20µM) was 
added after 20 min, the initial paralysis was abolished for 10 minutes with mecamylamine 
and 20 minutes with pempidine. Neither addition of mecamylamine nor pempidine alone 
showed an effect on worm motility. 
These results were consistent with NTZ having an effect at a nicotinic receptor in C. 
elegans similar to that of levamisole. Muscarinic receptor activity was then tested to assess 
the specificity of a nicotinic receptor effect. 
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3.4.2 Muscarinic anta ognists. 
Addition of the muscarinic receptor antagonist atropine (20µM) to C. elegans caused no 
paralysis or effect on movement of the worm. Pre-treatment and post-treatment with atropine 
20 minutes before or 20 minutes after addition of 10µg/ml NTZ failed to prevent or reverse 
characteristic NTZ-dependent paralysis. This suggests that the paralysis observed in C. 
elegans may be specifically associated with nicotinic receptor activity. 
The effect of nitazoxanide on the nicotinic receptor was therefore investigated further in C. 
elegans by examination of specific receptor mutants. 
3.5 Analysis of motility inhibition by NTZ in C eleeans using specific 
neuromuscular receptor mutants. 
Uncoordinated mutants of C. elegans have previously been used to examine macro- 
molecule function in the nematode nervous system (Richmond and Jorgensen, 1999). 
Although locomotion in the mutants is impaired, the muscles still contract allowing 
determination of the mechanism of action of various compounds such as levamisole which 
specifically targets nicotinic receptors as an agonist (Martin et al, 1997). 
Neuromuscular mutants of C. elegans were obtained to test potential nicotinic activity of 
NTZ. Assays were carried out to observe NTZ effect in the levamisole-resistant, nicotinic 
receptor mutants, 904,1072 and levl and these were compared to NTZ effects in the 'y- 
aminobutyric acid (GABA) receptor mutant 407. The wild type and levamisole-treatment 
were used as controls. 
Mutants 407,904, levl, 1072 and wild type C. elegans, maintained in axenic liquid 
medium, were each exposed to 10µg/ml NTZ (table 3.2). The wild type showed the 
characteristic paralysis after 20 minutes. The GABA receptor mutant, 407, which was more 
rigid than the wild type and moved very awkwardly in axenic media, showed evidence of 
slight paralysis at the same time as paralysis was observed in the wild type. Nicotinic 
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mutants 904, lev 1 and 1072, which all have reduced motility compared to the wild type and 
more jerky movement, showed no evidence of altered motility in the presence of 10µg/ml 
NTZ. Levamisole (lOgg/ml) showed paralysis in the wild type and increased paralysis in 
mutant 407, which was more clear than that seen with NTZ. In mutants 904, lev 1 and 1072, 
levamisole showed no effect. Blinded studies were attempted with the mutants, however 
each mutant had a characteristic type of motility in axenic media and were therefore easy to 
distinguish between prior to drug addition. 
Table 3.2 Effect of NTZ on C. eleLans nicotinic receptor mutants. 
C. elegans strain Motion Effect of LEV Effect of NTZ 
(10µg/m1) (10µg/m1) 
Wild type `S-shaped' 
GABA receptor Jerky movement 
mutant 407 stiff posterior 
Nicotinic receptor Slightly spastic 
mutant 904 kink in posterior 
Nicotinic receptor Spastic in 
mutant 1072 movement 
Nicotinic receptor Poor motility 
mutant 1ev 1 stiff posterior 
Spastic paralysis Spastic paralysis 
in posterior end 
Paralysis & Increased jerkiness 
some curling some paralysis 
No effect No effect 
No effect No effect 
No effect No effect 
Table 3.2 10µg/ml NTZ or LEV was added to mutants of C. elegans in 24 well plates (triplicate) containing 2 
ml of axenic media at room temperature and effects on motility were observed microscopically for 4 hours. 
With mutants 1072,904 and lev 1, spastic paralysis was not observed upon addition of NTZ or LEV during the 
allotted time. Mutant 407 however, on addition of levamisole became rapidly paralysed and slight curling of 
the worm was evident. Addition of NTZ caused increased worm jerkiness, followed by sluggishness leading to 
slight paralysis. Effects however, were difficult to determine due to the uncoordinated movement of the 
mutants. 
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3.6 Examination of the effect of NTZ at nicotinic receptors in C elejans using 
tetramethyl-rhodamine-labelled a-bungarotoxin (rhBTX). 
Interaction of NTZ/TIZ at nicotinic receptors was further examined in C. elegans using 
rhBTX, a known agonist for nicotinic receptors (Haughland, 1998). In contrast to the results 
obtained with trematodes (see Chapter 4. ), 20 minutes pre-incubation of C. elegans with 
20µM rhBTX followed by 2 hours incubation with control solvent (0.1% DMSO), 
examination by fluorescence microscopy showed no binding of rhBTX to the nicotinic 
receptors or to the surface of the worm. However, the pharyngeal area of the worm showed a 
large amount of fluorescence, suggesting ingestion of the rhBTX, rather than trans-cuticular 
entry (not shown). Treatment with NTZ/TIZ 10µg/ml for 20 minutes pre- and post 
incubation with 20µM rhBTX again showed no binding to C. elegans nicotinic receptors or 
surface marking. Fluorescence was still observed in the pharyngeal part of the worm. 
The study of the effects of NTZ on helminths was then extended to the parasitic nematodes 
Ascaris suum, Nematodirus spathiger and Haemonchus contortus. 
3.7 Effect of Romark drugs on Ascaris suum. 
In order to further investigate the effect of NTZ/TIZ on the receptors of nematodes the 
physiological effects of classical transmitter substances on the motor activity of nematode 
somatic musculature were examined and compared to those of NTZ/TIZ using A. suum (a 
roundworm similar to A. lumbricoides). 
Initial experiments on adult Ascaris suum motility using NTZ were carried out in glass 
beakers and effects compared to controls containing equal concentrations of the drug diluent, 
DMSO in APF. Addition of a final concentration of 40µg/ml NTZ, caused worm behaviour 
to alter slightly after 15-20 minutes, characterised by the worms coiling themselves into 
tighter positions. After 50-60 minutes the worms started to become rigid and movement was 
visibly different to that of the DMSO and APF alone controls. This lack of movement was 
evident for approximately 2 hours and then worms began to recover slightly. After 24 hours, 
worms were again sluggish and this sluggishness increased during the remainder of the 
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assay. Negative controls of worms in DMSO and APF only, were fairly active for the first 24 
hours of the assay. After this time all worms showed decreased motility, and sluggishness 
and no difference could be observed between drug-exposed and control worms after 48 
hours. No significant effect was observed with concentrations of drug below 40pg/ml. TIZ 
(maximum concentration tested 30pg/ml owing to lack of solubility) showed no effect on 
motility with the adult worms. 
3.7.1 Effect of NTZ on Ascaris suum muscle-strip preparations. 
Effects of NTZ were tested on a preparation of dissected Ascaris muscle in an organ bath 
attached to a tension sensor. Muscle contractibility was tested by addition of 30µM 
acetylcholine (Ach), which caused the muscle-strip to contract resulting in a rapid increase 
in tension, followed by a rapid decrease due to desensitisation of the tissue (figure 3.3 a). 
LEV (30µM) also caused a rapid increase in muscle tension, which diminished more slowly 
(figure 3.3 b). Addition of 150µM NTZ caused a similar contraction of the muscle but it was 
smaller and diminished more slowly than that observed with Ach or levamisole. Higher 
concentrations of NTZ (up to a final concentration of 600µM in the bath) increased both the 
amount of tension in the muscle-strip and the desensitisation period of the drug (figure 3.3 c 
and d; figure 3.4). The relatively long desensitisation period seen with NTZ suggests a 
longer persistence of NTZ at the receptor. Concentrations of NTZ below 100µM or the 
solvent alone (figure 3.3 e) showed no contraction of the Ascaris muscle. TIZ up to 100µM, 
showed no effect on A. suum muscle strip. This was the maximum concentration that could 
be tested due to lack of solubility of this compound. 
In order to test whether NTZ/TIZ were interacting with GABA receptors, they were added 
immediately after addition of Ach or LEV. Under these conditions GABA (30µM) causes 
rapid relaxation of the muscle strip and cessation of contractions via chloride channel 
opening (Maule et al, 2003). However, neither NTZ (10-600µM) or TIZ (10-100µM) altered 
the Ach or LEV dependent contractions. 
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Figure 3.3 Effect of NTZ on Ascaris scum muscle tension. 
Fig 3.3: 4.. cinn muscle strips were tensioned at I g, and the effect of addition of a) 30µM Ach, b) 30µM 
levamisole, c) 200µM NTZ d) 400µM NTZ and e) 0.2% DMSO (w/v) final concentration were measured. One 
horizontal division on the chart is 5 minutes and 8 vertical divisions represent Ig tension. Clear contraction can 
be seen on addition of 30µM Ach or 30µM levamisole. Addition of 200µM NTZ causes a slight contraction, 
which increases with increased drug concentration. Equivalent concentrations of drug solvent have no effect on 
Ascaris muscle. 
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Figure 3.4 Concentration dependence of effect of NTZ on contraction of Ascaris muscle. 
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Fig 3.4: Ascaris muscle strip was exposed to LEV (30µM) and NTZ (10-6(X) iM) in an organ-bath. Clear muscle 
contraction with 30µM LEV was observed. NTZ caused a slight muscle contraction at 100µM which increased 
with increasing concentration. Concentrations of NTZ below 100µM caused no observable contraction. Addition 
of DMSO only at concentrations equal to those used with the drugs did not cause contraction of the Ascaris 
muscle. 
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3.8 Examination of Possible NTZ effect on fumarate reductase of 
Haemonchus contortus. 
Another possible mechanism of anthelmintic action of NTZ is the possibility that the drug 
inhibits fumarate reductase in helminths, as suggested by Kuramochi et al, 1995. 
Haemonchus contortus has previously been used as a model for demonstration of fumarate 
reductase drug activity (Malkin & Camacho, 1972; Prichard, 1973) and this mechanism of 
action has previously been shown for thiabendazole with H. contortus (Bryant & Bennett, 
1983) and also for bithionol with A. lumbricoides (Ikuma et al, 1993). Levamisole has also 
been shown to have fumarate reductase inhibitory activity (James & Gilles, 1985). 
Preliminary experiments with Haemonchus contortus showed that addition of 10µg/ml NTZ 
caused paralysis in adult worms. This paralysis, characterised by initial jerkiness, developed 
slowly and was followed by a decrease in worm movement leading to tonic paralysis. 100% 
of worms were affected within 3 hours. No recovery of worm motility was observed up to 7 
hours post drug addition. Equal concentrations of DMSO, the drug solvent, had no effect on 
worm motility, and all worms were active up to 5 hours after solvent addition. After this 
time, worm activity started to decrease due to the inadequate in vitro culture conditions. 
Therefore, possible fumarate reductase inhibition as an additional mode of action was tested. 
Mitochondria were prepared from H. contortus and fumarate reductase assayed by 
differential oxidation of NADH in the presence/absence of fumarate. 
Mitochondrial preparations from adult H. contortus were found to oxidise NADH, with the 
rate of oxidation being significantly enhanced (P < 0.02) by the addition of 10µg/ml sodium 
fumarate (see table 3.3). The rate observed (approximately l0nmol/min/mg protein) is 
comparable to that observed by Prichard, (1973) and confirms the presence of the fumarate 
reductase system in this helminth. 
Addition of a final concentration of 1-20µg/ml NTZ or TIZ however, failed to inhibit the 
rate of NADH oxidation in the system. In fact the drugs increased the rate 18% and 23% at 
10µg/ml respectively. Higher concentrations of NTZ/TIZ also showed a slightly increased 
rate (see table 3.3 & fig 3.5). Rotenone (1O ig/ml), a known fumarate reductase inhibitor 
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(Bryant et al, 1983) significantly decreased the rate of NADH oxidation. Addition of 
20µg/ml rotenone, further decreased NADH oxidation rate. DMSO (0.2% w/v) only had a 
small affect on rate with a3% increase observed. 
Table 3.3 Effect of NTZ, TIZ, rotenone and DMSO on the fumarate reductase 
system in Haemonchus contortus. 
Additions Rate of NADH oxidation Percentage of rate of NADH oxidation 
(nmol/min/mg protein) f s. d. in presence of fumarate 
NADH Hepes 18.7: h 2.12 68.9 
+ 0.2% DMSO 
NADH Hepes 
+I Opg/ml NTZ 20.6 ± 0.6 76 
NADH Hepes 
+ 10µg/m1 
rotenone 3.9 ± 1.1 14 
Fumarate + NADH 27.1 ± 0.5 100 
Fumarate + NADH 27.8 ± 3.8 103 
+ 0.2% DMSO 
Additions Rate of NADH oxidation Percentage of 
Fumarate rate only (nmol/min/mg protein) f s. d. fumarate rate 
Fumarate 9.1 f 3.8 102 
+ 0.2% DMSO 
Fumarate 10.8 t 1.9 118 
+I Opg/ml NTZ 
Fumarate 11.5 ±4.5 126 
+ 20pg/m1 NTZ 
Fumarate 11.2 f 2.7 123 
+ IOpg/ml TIZ 
Fumarate 11.4 t 2.4 125 
+ 20µg/m1 TIZ 
Fumarate 0.7 ± 0.3 7 
+ 10µg/m1 rotenone 
Fumarate 0.5 ± 1.1 5 
+ 20pg/ml rotenone 
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Fumarate reductase activity was calculated by subtracting the NADH rate + fumarate from 
the NADH rate + an equal volume of buffered Hepes (replacing fumarate). The reaction 
rates are expressed as means ± standard deviation. T tests were carried out using a Student t- 
test with P<0.05 considered significant (see table 3.4). 
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Figure 3.5 Change in fumarate reductase activity in the presence of 
NTZ. TIZ. ROT and DMSO. 
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1= Fum only 2= Fum + 0.2% DMSO 3= Fum + 10µg/m1 NTZ 4= Fum + 20µg/m1 NTZ 
5= Fumarate + 10µg/m1 TIZ 6= Fum + 20µg/m1 TIZ 7= Fum + ROT 10µg/m1 8= Fum + ROT 20µg/m1 
Fig 3.5: Fumarate reductase was measured via NADH oxidation spectrophotometrically at 340nm. 
Rotenone at 10µg/ml significantly inhibited fumarate reductase (P < 0.0005). NTZ, TIZ (10 and 
20µg/ml) and DMSO increased fumarate reductase activity. Rate of NADH oxidation in the presence of 
fumarate was also increased by NTZ, TIZ and DMSO. 
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Table 3.4 Effect of NTZ, TIZ and ROT on fumarate activity. 
Drug rate. Control NTZ (10µg/ml) TIZ (IOgg/ml) Rotenone (10µg/m1) 
Mean fumarate 9.1 f 3.8 10.8 ± 1.9 11.2 ± 2.7 0.7 ± 0.3 
reductase activity. 
nmol/min/mg protein 
P value. - 0.3 0.2 0.0004 
Table 3.4: Fumarate reductase activity was determined in H. contortus mitochondria in the presence of NTZ, 
TIZ or rotenone. Means of triplicate values were compared by Student t-test. 
Results from this experiment clearly show that NTZ and TIZ are not inhibiting fumarate 
reductase in the Haemonchus contortus mitochondrial preparation. It is likely that inhibition 
of fumarate reductase is not part of the mechanism of action of these drugs. 
3.9 Larval migration inhibition assay. 
Results thus far point towards a neurophysiological mode of action of NTZ, which in some 
ways is comparable to the mechanism of action of levamisole. Studies were extended using 
the third-stage (L3) larvae of two species of trichostrongylid gastrointestinal nematodes: 
Nematodirus spathiger and Haemonchus contortus. 
In vitro detection of substances that impair the motility of infective L3 larvae of gastro- 
intestinal nematodes may be examined by testing the ability of drug exposed larvae to freely 
migrate through a nylon mesh (Wagland et al, 1992; Douch & Morum, 1993). This allows a 
comparison of drugs with unknown mechanism to those of known mechanism which cause 
inhibition of motility. Potential NTZ/TIZ induced inhibition of migration with these parasitic 
larvae was therefore examined and compared to that of levamisole, a known inhibitor of 
larval migration (Douch & Morum, 1993). 
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3.9.1 Motili and migration of Nematodirus spathiger. 
3.9.2 Sheathed worms. 
In preliminary experiments, microscopic examination 2 hours post addition of levamisole, 
FCCP or CCCP (each at 1Ogg/ml), showed a clear effect on the motility of N. spathiger 
larvae, characterised by curling and paralysis. Subsequent addition of these paralysed larvae 
to the migration chambers (containing the same concentration of drug) showed significant 
inhibition of migration of sheathed worms through the mesh into the well. The inhibition 
was concentration dependent (figure 3.6) and allowed dose response curves to be calculated, 
yielding IMg50 values (concentration (µM) causing 50% inhibition of migration under these 
conditions) for levamisole, CCCP and FCCP in the 10 micromolar range. Increasing the pre- 
incubation times from 2 hours to 4 or 8 hours yielded similar results. 
NTZ, TIZ and other Romark compounds at concentrations up to 30pg/ml did not affect 
motility of N. spathiger on microscopic examination after 2,4 and 8 hours. Neither did 
addition of larvae to the drugged migration chambers post drug-incubation, prevent the 
migration of the larvae through the mesh. Mebendazole, niclosamide and the drug solvent 
DMSO also had no effect. However with these negative controls 2-3% of worms were 
unable to migrate due to becoming trapped owing to creases in the mesh causing clumping. 
This was observed also for Romark compounds, and these percentages were subtracted from 
the positives. No negative control drug induced increased clumping of the larvae as 
compared to the small amount of clumping which occurs naturally. 
3.9.3 Exsheathed worms. 
In case the lack of effect of some compounds was due to lack of drug penetration of the 
sheath, the larval migration assay was repeated as above, with exsheathment of worms 
carried out using sodium hypochlorite (see materials and methods). IMgso's were again 
calculated using Sigmaplot 2000 (Figure 3.6). 
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Fig 3.6 Determination of inhibition of migration of exsheathed 
N. spathiger by levamisole, FCCP and CCCP. 
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Fig 3.6: Exsheathed N. spathiger larvae were exposed to levamisole (+), FCCP (4) and CCCP (o) at varying 
concentrations for 2 hours and ability to migrate through a nylon mesh quantitated in comparison to solvent- 
tested controls. Data were analysed using Sigmaplot 2000 to obtain IMg50values. 
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Levamisole, FCCP and CCCP inhibited migration of exsheathed larvae more potently than 
sheathed larvae, in accordance with the findings of Douch & Morum, 1993. The Romark 
compounds, however, still showed no inhibitory activity. The results are summarised in table 
3.5. 
Table 3.5 Summary of effect of drugs on N. spathiRer L3 larval migration. 
DRUG IMg50 exsheathed 
f S. E (µM) 
IMg50 sheathed 
f S. E (µM) 
NTZ N. E. N. E. 
DNNTZ N. E. N. E. 
TIZ N. E. N. E. 
DNTIZ N. E. N. E. 
Levamisole 11.50 ± 1.55µM 17.98 ± 1.12 
Niclosamide N. E. N. E. 
TIZg N. E. N. E. 
BZNT N. E. N. E. 
CCCP 31.04 ± 1.78µM 39.86 ± 1.32µM 
FCCP 27.89 ± 2.53µM 37.54 ± 2.01 µM 
MEB N. E. N. E. 
IMg50 = Concentration of drug which resulted in inhibition of migration 
through a nylon mesh in 50% of the worm population. 
N. E. = No Effect: Inhibition of migration not detected up to 30µg/m1. 
3.9.4. Haemonchus contortus. 
The inhibition of migration of H. contortus was also investigated. Incubation with NTZ, 
TIZ and other Romark compounds (for 2,4 or 8 hours) had no inhibitory effect on the 
migration of H. contortus larvae whether sheathed or exsheathed, and did not cause 
paralysis. This is interesting owing to NTZ (10µg/ml) causing paralysis in 100% adult H. 
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contortus within 3 hours. Levamisole caused both paralysis and migratory inhibition 
yielding IMg5o values of 5.7 ± 0.7µM and 3.2 ± 0.5µM for sheathed and exsheathed larvae 
respectively. These values are similar to those obtained by Douch & Morum, (1993). The 
uncouplers FCCP and CCCP again caused paralysis and hence inhibition of migratory 
movement of H. contortus and IMg50's for FCCP and CCCP were 29.3 t 1.3µM and 24.0 f 
0.9µM for sheathed larvae and 28.07 ± 1.1µM and 23.22 ± 0.7µM for exsheathed larvae. 
3.10 Assay of nitroreductase activity in C. elenans with nitazoxanide 
and tizoxanide. 
In anaerobic protozoa, NTZ is thought to be reductively activated to produce a toxic product 
(Adagu et al, 2002). Nitroreductases of sufficiently low redox potential are occasionally 
found in microaerophilic or facultatively anaerobic species. A nitroreductase for E. cloacae 
previously shown by Bryant & DeLuca, (1991) (see Appendix V) shows sequence homology 
to a protein of C. elegans. Therefore, the reduction of NTZ by C. elegans was investigated. 
Since nitroreductases for different species may be linked to either NADPH or NADH, they 
were tested separately as electron donors to NTZ/TIZ and nitrofurazone (NF). In the 
presence of C. elegans clarified homogenate (0.1-0.3mg/ml protein), no change in NTZ/TIZ 
absorbance at 412nm or NF absorbance at 375nm was seen in the presence of NADH. With 
NADPH a decrease in absorbance was seen, however this was also observed in the solvent 
(DMSO) control. Therefore no evidence for a nitroreductase capable of reducing NTZ/TIZ 
was seen in extracts of C. elegans obtained under conditions in which NTZ/TIZ cause 
paralysis. It remains possible that the putative nitroreductase is expressed only during 
anaerobic/microaerophilic growth conditions of C. elegans. 
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3.11 Examination of effect of NTZ on ATP levels in C. eleRans. 
Since the protonophores FCCP and CCCP affected C. elegans motility, the action of 
NTZ/TIZ could be due to uncoupling of oxidative phosphorylation as well as nicotinic 
activity. Therefore the effects of NTZ/TIZ on ATP levels in C. elegans were examined. A 
sensitive luminescence assay was used incorporating the luciferin/luciferase enzyme system, 
modified from that previously used by Ronner et al, (1999) and Ford et al, (1996). 
Incubation of C. elegans with NTZ and TIZ at 10µg/m1 for one hour at ambient 
temperature, caused a substantial decrease in ATP concentration, with a further decrease at 
20pg/ml (Table 3.6). CCCP (1Oµg/ml) similarly caused a decrease in ATP concentration. 
The corresponding denitro-compounds and levamisole had no effect on ATP levels. The 
solvent DMSO at the concentration present when drugs are in the system had no effect on 
ATP levels which remained comparable to levels found in worms direct from axenic media. 
Table 3.6 Effect of NTZ/TlZ on ATP levels in C. elegans. 
Treatment DMSO (A) NTZ (B) NTZ (C) TIZ (D) 
0.2% 10µg/m1 201tg/m1 10µg/m1 
Mean [ATP] f s. d. 
nmol mg protein" . 4.8± 1.1 2.8±0.8 1.7± 0.5 1.9±0.6 
Treatment DNNTZ (E) DNTIZ (F) LEV (G) CCCP (H) 
logg/ml 10µg/m1 10µg/m1 10µg/m1 
Mean [ATP] ± s. d. 
nmol mg protein''. 4.9 ± 0.2 5.1 ± 0.9 5.1 ± 0.5 1.8 ± 0.7 
Table 3.6: Mean [ATP] was calculated for each drug and compared to DMSO control. The above table shows 
the typical values of the drug effects on ATP levels in nmol mg protein 1. The data for several experiments 
were hence incorporated and analysed in figure 3.7. All drugs used showed no reduction in ATP levels when 
tested with the standard only. 
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Figure 3.7 Effect of NTZ/TIZ on ATP content of C. elegans. 
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Fig 3.7: C. elegans were incubated for 1 hour at room temperature with NTZ (10 or 20µg/ml), TIZ 
(10µg/ml), DNNTZ (10µg/ml), DNNTZ (10µg/ml), LEV (l0. tg/ml), CCCP (10µg/ml) or DMSO (0.2%). 
After total solubilising in alkali, ATP was determined as described in the methods. All assays were carried out 
in triplicate and similar results were obtained in separate experiments. Significant differences between values 
were calculated using a Student t-test (see table 3.7). 
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Table 3.7 
- 
Significance testing of ATP levels in drug exposed C. elejans. 
Comparison of drugs A vs B A vs C A vs D 
P value < 0.01 < 0.0001 < 0.00001 
Comparison of drugs A vs H B vs C B vs D 
P value < 0.0001 < 0.01 < 0.05 
A= DMSO (0.2 %), 
C= NTZ (20µg/ml), 
B =NTZ (10µg/m1) 
D= TIZ (l 0µg/ml) 
E= DNNTZ (10µg/m1) F= DNTIZ (10µg/ml) 
G= LEV (10µg/m1) H= CCCP (10µg/m1) 
Table 3.7: Clear significance difference of ATP levels in NTZ , TIZ and CCCP drug treated worms compared 
to the solvent control treated worms is evident. The difference between ATP reduction with I Opg/ml NTZ and 
1Opg/ml TIZ is also significant. With C vs D, A vs E, A vs F and A vs G no significant difference was 
observed. 
3.12 Discussion. 
The mechanism of action of NTZ, TIZ and other Romark compounds was examined using 
the free-living nematode C. elegans as a model. Surprisingly NTZ and TIZ were found to 
have an effect on the nicotinic receptor of the worm as well as demonstrating an effect on 
ATP production supporting their proposed protonophore activity. Studies were extended to 
the parasitic nematodes A. suum, N. spathiger and H. contortus, however, these nematodes 
were less susceptible to the Romark compounds. The other Romark compounds DNNTZ, 
DNTIZ and TIZg showed no activity against any nematodes examined. 
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3.12.1 Possible NTZ neuromuscular mode of action. 
a) Acetylcholinesterase inhibition. 
Exposure of NTZ or TIZ (10gg/ml) to C. elegans induced paralysis which took 
approximately 20 minutes to develop, was characterised by jerkiness and was transient. This 
paralysis was similar (but of slower onset) to that observed with levamisole, but differed 
markedly from the tonic and flaccid paralysis observed with ivermectin. Since paralysis in 
worms can be caused by either direct receptor interaction (e. g. by levamisole or pyrantel at 
the nicotinic receptor or ivermectin at the GABA receptor) (Martin et al, 1997), or by 
inhibition of acetylcholinesterase (e. g. pyrantel and metrifonate), causing build up of 
acetylcholine and hence paralysis (Hardman & Limbird, 1996), these two mechanisms were 
examined. With NTZ/TIZ, no inhibition in the hydrolysis of ASCh was evident, whereas 
clear inhibition of hydrolysis with the known acetylcholinesterase inhibitor, metrifonate was 
observed. This suggests that if a neuroreceptor-type mechanism is in effect, the two Romark 
compounds may be acting directly on the nicotinic receptor rather than inhibiting 
acetylcholinesterase. 
b) Direct receptor interaction. 
Owing to NTZ-induced paralysis being more similar to that of the nicotinic agonist 
levamisole than ivermectin, direct receptor interaction was hence studied using muscle 
preparations from A. suum, and known nicotinic antagonists. In neurophysiological 
investigations with A. suum muscle preparation, Ach and levamisole (30µM), clearly 
demonstrated muscle contraction as previously described by Colquhoun et al, (1991), 
however, NTZ did not display any effect until 100µM was added. At this concentration a 
small contraction was observed, which became larger on addition of higher concentrations. 
This suggests that NTZ/TIZ has weak nicotinic agonist properties against A. suum compared 
to levamisole. Interestingly the length of the muscle desensitisation period after NTZ 
addition was quite long, suggesting that the Romark compound has a high affinity for the 
nicotinic receptor even though in vitro potency is low. (this may be an artifact due to the 
high drug concentration used). Addition of NTZ up to 600µM, did not abolish the Ach or 
levamisole induced contraction, indicating that the NTZ/TIZ effect on the worm is not due to 
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interaction with chloride-channels and is therefore not GABA related. TIZ showed no effect 
on A. suum muscle preparation, but higher concentrations of the drug could not be tested due 
to its poor solubility. 
With pre- and post-treatment of the nicotinic antagonists mecamylamine and pempidine 
(201M), the effects of lOgg/ml NTZ/TIZ were temporarily prevented or abolished. This is 
similar to the prevention of levamisole induced paralysis in susceptible nematodes in the 
presence of mecamylamine and pempidine (James & Gilles, 1985). Pre- and post-treatment 
with the muscarinic acetylcholine antagonist, atropine (20µM) showed no prevention or any 
abolition of NTZ/TIZ induced drug effect. This again suggests that NTZ/TIZ is acting 
directly on the nicotinic receptor in C. elegans. 
c) Mutants. 
Nicotinic receptor interaction was further examined using the known C. elegans levamisole- 
resistant mutants 1072,904 and levl. Neither levamisole nor NTZ/TIZ affected the motility 
of these mutants, but did cause paralysis in the GABA-resistant C. elegans mutant, 407 at 
the same time as paralysis was observed with the wild-type. This suggests NTZ is acting 
specifically at the nicotinic receptor in the worm. However, the paralysis or lack of paralysis 
in the GABA mutant induced by levamisole or NTZ/TIZ was difficult to discern as the 
mutant already had severe motility disfunction and the drug-induced changes were very 
subtle. 
d) BTX. 
Unlike with trematodes, examination of rhBTX localisation was of little use with C. 
elegans. Due to BTX being a large peptide (fw 8500), it could not be absorbed across the 
cuticle. It appears though that BTX was being ingested since fluorescence was observed in 
the pharyngeal area. 
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3.12.2 NTZ as a protonophore. 
a) C. elegans. 
Examination of NTZ/TIZ structure has suggested that these drugs may have protonophoric 
activity (D. C. Warhurst, unpublished data, 2000). In order to examine this possible 
mechanism of action in NTZ/TIZ, the action of the known protonophores FCCP and CCCP 
on C. elegans were compared with NTZ and TIZ. However, preliminary experiments 
showed FCCP and CCCP at 10µg/ml to cause a more rapid and tonic paralysis in the worm 
than that observed with NTZ. Also NTZ or TIZ induced paralysis was transient, with worms 
able to make a recovery, whereas worms exposed to FCCP and CCCP made no recovery. 
This lack of recovery in C. elegans following FCCP and CCCP would be expected from a 
protonophore and recovery in NTZ/TIZ exposed worms suggests a different mode of action. 
However non-lethal protonophoric activity may occur due to either NTZ being metabolised 
and hence detoxified by the worm or the worm ceasing drug ingestion. NTZ may also be 
more rapidly excreted from C. elegans than FCCP and CCCP. Niclosamide, though 
previously shown to have activity against the nematode Angiostrongylus cantonensis in vitro 
(Sano et al, 1982) did not affect C. elegans. This may be due to metabolism of the drug or a 
delayed toxic effect. 
In the larval migration study, both FCCP and CCCP demonstrated an inhibitory effect that 
was not seen with any Romark compound. According to Fry & Jenkins, (1984) the free- 
living L3 larvae of the trichostrongylid Nippostrongylus brasiliensis are susceptible to 
uncoupling by protonophores. Thus inhibition of larval migration caused by possible 
oxidative phosphorylation inhibition due to FCCP or CCCP is a possibility. NTZ and TIZ 
could also be able to demonstrate this effect, yet, owing to these Romark compounds having 
lower log P values than FCCP and CCCP, it is possible that NTZ/TIZ were unable to enter 
the larvae by trans-cuticular absorption. This is also in accordance with Fry & Jenkins, 
(1984) where not all electron transport inhibitors were able to penetrate nematode cuticles. 
Therefore potential lack of drug absorption across the nematode cuticle did not allow a 
satisfactory comparison between NTZ/TIZ and FCCP/CCCP in this study. 
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NTZ and TIZ however, at motility-inhibiting concentrations, significantly lowered ATP 
concentrations in C. elegans, as did FCCP and CCCP, while levamisole at 10µg/ml did not. 
This reduction of ATP was possibly due to NTZ/TIZ acting as uncouplers of oxidative 
phosphorylation, a mechanism supported by the similar results observed with FCCP and 
CCCP. However the difference in paralysis between NTZ and FCCP/CCCP suggests a 
differing mechanism or the presence of a secondary mechanism with NTZ. Another 
possibility is that FCCP and CCCP may be more potent than NTZ/TIZ. 
b) A. suum. 
Examination of the possible protonophoric effect of NTZ/TIZ was tested using oxygen 
uptake in adult A. suum mitochondria. However, though oxygen uptake was observed, no 
increase in rate was observed with addition of succinate or ADP. Also, addition of NTZ/TIZ, 
FCCP or CCCP failed to have any effect on the rate of respiration. This may be due to a 
couple of reasons. Firstly after A. suum matures to the L3 stage it becomes increasingly 
anaerobic and the specific activity of fumarate reductase increases remarkably (Takamiya et 
al, 1993). Thus adult Ascaris mitochondrial electron transfer proceeds through an NADH- 
linked reduction of fumarate resulting in the formation of succinate (Köhler & Bachmann, 
1978; Köhler & Bachmann, 1980). Any effect of NTZ, TIZ and other uncouplers therefore 
would not necessarily be detected through changes in oxygen uptake because of the 
unimportance of this process to the worm in its anaerobic environment. This is further 
supported in the literature, where Cheah (1976) showed that malate and succinate-supported 
oxidase activities in A. suum were found to be insensitive to antimycin A and cyanide 
compounds. 
3.12.3 NTZ mode of entry. 
The mode of entry of NTZ into nematodes is not known. However, owing to there being a 
difference in speed of onset of paralysis for NTZ/TIZ compared to levamisole, FCCP and 
CCCP, a few points can be raised. On addition of lOµg/ml NTZ and TIZ, paralysis took 
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approximately 20 minutes to occur, a time significantly different to the rapid >5 ! 40 minutes 
onset of paralysis with 10µg/ml levamisole and >3 55 minutes for 10µg/ml FCCP and 
CCCP. This suggests a different drug potency or delayed mechanism of drug entry into the 
worm. Delayed entry is supported by the calculated partition coefficient (log P) for NTZ and 
TIZ (1.8 and 2.0) being lower than that of levamisole (2.8), and FCCP (3.8) showing that 
levamisole and FCCP are more lipophilic, and therefore probably more readily able to cross 
the nematode cuticle, hence producing a faster drug effect. Another possibility for the 
delayed paralytic response with NTZ/TIZ is that rather than the drug crossing the cuticle, C. 
elegans is ingesting the drug. Experiments using rhBTX, a weak agonist of A. suum, 
nicotinic receptors (Walker et al, 1992) show that the C. elegans swallow the rhBTX 
because a large amount of fluorescence is visible in the pharynx. The possible need for drug 
ingestion for NTZ and TIZ but not with levamisole is further supported by the larval 
migration assay, where with sheathed Haemonchus contortus and Nematodirus spathiger L3 
larvae, clear paralytic effects were observed with levamisole producing IMg5o's of 17.98µM 
and 5.65µM respectively. Effects however, were not seen with NTZ and TIZ. (and hence no 
inhibition of migration) at double the concentration for 6 times the time to cause 100% 
paralysis in C. elegans. Owing to the trichstrongylid L3 larvae relying on food reserves and 
not feeding until they find their position in host (Vanden Bossche et al, 1985), it is likely that 
NTZ and TIZ are not ingested by these larvae, hence the reason no drug activity is observed. 
This suggestion that the Romark compounds are not able to pass through the cuticle and 
hence affect the worms appears to be supported. Cuticle importance was further highlighted 
where the IMgso values for levamisole were less with exsheathed worms, being 11.5µM and 
3.21M for N. spathiger and H. contortus respectively, showing that sheath plus cuticle may 
hinder drug entry to a greater extent. 
Alternatively to lack of cuticular absorption, NTZ/TIZ may simply have too low an in vitro 
potency (dissociation constant) compared to levamisole to be effective in these species. This 
was observed in Ascaris suum where in vitro addition of 600µM NTZ showed a much lower 
effect compared to 30µM levamisole. This difference of in vitro potencies with C. elegans 
has already been observed using pyrantel and morantel. The in vivo potencies of pyrantel, 
morantel and levamisole against parasitic nematodes are very similar (Geary, 1999). 
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However, when these drugs are used in vitro with C. elegans, morantel and pyrantel are fifty 
and one hundred fold less potent than levamisole respectively (Geary, 1999). This may 
explain why the paralysis with levamisole was more rapid in C. elegans than with NTZ, and 
why levamisole drug activity with A. suum was also higher. 
3.12.4 Inhibition of fumarate reductase. 
From results thus far, a neurophysiological action on nematode nicotinic receptors similar 
to that of levamisole looked likely. However, levamisole also inhibits fumarate reductase in 
H. contortus (Köhler, et al, 1978) and Kuramochi et al, 1995 previously proposed that this 
may be part of the NTZ/TIZ drug mechanism. Therefore, studies with H. contortus were 
carried out to examine potential NTZ/TIZ inhibition of fumarate reductase, However, these 
drugs did not inhibit fumarate reductase activity in H. contortus. 
3.12.5 Possible reduction of NTZ as a mode of action. 
Another possible mechanism of action of NTZ/TIZ is reductive activation as in protozoa 
and bacteria (Sisson et al, 2002). A nitroreductase in bacteria was found in 1991 (Bryant & 
DeLuca) which is similar to sequences from C. elegans (appendix V). Studies were 
therefore carried out to investigate if NTZ/TIZ induced paralysis was due to enzyme 
induced reduction of the drug. However C. elegans extracts did not demonstrate detectable 
NTZ or NF nitroreductase activity. Therefore NTZ/TIZ induced paralysis in C. elegans is 
unlikely to involve drug reduction. Nitroreductase activity however, could still be important 
as a mode of action in parasitic worms which are metabolically anaerobic as adults e. g. A. 
suum. Also if C. elegans could be grown anaerobically there is a possibility that a 
nitroreductase mechanism could occur. 
3.12.6 Conclusions. 
From work with nematodes, the majority of results are consistent with a neurotoxicological 
effect on the nicotinic receptor of the worm being the primary mechanism of action of 
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NTZ/TIZ. However inhibition of ATP synthesis presumably due to protonophoric 
uncoupling also occurs. Difference in drug effect was evident with different species of 
nematodes with C. elegans being more susceptible than A. suum, and trichostrongylid larvae 
remaining unaffected. This may be due to nicotinic receptor structural variation, variable 
absorption or drug detoxification. 
NTZ has been shown to be highly active against a variety of nematodes in vivo (Davila- 
Gutierrez et al, 2002; Favennec et al, 2003; Juan et al, 2002) and has shown comparable 
cure rates with well established anthelmintics e. g. mebendazole and praziquantel. It remains 
a possibility therefore, that the in vitro potency of NTZ is lower than other drugs hence 
producing low activity, whereas in vivo the drug potency is higher, resulting in increased 
worm susceptibility. There is also a large genetic variation between different species of 
nematodes and this could also explain the difference in NTZ potency. 
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4.1 Introduction. 
Though anthelmintic chemotherapy for trematodes is currently satisfactory, the finding of 
novel compounds is still a necessity. Praziquantel (PRAZ) is the drug of choice for 
schistosomiasis and other trematode infections e. g. paragonimiasis and fasciolopsiasis (De 
Silva, 1997), with metrifonate (for Schistosoma haematobium), oxamniquine (for 
Schistosoma mansoni) and in some cases mebendazole (for S. mansoni and S. 
haematobium) also being used. However, the possibility of resistance developing against 
PRAZ is a matter of concern and a new antischistosomal drug is needed. Furthermore, 
PRAZ has only very low activity against Fasciola hepatica (De Silva, 1997). Recently, the 
novel anthelmintic NTZ has shown good activity in vitro against F. hepatica and has 
produced a cure rate of 87% in clinical trials (Rossignol et al, 1998; Favennec et al, 2003 ). 
Although NTZ has not shown promise in animal experiments with schistosomes, (Romark 
Data) preliminary results in vitro showed a potent drug effect indicating that these 
organisms would be useful in examining mechanisms of action in vitro. This chapter 
describes investigations into the mechanisms of effect of nitazoxanide in Schistosoma 
mansoni and Schistosomajaponicum. Effects on worm motility, worm morphology, ATP 
synthesis and nutrient uptake are examined. Drug effects on the five different stages of 
Schistosoma mansoni are also noted and compared. 
4.2. Effects of Romark compounds and control drugs in the absence of serum. 
4.2.1 Nitazoxanide and tizoxanide: effects on adult S. mansoni and S. japonicum. 
Pairs of freshly isolated S. mansoni were placed into 1.5m1 of medium 169 (without phenol 
red), in wells of a 24 well flat-bottomed microplate (Nunc) at 37°C. NTZ or TIZ in DMSO 
were added at varying concentrations ranging from 0.1 to 30pg/ml and the effects observed 
using a Reichert-Jung inverted microscope at 20x magnification and ambient temperature. 
In contrast to the slow and partial effects seen with C. elegans, addition of 
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10µg/ml NTZ or TIZ (33µM and 381M respectively) caused the worm pair to curl and 
become paralysed within 2 minutes. 
Paralysis was tonic, characterised by rigidity and shrinkage (Figure 4.1c). Within 10 
minutes worms were moribund, showing no movement except in the gut. Males were 
affected somewhat faster than females, and worm couples became separated within 30 
minutes. After 2-3 hours, clear tegumental damage was seen, particularly in the males, 
characterised by blebbing, granulation, vesiculation and darkening. There was no sign of 
recovery and all worms were dead at 24 hours. These effects were similar for all 
concentrations tested, with 0.7µM NTZ and 0.8µM TIZ being the minimum concentration 
to kill 100% of the worms (though onset of paralysis and worm death was less rapid). At 
concentrations below these, the onset of sluggishness etc was very slow, taking up to 24 
hours to occur. Also, at these lower concentrations the difference in drug effect between 
males and females was more marked. For males, sluggishness and some paralysis still 
occurred at 0.3µM, but for females, concentrations below 0.5µM produced little effect. The 
DMSO solvent controls did not show significant differences in motility or appearance from 
the untreated controls. Untreated worms in medium 169 remained active for up to 15 days 
in a 37°C incubator in the presence of 5% C02/ 95% air. A comparative NTZ/TIZ effect on 
four week old juvenile worms was identical to that observed with the seven week old adult 
Worms. 
If the medium containing 0.7µM or less NTZ/TIZ was removed after 4 hours, and replaced 
with fresh medium, a partial recovery of activity occurred, but the worm tegument did not 
repair. However, at 10µg/ml (33µM and 38µM for NTZ and TIZ respectively) drug 
concentration, no reversal of toxicity was apparent and 100% worm death was observed 
after 24 hours. 
Similar experiments were carried out using fresh isolates of adult S. japonicum. At 
logg/ml the effects of NTZ and TIZ on S. japonicum involved curling and paralysis in a 
similar way to that observed with S. mansoni. Again worms became moribund after 10 
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minutes and 100% mortality was reached within 24 hours. However, due to a lack of 
availability of S. japonicum, the range of concentrations tested was restricted. 
4.2.2. Effect of praziquantel on adult S. mansoni. 
In the same way as above, the control drug PRAZ was added to S. mansoni. At 10µg/ml 
(32µM) PRAZ caused immediate paralysis in 100% of worms. This effect was similar to 
that seen with NTZ and TIZ except that the observed paralysis was different (see fig 4.1. b), 
characterised by a flaccid curling, shrinkage and darkening, which compares differently to 
the rigidity of the curling with NTZ. Again 100% of worms showed total flaccid paralysis 
after 10 minutes and all were moribund between 10 to 30 minutes. Unlike NTZ and TIZ 
however, death of the worms could take up to five days at this concentration. At lower 
concentrations the paralytic effect of PRAZ was the same and just as rapid, with the lowest 
concentration to kill 100% of worms within 5 days being approximately 0.5µM. 
4.2.3. Effect of other Romark compounds with adult S. mansoni. 
Of the other Romark compounds, DNNTZ, DNTIZ and TIZg had no effect on motility or 
morphology in adult S. mansoni, at concentrations between 0.1 gg/ml and 30pg/ml. With 
BZNT (IOgg/ml) (40.1µM), paralysis was observed as with NTZ and TIZ. The observed 
paralysis was similar in appearance, but took longer to occur than with NTZ and TIZ, 
however blebbing, granulation and darkening of the tegument were still in evidence. 
Exposure to BZNT at 10gg/ml did not result in a killing effect with adult worms and all 
worms showed some movement, though characterised by sluggishness, after 120 hours. 
4.2.4 Effect of Romark compounds with schistosomula of S. mansoni. 
Schistosomula of S. mansoni when exposed to 10µg/ml NTZ and TIZ at 37°C became 
rapidly paralysed but unlike adults, paralysis was characterised by a total lack of motility. 
Again in the schistosomula, tegument damage was observed and severe blebbing was 
present at higher concentrations. Unlike with the adults, NTZ and TIZ exposure to 
schistosomula at lower concentrations (< 1µM), still led to 100% death and no recovery 
was observed at 0.7µM when removed from drug after 2 hours. With BZNT paralysis was 
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rapid as with NTZ and TIZ and 0.2µM BZNT killed 100% of exposed schistosomula. This 
lesser effect observed with adults and strong effect with schistosomula, suggests that BZNT 
has a slightly different mode of action to that of NTZ and TIZ. The solvent control DMSO 
had no effect on schistosomula. In medium 169, schistosomula were able to survive at least 
7 days in a 37°C incubator in the presence of 5% C02/ 95% air. 
4.2.5 Effect of praziguantel and niclosamide with schistosomula of S. mansoni. 
PRAZ and NIC were added to schistosomula in the same way as described for NTZ, in a 
concentration ranging from 0.1 to 20gg/ml. Where these concentrations of NTZ caused 
rapid paralysis in 100% of schistosomula, addition of PRAZ at all concentrations showed 
no effect on worm motility or morphology in a time period of up to 3 hours. After this time 
however, sluggishness was observed at concentrations above 1011g/ml (32µM) and at 24 
hours 100% of schistosomula showed paralysis. Blebbing and tegumental damage however, 
were not seen. NIC at 10µg/ml (30.61M) caused rapid paralysis in schistosomula and all 
worms at this concentration were moribund after 2 hours drug exposure and dead within 24 
hours. Addition of 1 gg/ml (3.1µM) NIC resulted in a slower onset of paralysis with some 
worms still alive at 24 hours. 
4.2.6 Min's of S. mansoni with Romark compounds and control drugs (no serum). 
LD50's with adult S. mansoni, were calculated for NTZ, TIZ, PRAZ and NIC after 120 
hours exposure, using Sigmaplot 2000 in the same way as for C. elegans. The LD50 of drug 
effect on schistosomula was difficult to calculate due to the low concentrations and speed in 
which paralysis occurred (<1 µM). However after 120 hours drug exposure, death in adult 
worms was easier to determine and hence LD50's could be calculated. All LD50's were at 
similar concentrations (see table 4.1) and the concentration difference between that which 
caused death in 100% of worms and no death was very small. 
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Table 4.1 LDso's of S. mansoni with Romark compounds and control drugs. 
DRUG LD50 ± S. E. µM 
Nitazoxanide 0.56 ± 0.02 
Tizoxanide 0.63 ± 0.03 
Praziquantel 0.32 ± 0.03 
Niclosamide 0.43 ± 0.01 
Tizoxanide glucuronide (no effect at 113.5) 
Denitro-nitazoxanide (no effect at 153.2) 
Denitro-tizoxanide (no effect at 137.1) 
LD50 = Concentration of drug which results in 50% death of 
adult S. mansoni after 120 hrs. 
S. E = Standard Error. 
4.3. Effect of other drug types with adult S. mansoni. 
4.3.1 Effect of protonophores. 
To examine potential protonophore activity as an antischistosomal mechanism of NTZ and 
TIZ, the known uncouplers niclosamide, FCCP and CCCP and proguanil were used so as to 
compare effects on adult schistosomes and schistosomula. The anti-cestodal drug, 
niclosamide had an immediate paralytic effect on schistosomes, killing schistosomula 
within 24 hours at 15.31tM and limiting movement at 0.6µM. With adult Schistosoma 
mansoni, niclosamide, FCCP and CCCP all caused paralysis in the worm within 2 minutes 
at lOgg/ml, and death was observed in 100% of worms after 24 hours. This speed of effect, 
type of paralysis and 100% mortality in the exposed worms after 24 hours was identical to 
that of NTZ and TIZ. This suggests a similarity in mode of action of NTZ and TIZ to these 
known uncouplers. The anti-malarial drug, proguanil (tested as some of the other 
biguanides have effect on mitochondria (Jailing & Olsen, 1984)), also affected adult S. 
mansoni at 10µg/ml (34.5µM) and caused mortality in 25% of worms after 120 hours. The 
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type, speed and strength of effect however was different to that observed with the other 
uncouplers in that 100 % mortality was not reached within 24 hours at 10µg/m1.. 
4.3.2. Effects of known schistosomicidal drugs on adult S. mansoni. 
Other schistosomicidal drugs of known mechanism of action were compared with Romark 
compounds. The acetylcholinesterase inhibitor, metrifonate (MET) at 10µg/ml (38.85µM) 
caused paralysis in 100% of worms, but unlike with NTZ and TIZ, this paralysis took up to 
15 minutes to develop. Furthermore the paralysis was characterised (especially in females) 
by rigidity without any curling (fig 4.1d). Oxamniquine (OXA) also at 10µg/ml (35.8µM), 
caused excitation and over activity in adult S. mansoni after 15-20 minutes, in agreement 
with the findings of Foster & Cheetham, (1973); Chavasse et al, (1979). However after 24 
hours all worms were still alive but were sluggish. No mortality was seen in schistosomes 
with OXA after 120 hours demonstrating a poor in vitro activity of the drug under the 
conditions used.. This again is in accordance with findings of Foster & Cheetham, (1973), 
who demonstrated very little in vitro drug activity below 80µg/ml (286.4µM). Other drugs 
to show a schistosomicidal effect were lucanthone (LUC), hycanthone (HYC), niridazole 
(NIR), RO11 and mebendazole (MEB). At concentrations of 10µg/ml all of these drugs 
caused paralysis. RO11 (a benzodiazepine derivative) was initially the most effective with 
paralysis occurring at the same rate as NTZ and all worms becoming moribund within 24 
hours (Worms however were still alive after 120 hours). With niridazole and mebendazole, 
paralysis was slower in occurring taking several hours with regards to mebendazole. After 
24 hours all worms exposed to niridazole and mebendazole were moribund. With 
mebendazole death was observed in 25% of worms after 5 days, however with niridazole, 
no worm death was observed. This suggests that although NTZ and niridazole are 
structurally similar, the mechanism of action of these two drugs is different, or niridazole 
may need to be metabolised. Lucanthone 10µg/ml (29.4µM) initially had no in vitro effect 
on S. mansoni as previously observed by Pica-Mattoccia & Cioli, 1986. After 24 hours 
however, paralysis and discolouration of the worms was observed suggesting that the 
worms had changed lucanthone to the active metabolite hycanthone. Lucanthone caused 
100% mortality in worms by 48 hours. However, hycanthone at logg/ml (28.05), like 
lucanthone initially had no apparent effect on worms. After 48 hours however, sluggishness 
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became evident followed by paralysis. Males were primarily affected more than females 
and after 120 hours 50% of males were dead with the other 50% moribund, whilst the 
females were elongated and slightly paralysed. Hycanthone at 10µg/ml caused tegumental 
damage and granulation with blebs evident in males, recovery after 120 hours was unlikely. 
Strangely the effect of lucanthone on the schistosomes was greater than that of hycanthone. 
Ivermectin 10µg/ml (37.1µM) also had an effect on schistosomes. The effect was initially 
very slow but resulted in 100% worm mortality after 120 hours characterised by tegumental 
darkening and disruption. 
4.3.3 Assay of Artemether and its derivatives with adult S. mansoni. 
Artemether and its derivatives e. g. artesunate have previously been shown to have 
schistosomicidal activity in vivo (Utzinger et al, 2001) and in vitro (Xiao et al, 2003). 
Artemether, artesunate and dihydro-artemisinin (DHA) were assayed as before with adult S. 
mansoni at concentrations of 1-20gg/ml to examine and compare effect with that of NTZ 
and TIZ and the known schistosomicidals. Artesunate, Artemether and DHA at all 
concentrations tested, showed no effect on motility, morphology or mortality with 100% of 
test worms showing normal movement compared to that of the DMSO control after 120 
hours. These results were as expected, for Xiao et al, 2003 state that haemin is required in 
the medium in order to release the toxic free radical and hence produce a drug-effect. 
Other drugs were also tested for NTZ comparison, including levamisole, thiabendazole, 
oligomycin, SHAM, antimycin A and nitrofurazone. Of these SHAM and oligomycin had 
some inhibitory effect on motility of the worms but did not cause mortality. The effect of 
all these drugs was different to that observed with the known uncouplers and NTZ. Of all 
drugs tested, the known uncouplers (niclosamide, FCCP and CCCP), NTZ, TIZ and PRAZ 
showed the most marked effect on the worms, all causing 100% mortality after 120 hours in 
IOgg/ml concentrations. 
From the schistosome drug assay, many of the drugs tested affected schistosome activity, 
with many varying effects. However, only FCCP, CCCP and niclosamide produced a 
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similar effect to that of NTZ and TIZ in terms of speed of paralysis, type of paralysis and 
similarity in worm morphology and mortality. 
The results of the tests are summarised in table 4.2 (see below) where effect on motility 
and mortality of the worms is used to demonstrate the activity of the drug. All drugs were 
applied at 1Ogg/ml to adult S. mansoni in 24 well plates at 37°C and monitored by 
microscopy at regular intervals. The following criteria were used to compare the effect on 
worm activity on drug exposure. 
Key to table 4.2. 
5 Excitatory behaviour (Overly active) 
4 Active (normal) 
3 Reduced activity 
2 Sluggish 
1 Moribund (Minimal body Movement, but gut moving) 
0 No movement of body or gut ± worm disintegration. Parentheses 
show percentage mortality. 
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TABLE 4.2 Drug effects on adult S. mansoni motility/activity over time 
Drug 
10 ml 
10min 30min lhr 2hrs 4hrs 24hrs 48hrs 96hrs 120 hrs 
NTZ 1 1 I 1 1 0 100% 0(100%) 0(100%) 0(100%) 
TIZ 1 1 I 1 0 100% 0(100%) 0(100%) 0(100%) 
BZNT 4 4 4 3 3 2 2 2 2 
DNNTZ 4 4 4 4 4 4 4 4 4 
TIZ 4 4 4 4 4 4 4 4 4 
PRAZ I 1 1 1 1 0(12.5%) 0(94%) 
NIC 1 1 1 0(100%) 0(100%) 0(100%) 0(100%) 
FCCP 1 1 1 0(100%) 0(100%) 0(100%) 0(100%) 
CCCP 1 1 1 0(100%) 0(100%) 0(100%) 0(100%) 
OXA 4 4 5 5 5 2 3 3 3 
MET 2 1 1 1 1 1 2 2 2 
NIRI 2 2 1 1 1 1 1 1 1 
MEB 4 4 4 3 2 1 1 1 0(25%) 
RO11 2 1 1 1 1 1 1 1 1 
NITF 4 4 4 4 4 4 4 4 4 
LEV 4 4 4 4 4 4 4 4 4 
LUC 4 4 4 4 4 1 0000%) 0000%) 0(100%) 
HYC 4 4 4 4 4 3 2 2 0(25%) 
SHAM 3 3 3 2 2 2 2 2 2 
THIA 4 4 4 4 4 4 4 4 4 
PROG 4 4 4 4 4 4 2 0 12.5% 0(25%) 
OLIG 4 4 4 4 4 3 3 2 2 
Ivey 4 4 4 4 4 4 3 2 0 100% 
AntiA 4 4 4 4 4 4 4 4 4 
ART 4 4 4 4 4 4 4 4 4 
ARTES 4 4 4 4 4 4 4 4 4 
DHA 4 4 4 4 4 4 4 4 4 
DMSO 
-ve 
control 
4 4 4 4 4 4 4 4 4 
Medium 
-VC 
control 
4 4 4 4 4 4 4 4 4 
Drug abbreviations. 
NTZ=Nitazoxanide, TIZ=Tizoxanide, BNZT=2-benzamido-5-nitrothiazole, 
DNNTZ=Denitro-nitazoxanide, TIZg=Tizoxanide Glucuronide, PRAZ=Praziquantel, 
NIC=Niclosamide, FCCP= Carbonyl cyanide p-(trifluoromethoxy) phenyl-hydrazone, 
CCCP= Carbonylcyanide m-chlorophenylhydrazone, OXA=Oxamniquine, MET=Metrifonate, 
NIRI=Niridazole, MEB=Mebendazole, RO11 = Methylclonazepam, NITF= Nitrofurazone, 
LEV=Levamisole, LUC=Lucanthone, HYC=Hycanthone, SHAM= Salicyl hydroxamic acid, 
THIA=Thiabendazole, PROG=Proguanil, OLIG=Oligomycin, Iver = Ivermectin AntiA=Antimycin A, 
ART= Artemether, ARTES= Artesunate, DHA= Dihydro-Artemisinin. DMSO= Dimethyl sulfoxide. 
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Figure 4.1 Difference in paralysis between an unaffected worm (DMSO only) 
and that of worms exposed to 10u&/ml nraziouantel, nitazoxanide 
and metrifonate. 
a) 
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Figure 4.1 a shows an adult male of S. mansoni 20 
minutes after 0.1 % DMSO exposure. No paralysis 
is in evidence. 
c) 
fli 
Figure 4.1 c shows paralysis in 2 adult males after 
20 minutes exposure to I Oµg/ml NTZ. The paralysis 
is characterised by contraction and shrinkage of the 
worm. This form of paralysis is identical to that seen 
with niclosamide, FCCP and CCCP. 
b) 
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Figure 4.1b shows an adult male of Smansoni 20 
after 10µg/ml praziquantel exposure. The worms 
clearly show paralysis characterised by curling. 
Worms are flaccid. 
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Figure 4.1d shows paralysis in 2 adult females 
20 minutes after exposure to 10µg/ml 
metrifonate. The paralysis is characterised 
by rigidity in the worm, but instead of 
contraction the worm elongates. 
Fig 4.1: Drugs (10µg/m1) were added to 4 pairs of adult S. mansoni in 1.5m1 of medium 169. Drug effects 
observed after 20 minutes incubation were recorded. All pictures are under x40 magnification 
of a dissecting microscope (Nikon). 
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Figure 4.2 Comparison of activity of NTZ/TIZ and other anthelmintics 
against Schistosoma mansoni. 
H 
F- 
U 
Q 
DRUG 
Drug activity is defined as 0 Not Effective. 
1 Slight Effect. 
2 Moderate Effect. 
3 Good Effect (killing <50%) 
4 Very Good Effect (killing >50%) 
Fig: 4.2: Four pairs of adult S. mansoni were exposed to I Üµg/m1 of drug in vitro for 120 hours at 37°C in the 
absence of serum. NTZ and TIZ showed very good activity against worms and activity is clearly as effective 
as that seen with praziquantel and niclosamide with all drugs killing over 90% of worms after 120 hours. 
BZNT had a moderate effect as did metrifonate. Both mebendazole and hycanthone showed a good effect, 
killing 25% of worms. DNNTZ, DNTIZ and TIZg had no effect on schistosomes. The anti-nematodal drug 
LEV similarly had no effect. 
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4.4 Effects of drugs on schistosomes in the presence of serum. 
4.4.1 Effects of Romark compounds. 
Since NTZ and TIZ have a high affinity for albumin (99% binding) (Romark Laboratories 
Clinical Investigator's Brochure, 1999) the drug assay was repeated in the presence of 10% 
v/v foetal calf serum (FCS) (10%) (Sigma). On addition of NTZ, TIZ and BZNT to 
schistosomula of S. mansoni, paralytic effects were observed as before, but the efficacy of 
the drugs was reduced and minimal concentrations of drug to show effect in 100% of the 
schistosomula were 1.641AM for NTZ, 1.9µM for TIZ and 0.8µM for BZNT. With adult S. 
mansoni the presence of serum reduced the killing effect of NTZ and TIZ, with 
approximately Ipg/m1 (3.3µM and 3.8µM respectively) being the minimum concentration 
for both drugs to kill 100% of worms. Below this concentration female worms were 
relatively unaffected (though showing some sluggishness), males however, still showed 
paralytic effects after 120 hours (without mortality) at 1.28µM and 1.51µM for NTZ and 
TIZ respectively. LD50's in the presence of serum, were hence lower than those observed in 
serum-free medium (see table 4.3). DNNTZ, DNTIZ and TIZg had no effect on adult or 
juvenile schistosomes in the presence of 10% FCS. 
4.4.2 Effects of control drugs. 
Control drugs niclosamide and praziquantel were used to compare their activity with the 
reduced activity of NTZ and TIZ in the presence of serum With adult worms and 
schistosomula, both PRAZ and NIC, showed no significant difference in their effect and 
were as active at lower concentrations as they had been without serum. LD50 results for 
adults were calculated and found to be approximately the same as those found when FCS 
was absent (see table 4.3). 
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Table 4.3 LDso's of adult S. mansoni with Romark compounds and 
control drugs in the presence of serum. 
DRUG LD50 ± S. E. gM 
Nitazoxanide 2.63 ± 0.02 
Tizoxanide 2.92 ± 0.02 
Praziquantel 0.3 ± 0.01 
Niclosamide 0.44 ± 0.02 
Tizoxanide glucuronide (No effect at 113.5) 
Denitro-nitazoxanide (No effect at 153.2) 
Denitro-tizoxanide (No effect at 137.1) 
LD50 = Concentration of drug which results in death of 50% adult S. mansoni after 120 hrs. 
S. E = Standard Error. 
Differences between the LD50 values for NTZ and TIZ in the absence of serum to those 
LD50 values observed with the addition of 10% FCS were calculated using a Student t-test. 
Values were found to be highly significant with P<0.000000 1 for both drugs. 
4.5 Schistosome neuromuscular transmission: Receptor investigation. 
Since paralysis in nematodes by NTZ was likely due to a specific neuromuscular effect at 
receptors; effect at schistosome receptors was hence tested using the same nicotinic and 
muscarinic antagonists as with C. elegans and also the specific agonist for schistosome 
nicotinic receptors a-bungarotoxin (BTX) (Camacho et al, 1995). 
4.5.1 Receptor antagonists. 
As for C. elegans, the nicotinic antagonists mecamylamine and pempidine were used to 
see if they had a reversible or blocking effect on NTZ-induced paralysis in S. mansoni. 
Pempidine (10µM) treatment failed to protect or abolish the NTZ induced effect with adult 
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S. mansoni. However, pempidine alone also altered the motility of S. mansoni causing 
sluggishness; hence effects of NTZ were difficult to interpret. Mecamylamine did not 
protect against NTZ-dependent paralysis of adult S. mansoni either with co-addition or pre- 
treatment, neither did it abolish the NTZ/TIZ induced paralysis. This was not unexpected as 
mecamylamine has previously been found to be an ineffective antagonist of acetylcholine 
in S. mansoni (Day et al, 1996). The muscarinic antagonist atropine had no effect on 
schistosome motility and both pre-treatment and post-treatment did not prevent or abolish 
paralysis on exposure to 1O tg/ml (33µM) NTZ. 
Since S. mansoni is not readily amenable to genetic manipulation and little of the genome 
sequence was known, the question of specific effect at nicotinic receptors was addressed 
using the neurotoxin and nicotinic specific agonist BTX (Tornoe et al, 1995; Haughland, 
1998). 
4.5.2 Effect of BTX. 
Addition of 10-40µM BTX showed no effect on motility or viability of adult S. japonicum 
and S. mansoni, schistosomula of S. mansoni or adult C. elegans after 24 hours. BTX 
likewise, did not show any antagonistic effect and hence demonstrated no drug reversibility 
in worms paralysed by pre-addition of 10µg/ml NTZ/TIZ. Neither did pre-incubation with 
BTX for 20 minutes inhibit the paralytic effect of 10µg/ml NTZ/TIZ. 
Antagonistic effects with schistosomicidal drugs and specific nicotinic receptor agonists 
has previously been demonstrated using fluorescent dansyl-choline (DNS-chol) which has 
specificity for acetylcholine receptors in schistosomes (Hillman et al, 1976). In that study 
the fluorescent binding of DNS-chol was blocked by hycanthone. Also, the fluorescent 
rhodamine labelled a-bungarotoxin (rhBTX) has been previously used to visualise the 
nicotinic receptors of S. haematobium (Camacho et al, 1995). To further examine a possible 
effect on schistosome nicotinic receptors, rhBTX was used to see if the presence of 
NTZ/TIZ caused dissociation or failure of rhBTX binding. 
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4.5.3 NTZ/TIZ: Effect on fluorescent binding of agonists to schistosome receptors. 
4.5.3.1 Effect on rhBTX binding. 
To test whether NTZ/ TIZ could affect BTX binding, the fluorescent rhBTX was used. 
RhBTX was able to bind to nicotinic receptors in schistosomula (figure 4.3a) and adult 
schistosomes (figure 4.4 a) but not C. elegans (see earlier). The addition of NTZ or TIZ 
(10µg/ml) after 20 minute pre-incubation with rhBTX (20µM), resulted in considerable loss 
of the initial rhBTX fluorescent binding in both schistosomula (figure 4.3 b) and adults 
(figure 4.4 b). A smoothing of the schistosomulum surface was also observed in the 
presence of NTZ under differential interference contrast illumination (fig 4.3 b). When 
worms were exposed to NTZ/TIZ (30µM) for 20 minutes and then rhBTX (20µM) added, 
failure of rhBTX binding was also observed. At lower concentrations of NTZ (1µg/ml), 
there was no decrease in binding. Inhibition of rhBTX binding in the presence of NTZ and 
loss of already bound rhBTX on exposure to NTZ suggests a competition for the nicotinic 
receptor between rhBTX and NTZ/TIZ. This is consistent with a specific neuromuscular 
agonist effect of NTZ in the fluke. Untreated schistosomula and adult schistosomes of both 
species showed no auto-fluorescence under microscope examination. 
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Figure 4.3a) RhBTX marking of nicotinic receptors in S. rnansoni schistosomula. 
Figure 4.3b) NTZ inhibition of rhBTX binding in S. mansoni schistosomula. 
Fig 4.3a: 20µM rhBTX was added to schistosomula and incubation carried out for 2 hours. Clear binding 
of rhBTX at schistosome nicotinic receptors can be seen In Fig 4.3 b) 10µg/ml NTZ was added 20 
minutes after rhBTX addition and incubation carried out for a further 2 hours. Typical inhibition of 
rhBTX binding in the presence of NTZ is shown. Smoothing of the schistosomulum surface is evident. 
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Figure 4.4: a RhBTX marking of nicotinic receptors in Schistosoma adult. 
Fig 4.4 a: 20µM rhl3TX was added to adult S. mansonni (top) and adult .S japonnicurn (bottom) 
and incubation carried out for 2 hours. Clear fluorescent marking of schistosome 
nicotinic receptors with rhBTX can be seen. 
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Figure 4.4 b) NTZ inhibition of rhBTX binding in Schistosoma adults 
Fig 4.4 b: 10µg/m1 NTZ was added 20 minutes after rhBTX addition and incubation carried out for a 
further 2 hours. Clear inhibition of rhBTX binding in the presence of NTZ can be seen in 
S. mansoni (top) and S. japonicunn (bottom). 
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The Romark compounds, DNNTZ and TIZg which do not cause paralysis, used as negative 
controls showed no inhibition of rhBTX binding in either adult or larval stages of the two 
schistosome species. BZNT was also used, since it has a severe effect on schistosomes 
indicating toxicity. However, BZNT did not show inhibition of rhBTX binding in adults, 
but altered the pattern of fluorescence (not shown) in schistosomula. To test if inhibition 
was due to a protonophoric effect, CCCP was used. Again however, no inhibition of BTX 
binding was observed. Other negative controls DMSO and levamisole showed no inhibition 
of rhBTX binding in schistosomes. 
4.5.3.2 Effect on Bodipy pirenzepine binding. 
To gain further insight into specificity of NTZ effects at nicotinic receptors, another type 
of cholinergic receptor was examined: muscarinic. A fluorescent derivative (Bodipy red) of 
pirenzepine dihydrochloride (excitation 560 nm, emission 569nm) (Molecular Probes) was 
used, which is a selective agonist of the muscarinic M1 receptor (Wang et al, 1994). 
When treated with the muscarinic agonist, BoP (6.5µM), S. mansoni adults showed 
widespread dotted fluorescence (figure 4.3a). When NTZ l0µg/ml was added both as pre- 
and post-treatment to BoP incubated worms, no effect on binding was observed, and the 
binding pattern actually intensified (figure 4.3b). Control drugs DNNTZ, TIZg and DMSO 
had no effect on BoP binding. 
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Figure 4.5 a Bodine marking of S. mansoni adults. 
Figure 4.5 b NTZ with Bodiuv in S. mansoni adult, showing no inhibition. 
Fig 4.5a: 6.5µM Boll was added to adult S. inansoni and incubation carried out for 2 hours. 
Clear fluorescent marking of schistosome muscarinic receptors with Boll can be seen . 
In fig 4S b pre- and post-treatment 10µg/ml NTZ intensifies this binding. 
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4.6 Test of fluorescent auenchina by NTZ. 
Inhibition of RhBTX, or BoP fluorescent binding in the presence of NTZ could be due to 
fluorophore quenching. Possible quenching was determined by examining rhBTX and BoP 
fluorescence in the presence and absence of NTZ using a Spectra Max Gemini fluorescent 
plate reader (see table 4.4). A5 t1 sample of each of these solutions was then transferred to 
a clean slide and examined under the 1 Ox magnification of a fluorescent microscope and the 
relative fluorescence qualitatively assessed by eye. 
Table 4.4: Quenching of BTX and BoP fluorescence by NTZ. 
Sample RFU % quenching 
Medium 169 361 n/a 
NTZ (33µM) 340 n/a 
Tetramethyl cr-bungarotoxin (20µM) 2339 n/a 
Bodipy Pirenzepine (6.5µM) 695 n/a 
Tetramethylcr-bungarotoxin (20µM) and 
NTZ (I01tg/ml) 
1289 52% 
Bodipy Pirenzepine (6.5µM) and NTZ 
(l 0µg/ml) 
466 33% 
Control: DMSO 369 n/a 
RFU= Relative Fluorescent Units. n/a = not applicable. 
Table 4.4: Effects of NTZ on the fluorescence of rhBTX and BoP was measured in a Spectra Max 
Gemini fluorescent plate reader using excitation 553nm, emission 577nm for rhBTX 
and excitation 560nm, emission 569nm for Bodipy with a cut off for both at 565nm. 
NTZ quenched fluorescence of rhBTX and BoP by 52% and 33% respectively. 
On examination of the fluorophores, using the fluorescent microscope, no visible decrease 
in the amount of rhBTX fluorescence could be determined in the presence of NTZ. 
Therefore NTZ induced inhibition/dissociation of rhBTX at schistosome nicotinic receptors 
was due to the presence of drug and not due to quenching of the fluorophores. 
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4.7 Examination of morphological effect on schistosomes. 
4.7.1 SEM of schistosome to uý ment. 
Effects of NTZ on schistosomes have included, blebbing, shrinkage, granulation and 
darkening of worm tegument. This damage is similar to that observed with PRAZ. Previous 
work by Apinhasmit et al, (1998) and Mansoury, (1997) has demonstrated PRAZ induced 
tegumental damage with the trematodes Opisthorchis viverrini and S. mansoni respectively 
using Scanning Electron Microscopy (SEM). This tegumental damage has been 
demonstrated in a number of studies to be a major part of drug action e. g. hycanthone with 
S. mansoni and S. japonicum (Hillman et al, 1977). Therefore to clarify NTZ-induced 
effects on S. mansoni in more detail, the tegument of drug-treated worms was examined by 
SEM. 
Ultrastructural changes of the tegument of adult Schistosoma mansoni were investigated 
after in vitro incubation (without FCS) with 10µg/m1 of NTZ, DNNTZ and BZNT for 1 
hour. 0.2% DMSO was used as a negative control. 
4.7.2 Effect of DNNTZ and DMSO. 
The addition of 10µg/ml DNNTZ had no effect on schistosome tegument, with no 
blebbing, desquamation or formation of lesions evident. This is similar to the DMSO 
control where tegument disruption was also not observed (Figure 4.6). Addition of either 
DNNTZ or the drug diluent DMSO (0.2%) had no effect on worm motility and did not 
cause worm pairs to separate. 
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Figure 4.6 UMSO and DNNTZ effect on the tegumental surface of S. mansoni. 
Addition of DNNTZ shows no presence of blebs and 
tegument of male schistosome appears intact. 
Magnification 1000x 
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Addition of IOpg/ml DNN'I'Z does not cause paralysis or 
worm separation with S. fnansoni. Magnification 45x. 
Similarly addition of DMSO (0.2%) does not result in 
worm pair separation. 
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DNNTZ + male worm Magnification 3000x 
Addition of DMSO shows no presence of blebs and 
tegument of male schistosome appears intact. Lack of 
effect is identical to that observed with DNNTZ. 
Magnification I000x 
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DMSO + male worm. No tegument damage is 
present. Magnification 3000x 
Fig 4.6: Adult worm pairs were exposed to lOµg/ml DNNTZ a) or the equivalent 
volume of DMSO b) for I hour. Examination of tegument was then performed using 
SEM. With the addition of DNNTZ no tegumental differences were observed 
compared to the DMSO control. Female tegument was also unaffected. 
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DMSO + female worm. No tegument damage or 
abrasion is present. Magnification 3000x 
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4.7.3 Fflect of NTZ. 
SI. M examination of the samples showed that 1 hour exposure with 10µg/ml NTZ 
damaged the male and female schistosome tegument compared to that of the DMSO 
control. Males were more susceptible to the NTZ-induced damage than females. However, 
the extent of NTZ damage depended on the body part of the fluke. Damage to the male 
tegumental surface was extreme and characterised by blebbing due to the swelling of 
microvilli, and in some areas disruption of these structures had occurred forming lesions 
resulting in erosion and desquamation of the tegumental surface. The ventral as well as the 
dorsal surfaces of the male worm showed the same changes whereas the anterior part 
tended to he less damaged than the posterior part. With the female worm damage to the 
tegument was less clearly seen, but was characterised by an abraded appearance and 
showed swelling in some areas. 
Figure 4.7 NTZ induced damage of S. mansoni tei! umental surface. 
S. mansoni worm pair at 45x magnification. 
Clear NTZ induced separation of worm pair is 
evident. Male is above. 
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NTZ induced blebbing clearly evident on the 
tegumental surface of the male adult worm. 
Magnification 1500x 
NTZ induced blebbing on tegumental surface of adult 
male worm. Magnification 1000x. 
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NTZ exposure shows clear damage to the tegument causing 
lesions and warping. Blebbing and desquamation of the 
tegumental surface are also evident. Magnification 3000x 
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NTZ induced blebbing on tegumental surface of adult 
male worm. Magnification 1000x. 
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Addition of IOµg/ml causes abrasion and increased 
coarseness of female tegument. Effects are not as severe as 
those observed with male worms. Magnification 3000x 
Fig 4.7: Adult worm pairs were exposed to IOpg/ml NTZ for 1 hour. Examination of tegument was 
then performed using SEM. In comparison to the DMSO control, addition of NTZ caused severe 
blebbing and desquamation of the male tegurnental surface and caused the formation of lesions. 
Female tegument was significantly less affected but took on an abraded (rough) appearance and 
appeared more swollen compared to the DMSO control. 
4.7.4 F fect of BZNT. 
Effects of 13ZNT exposure on worms were similar to those observed with NTZ, and the 
compound caused blebbing and desquamation of the tegumental surface of the male. At 
higher magnifications, clear damage could be seen in the tegument characterised by the 
lormation of lesions. Female tegument effect was identical to that observed with NTZ. 
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Figure 4.8 BZNT induced damage of S. mansoni tegumental surface. 
BZNT induced blebbing on the tegurnental surface of 
male S. inansoni. Magnification 1000x 
Blebbing and clear tegumental disturbance are evident 
with BZNT. Magnification 3000x. 
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Addition of 10µg/ml BZNT causes severe damage to the tegument of male 
schistosomes. Damage is characterised by desquamation of tegumental surface, and 
the formation of lesions. BZNT induced damage appears more severe than that 
observed with NTZ. 
Magnification x 3000 
Fig 4.8: Adult worm pairs were exposed to IOµg/ml BZNT for 1 hour. Examination of tegument 
was then performed using SEM. In comparison to the DMSO control, addition of BZNT caused 
severe blebbing and desquamation of the niale tegumental surface and caused the formation of 
lesions in a similar way to that observed with NTZ. Tegumental disruption however seemed 
more severe with BZNT than with NTZ even though drug induced effect was less marked. 
Female tegument like that observed with NTZ was significantly less affected. 
4.8 Inhibition of S. mansoni glucose uptake by nitazoxanide. 
The tegumental damage observed when S. mansoni was exposed to 10itg/ml NTZ is 
similar that reported with Opisthorchis viverrini (a liver fluke) when exposed to 10µg/mI 
praziyuantel (Apinhasmit et al, 1988). Andrews & Thomas, 1979, have shown addition of 
PRAZ can affect absorption of nutrients such as glucose in Hymenolepis diminuta. Adult 
Schi. wosoma mansoni and S. haematobium rapidly take up glucose from the medium 
(Camacho and Agnew, 1995). In order to test whether NTZ/TIZ affected nutrient content, 
glucose uptake by S. mansoni schistosomula and adults was examined in the presence of 
NTZ and other drugs in medium 169 without FCS. 
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4.8.1 Effect of NTZ on glucose uptake by schistosomula. 
Pre-incubation for 30 minutes with 20µg/ml PRAZ, NTZ, TIZ, DNNTZ and BZNT 
inhibited glucose uptake by S. mansoni schistosomula (table 4.5). NTZ and TIZ gave the 
highest inhibition, with both demonstrating a 60% drop in glucose uptake compared to the 
DMSO control and both showed highly significant differences. DNNTZ inhibited glucose 
uptake by 19% at 20µg/ml, even though it had no effect on worm motility or morphology at 
this concentration. At lower concentrations the praziquantel inhibition of glucose uptake 
changed little from 44% at 20gg/ml to 58% at both 10µg/ml and 1µg/ml. NIC showed no 
inhibition of glucose uptake at all concentrations used, however NIC was seen to increase 
uptake suggesting an effect on electron transport (uncoupling) or glycolysis. 
Though both NTZ and PRAZ inhibited glucose uptake at 10 and 20gg/m1, the killing effect 
in vitro of NTZ and TIZ was more rapid than that observed with PRAZ. This suggests that 
though glucose uptake in schistosomula was affected with addition of both drugs, the more 
rapid death observed with NTZ shows that drug induced inhibition of nutrient absorption is 
not the primary mechanism of action of NTZ/TIZ. 
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Table 4.5 Effect of NTZ/TIZ on glucose uptake in S. mansoni schistosomula. 
DRUG (µg/ml) Deoxy-glucose uptake ± s. d 
ng glucose/ gg protein/ min. 
(n=3) 
% Inhibition P value 
N. S = not 
significant 
DMSO (0.2%) 7.8 ± 0.4 0 control 
PRAZ (20) 4.4 ± 0.6 44 P<0.0001 
PRAZ (10) 3.3 ± 0.2 58 P<0.000001 
PRAZ(1) 3.3±0.2 58 P<0.000001 
NTZ (20) 3.1 ± 0.5 60 P<0.00001 
NTZ (10) 4.2-+0.2 46 P<0.00001 
NTZ(1) 7.8±0.2 0 N. S 
TIZ (20) 3.1 ± 0.5 60 P<0.00001 
TIZ (10) 6.0 ± 0.4 23 P<0.001 
TIZ(1) 8.4±0.6 -8 N. S 
NIC (20) 8.2 ± 0.2 -5 N. S 
NIC (10) 8.7 ± 0.6 - 12 N. S 
NIC (1) 8.2 ± 0.2 -5 N. S 
DNNTZ (20) 6.3 ± 0.4 19 P<0.01 
DNNTZ (10) 7.0 ± 0.3 10 N. S 
DNNTZ (1) 8.2 ± 0.2 -5 N. S 
BZNT (20) 6.6 ± 0.4 15 P<0.01 
BZNT (10) 6.9 ± 0.3 12 P<0.02 
BZNT(1) 8.5±0.2 -9 N. S 
TABLE 4.5: The above table shows a typical result of glucose uptake studies. Praziquantel at all 3 
concentrations inhibited uptake of glucose in schistosomula, consistent with the earlier findings of 
Harder, 1987. NTZ and TIZ, also significantly inhibited glucose uptake at 20gg/ml and lO tg/ml but 
not at 1 gg/ml. At 1Ogg/ml the inhibition of NTZ is greater than that of TIZ. DNNTZ showed a 
significant inhibition of glucose uptake only at the highest dose even though no effect on worm 
motility was observed. NIC, though having very strong paralysing and toxic effect, at these 
concentrations did not significantly affect glucose uptake. However uptake was stimulated suggesting 
a possible effect on glycolysis. For concentration conversions from gg/ml to µM see appendix IV. 
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Figure 4.9 Percentage of glucose uptake in drug exposed schistosomula. 
PRAZ DMSO represents 100% uptake NTZ 
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vvashed and glucose uptake measured in a ß-counter. Addition of PRA-Z. NT Z or TIZ showed a clear 
inhibito» effect on glucose uptake. 1)NNTZ and I3ZNT shored a slight effect at higher concentrations. NIC 
did not affect glucose uptake, but increased it suggesting an effect on glycolysis. 
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4.8.2 Effect of NTZ on glucose uptake by Adult S. mansoni. 
Glucose uptake was measured in 100µl samples containing 2 pairs of adult S. mansoni pre- 
incubated (as for schistosomula) for 30 minutes in the presence or absence of drugs. NTZ 
and TIZ inhibited uptake of glucose at both I Ogg/ml and 1 gg/ml and again NTZ showed 
more inhibition than TIZ (table 4.6). PRAZ though showing good inhibition with 
schistosomula, at lOgg/m1 did not show any inhibition with adult worms. However at 
Igg/ml PRAZ significantly increased uptake (+ 21%). DNNTZ, and NIC did not show 
significant inhibition, but NIC showed a significant increase in glucose uptake of 26% and 
25 % at l0µg/ml and 1 µg/ml respectively. 
Table 4.6 Table showing percentage inhibition of glucose uptake in adult 
S. mansoni compared to DMSO control. 
DRUG (tg/ml) Deoxy-glucose uptake ± s. d 
ng glucose/ µg protein/ min. 
n=3 
% Inhibition P value 
N. S = not significant 
DMSO (0.2%) 89.6 ± 9.2 0 Control 
PRAZ (10) 91.3 ± 2.7 -1 N. S 
PRAZ(1) 108.3±6.6 -21 P<0.002 
NTZ(10) 54.4±6.3 39 P<0.01 
NTZ (1) 78.6 f 7.1 12 N. S 
TIZ(10) 61.7±9.3 31 P<0.03 
TIZ (1) 79.5 ± 15.9 11 N. S 
NIC (10) 113.1 f 8.8 - 26 P<0.002 
NIC (1) 111.7 ± 17.1 - 25 P<0.002 
DNNTZ (10) 86.9 t 3.2 3 N. S 
DNNTZ (1) 98.2 f 11.4 - 10 N. S 
TABLE 4.6: The above table shows a typical result of glucose uptake studies with adults. NTZ and 
TIZ, significantly inhibited glucose uptake at 10µg/ml but not at 1 µg/ml. PRAZ at 1µg/ml and NIC at 
both concentrations stimulated uptake of glucose in schistosomes, with increased uptake being 
significantly different to that of the DM SO control. The slight inhibition of glucose uptake by 
DNNTZ at 10µg/ml nor increased uptake at 1 tg/ml were not significantly different to the DMSO 
control. For concentration conversions from µg/ml to gM see appendix IV 
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Figure 4.10: Percentage of glucose uptake in drug exposed S mansoni adults 
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FIG 4.10: Drugs at concentrations of 10 and I µg/m1 were added to wells containing 2 pairs of adult 
Smansoni in l00pl medium 169. After 30 minutes drug exposure followed by 20 minute addition of [3H] 
deoxy-glucose, worms were washed and glucose uptake measured in a ß-counter. Addition of NTZ or TIZ 
showed a clear effect on glucose uptake. DNNTZ showed a very small inhibition at the higher 
concentrations. NIC and PRAT. did not affect glucose uptake but appeared to stimulate it. 
The results show that NTZ and TIZ are significantly inhibiting glucose uptake in 
schistosomula and adults at higher concentrations than I µg/ml. This may be due to the 
damaging effect that these drugs have on the tegument of the worm. However owing to the 
rapid paralysis occurring in adults with addition of 1 gg/ml NTZ/TIZ and no evident 
inhibition of glucose at this concentration, it can be assumed that impairment of nutrient 
absorption is independent of NTZ/TIZ observed paralysis. 
4.9 Examination of effect of NTZ on ATP levels in S. mansoni. 
Luminometric assays were carried out with adult S. mansoni in the same way as for C. 
elegans described in section 3.11. After 30 minutes drug exposure in the absence of serum, 
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worms were dissolved in 0.1 M NaOH/ EDTA and plates read for luminescence in a Wallac 
ß-counter. 
Incubation of S. mansoni, with NTZ and TIZ at 10µg/ml for 1 hour at 37°C caused a 
significant decrease in ATP concentration. This decrease in ATP concentration was not as 
low after incubation with lµg/ml. FCCP and niclosamide (1Oµg/ml) similarly caused a 
significant decrease in ATP concentration, with both drugs showing a comparable effect to 
NTZ/TIZ. PRAZ did not show as much decrease in ATP concentration as NTZ at 10µg/m1, 
however at 1 gg/ml a more significant and comparable decrease was observed. The 
corresponding denitro-compounds had no effect on ATP levels. The solvent DMSO at the 
concentration present when drugs were in the system had no effect on ATP levels which 
remained comparable to levels found in worms direct from medium 169. 
Table 4.7 Effect of NTZITIZ on ATP levels in S. mansoni. 
Treatment DMSO (A) NTZ (B) NTZ (C) TIZ (D) 
0.2% 10µg/m1 1 gg/ml 10µg/m1 
Mean [ATP] 16.3 9.9 10.3 10.3 
nmol mg protein'. 
S. D. 3.5 3.3 2.7 3.1 
Treatment TIZ (E) DNTIZ (F) NIC (G) PRAZ (H) 
1 µg/m1 10µg/m1 10µg/m1 10µg/ml 
Mean [ATP] 10.9 16.1 10.7 13.2 
nmol mg protein 1. 
S. D. 2.4 3.3 3.0 2.7 
Treatment PRAZ (I) FCCP (J) 
1µg/ml 10µg/m1 
Mean [ATP] 10.9 10.3 
nmol mg protein 1. 
S. D. 2.9 3.6 
Table 4.7: Mean [ATP] was calculated for each drug and compared to DMSO control. The above table 
shows the typical values of the drug effects on ATP levels in nmol mg protein 
1. The data for several 
experiments were hence incorporated and analysed in figure 4.11. 
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Figure 4.11 Effect of NTZ/TIZ on ATP content of S. mansoni. 
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Fig 4.11: S. mansoni were incubated for 30 minutes at 37°C with NTZ (10 or 1. ig/ml), TIZ (10 or I µg/ml), 
DNNTZ (10µg/ml), NIC (10µg/m1), PRAZ (10 or 1µg/m1), FCCP (10µg/m1) or DMSO (0.2%). After 
solubilising in alkali, ATP was determined as described in the methods. All assays were carried out in 
triplicate and similar results were obtained in separate experiments. Significant differences between values 
were calculated using a Student t-test (see table 4.8). 
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Table 4.8 Significance testing of ATP levels in drug exposed C. eleLans. 
Comparison of drugs A vs B A vs C A vs D 
P value < 0.005 < 0.02 < 0.02 
Comparison of drugs A vs E A vs F A vs G 
P value < 0.02 N. S. < 0.01 
Comparison of drugs A vs H A vs I A vs J 
P value N. S. < 0.02 < 0.01 
N. S. = Not significant. 
A= DMSO (0.2 %), B =NTZ (10µg/m1) 
C= NTZ (1 µg/m1), 
E= TIZ (1 µg/ml) 
G= NIC (10µg/ml) 
I= PRAZ (1 µg/ml) 
D= TIZ (10µg/m1) 
F= DNNTZ (lOµg/ml) 
H= PRAZ (IOgg/m1) 
J= FCCP (10µg/m1) 
Table 4.8: Clear significance difference of ATP levels in NTZ , TIZ, NIC and FCCP 
drug treated worms 
compared to the solvent control treated worms is evident. Addition of lOµg/ml PRAZ did not significantly 
reduce ATP levels, whereas I µg/ml did. DNNTZ did not significantly reduce ATP levels in S. mansoni. 
4.10 Assay of nitroreductase activity in S. mansoni with NTZ and TIZ. 
Niridazole, an antischistosomal nitrothiazole derivative, is reduced by adult Schistosoma 
mansoni to one or more reactive intermediates (Tracy et al, 1983). Studies were therefore 
carried out to examine whether reduction of NTZ/TIZ occurred in the presence of S, 
mansoni. 
Anaerobic conditions were created by purging a septum-sealed cuvette with argon in the 
presence of an oxygen-scavenging enzymatic system. On the mixing of the S. mansoni 
homogenate (0.3mg/ml protein) with NADH (or NADPH) and glucose-6-phosphate, 
however, the absorbance of NTZ/TIZ at 412nm was unchanged. Using niridazole instead to 
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test nitroreductase activity, also gave a negative result in contrast to the findings of Tracy et 
al, (1983) where addition of S. mansoni homogenate caused disappearance of absorbance of 
niridazole at 400nm. This may be due to the differences in the maintaining of anaerobic 
conditions. Tracy et al, used an anaerobic chamber, with a side-arm attached to the cuvette 
to ensure anaerobic conditions were present at all times. The septum-sealed cuvette used 
here may not have been completely satisfactory. It is therefore likely that some oxygen may 
still have remained in the system, and this could have inhibited the enzyme. 
4.11 Examination of NTZ action on et hatchine, miracidia and cercariae motility. 
Praziquantel affects S. mansoni egg hatching and the motility of the free-living miracidia 
(Andrews, 1978). For comparison, NTZ and TIZ and other Romark compounds were tested 
for similar effects. 
4.11.1 Eggs. 
Eggs placed under light hatch very rapidly, releasing the fast swimming, free-living 
miracidia. When eggs were pre-exposed (for 30 minutes) to 10µg/ml and lµg/ml NTZ or 
TIZ and then illuminated, no inhibition of egg hatching was observed, and the majority of 
eggs hatched within 30 minutes. When eggs were exposed to 10µg/ml and 1 gg/ml PRAZ, 
egg-hatching was clearly inhibited (as reported by Andrews, 1978) with many eggs 
remaining un-hatched after 2 hours. DNNTZ and DMSO (0.2%) had no inhibitory effect on 
egg-hatching. 
4.11.2 Miracidia. 
No initial effect on miracidial swimming speed or morphology was observed with 10µg/ml 
and 1µg/ml NTZ or TIZ. However, approximately half an hour after drug exposure, 
miracidia exposed to either drug became sluggish moving less rapidly than the DMSO 
control. After 1 hour exposure to NTZ and TIZ all miracidia became immobile, and many 
were swollen and rounded. No recovery of the miracidia was observed. PRAZ at 1Ogg/ml 
and 1 gg/ml also slowed down miracidial movement. The effects however, were not as 
strong as those of NTZ, since after 1 hour in PRAZ, the miracidia were still able to swim. 
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DNNTZ and the solvent control DMSO (0.2%) had no effect on miracidial movement or 
morphology. 
4.11.3 Cercariae. 
Studies were also carried out on cercariae to see if Romark compounds had any effect on 
motility or viability. On exposure to 10µg/ml and 1 µg/ml NTZ and TIZ, cercariae showed 
sluggishness after 30 minutes and were unable to move properly. After 1 hour cercariae 
were unable to swim, although the tail was able to move normally. Cercariae also showed 
some slight morphological change with NTZ and TIZ, characterised by a crookedness in 
the tail and swelling of the head. PRAZ and NIC at 1 pg/ml also slowed down cercarial 
swimming and had a similar effect on motility to that of NTZ and TIZ but did not induce 
any morphological changes. DNNTZ and DMSO had no effect on motility or morphology 
of cercariae. 
From these results, NTZ and TIZ show clear activity on all stages of the schistosome life- 
cycle except the egg. DNNTZ and DMSO showed no effect on any of the life cycle stages. 
4.12 Examination of molluscicidal properties of NTZ. 
The molluscicidal activity of BZNT 2- benzamido-5-nitrothiazole and NIC niclosamide 
have been recently studied (Dreyfuss, 1996: Rondelaud, 1996). Potential NTZ and TIZ 
activity as molluscicides was examined at 0.5mg/litre and 1mg/litre using niclosamide as a 
positive control and DMSO as a negative control. The snails used were Biomphalaria 
glabrata, the intermediate host of S. mansoni. 
Upon exposure to NTZ and TIZ at either concentration, no effect on snail mobility or 
viability was observed up to 48 hours, when all snails were alive and showed normal 
activity. With NIC addition, snails became immobile within 2 hours, withdrawing into their 
shells. After 48 hours 25% of snails were dead at 0.5mg/litre and 45% of snails were dead 
at 1mg/litre. Therefore, neither NTZ nor TIZ has molluscicidal activity against the S. 
mansoni intermediate host B. glabrata. 
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4.13 Discussion. 
Although NTZ has good activity against Fasciola hepatica in humans (Favennec et al, 
2003) this trematode was not available to study. Therefore, the mechanism of action of 
NTZ against trematodes was examined using the blood-fluke Schistosoma mansoni. Both 
NTZ and TIZ showed clear activity against all stages of schistosomes apart from the eggs, 
characterised by rapid paralysis, shrinkage and tegumental damage. The drug effects were 
diminished in the presence of serum. Nutrient uptake was also affected in the presence of 
NTZ, and ATP levels were significantly lowered. BZNT, a related compound, was also 
active against schistosomes but the effects were distinct from those of NTZ. 
4.13.1 Paralytic effect. 
a) Without serum. 
NTZ or TIZ (10µg/ml and 1 ig/ml) caused a rapid curling of adult S. mansoni and 
paralysis; separation of pairs was followed by shrinkage and darkening of the tegument. 
The effects were comparable to those of PRAZ with similar potency and speed of paralysis 
development. However, NTZ and TIZ produced a quicker killing effect, with 100% 
schistosome mortality observed by 24 hours, whereas schistosomes exposed to PRAZ took 
up to 120 hours to die. BZNT also caused paralysis but with a slower onset, and this was 
not lethal within 120 hours. 
In schistosomula, NTZ and TIZ, similarly at lOgg/ml, caused rapid paralysis and 
tegumental disruption which was more profound than that observed with PRAZ which 
acted only after about 3 hours. BZNT caused rapid paralysis and mortality occurred at 
lower concentrations than observed with NTZ. These differences suggest a difference 
between mechanisms of action of BZNT and NTZ. 
The protonophores FCCP, CCCP and niclosamide showed very similar paralysis 
production in S. mansoni adults to that observed with NTZ and TIZ, characterised by 
shrinkage and curling. This suggests that a protonophore effect may be an important aspect 
of the mechanism of action of NTZ against schistosomes. 
190 
Chapter 4- Trematodes. 
b) With serum. 
Addition of 10% FCS to the medium significantly lowered activity of NTZ/TIZ against 
schistosomes. This is due to the drug having a high affinity for albumin with >99% bound 
to albumin in human blood. (Romark, Pharmaco-Toxicological expert report, 1999). FCS 
did not, however lower the activity of praziquantel presumably because of lesser binding to 
serum proteins: 20% of PRAZ was unbound (Vanden Bossche, 1985). NTZ was found to 
be inactive against S. mansoni in mice Q. D. Bickle (2000) (personal communication). 
Presumably this is related to the very low concentration of free NTZ / TIZ in the plasma. 
4.13.2 Drug uptake. 
The rapidity of NTZ effects on S. mansoni suggest that the drug is absorbed very rapidly. 
Since trematodes, unlike nematodes lack a cuticle, and actively absorb nutrients e. g. 
glucose through the tegument (Rogers & Bueding, 1975), it seems likely that the drugs are 
being absorbed directly rather than ingested. This is supported by the clear tegumental 
disruption after 1 hour NTZ exposure. Ingestion however, could also be occurring. 
4.13.3 Tegumental damage. 
By light microscopy NTZ caused blebbing and granulation of the schistosome tegument. 
Adult males were the most affected and were also more susceptible than females to lower 
concentrations of drug. Scanning electron microscopy also confirmed these observations 
and also showed desquamation, lesions and tegumental swelling. These effects were very 
similar to those of PRAZ (Apinhasmit & Sobhon, 1996) on the liver fluke Opisthorchis 
viverrini. 
4.13.4 Glucose uptake. 
NTZ or TIZ (IOug/ml) significantly inhibited uptake of glucose in adult S. mansoni or 
schistosomula. Rogers & Bueding, (1975) have shown that in S. mansoni glucose is 
actively taken up by the tegument and accumulates over time. Inhibition of glucose uptake 
in this study is therefore, probably associated with the severe damage of the tegument 
observed with NTZ exposure affecting active absorption. At a lower concentration of NTZ 
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(lµg/ml), glucose uptake was less affected, and correlated with the level of tegumental 
damage. However, owing to the speed in which paralysis and death occurred in the flukes, 
it is likely that another mechanism of toxicity causes the pathogenesis. PRAZ did not 
inhibit glucose uptake in adults which further suggests that nutrient transport is unrelated to 
the rapid paralysis produced by this drug. PRAZ did inhibit glucose uptake in 
schistosomula, and its slow toxic effect on this stage could be due to this. 
4.13.5 NTZ effect at nicotinic receptor. 
a) Nicotinic antagonists. 
Effects of NTZ on nicotinic receptors were investigated using the same receptor 
antagonists as used for C. elegans (see chapter 3). Pre- or post-treatment with 
mecamylamine, pempidine or atropine neither prevented nor abolished, respectively, 
NTZ/TIZ induced paralysis in schistosomes. This is in agreement with previous studies by 
Day et al, (1996), in which mecamylamine was an ineffective antagonist of acetylcholine in 
S. mansoni. Presumably, this may be due to the structure of acetylcholine receptors being 
different in trematodes to those in nematodes thus preventing antagonistic action. However 
they were still similar enough to interact with NTZ. 
b) Alpha-Bun arotoxin (BTX). 
Since mutants/genetic methods are not available for schistosomes, the nicotinic-like 
acetylcholine receptors of the schistosome were examined directly using a specific protein 
toxin (rhBTX) which can be visualised binding to schistosomes (e. g. S. haematobium, 
Camacho, 1995). Nicotinic acetylcholine receptors (nicotinic AchRs) are ligand- gated ion 
channels that produce an increase in Na' and KK permeability, depolarization and excitation 
upon activation (Haughland, 1998). Alpha- bungarotoxin, binds with a high affinity to the 
a-subunit of the nicotinic acetylcholine receptors of neuromuscular junctions (Haughland, 
1998). Molecular Probes supply several fluorescent a-bungarotoxin conjugates to facilitate 
visualisation of nicotinic AchRs and a-bungarotoxin with an attached fluorophore of 
tetramethylrhodamine was used to study possible nicotinic receptor interaction by NTZ. 
The wavelengths of excitation and emission of tetramethyl-rhodamine (both over 500nm), 
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were free from interference by the yellow NTZ and analogues, whose absorbance peaks are 
below 500nm. 
RhBTX clearly binds to nicotinic receptors in S. mansoni and S. japonicum adults and 
schistosomula. Addition of NTZ or TIZ inhibited or abolished this binding. The inhibition 
of rhBTX binding by NTZ suggests that it competes with rhBTX for the receptor, leading 
to a displacement of rhBTX or prevention of binding of rhBTX. This suggests that NTZ is 
an agonist for the nicotinic AchR, identical to a likely primary mechanism of action of NTZ 
in C. elegans deduced from genetic analysis (Chapter 3). In schistosomula the rapidity of 
drug effect and evidence of surface layer degradation under phase contrast suggest a 
surface membrane-associated mode of entry by NTZ. The pattern of fluorescence observed 
in this study was different to that previously shown by Camacho & Agnew, (1995), owing 
to rhBTX incubation carried out at 37°C instead of cold medium which presumably 
prevented uptake of the reagent into the body. BZNT did not inhibit rhBTX binding in 
adults, but in schistosomula caused a chaotic pattern of fluorescence. This difference in 
pattern of fluorescence in the presence of BZNT, also supports that this drug may have a 
different mode of action to NTZ and suggests extensive damaging of the organism. BTX on 
its own, had no effect on worm motility and did not appear to prevent NTZ-related motility 
changes. 
A control study was carried out using pirenzepine, a muscarinic agonist which binds to the 
Mi muscarinic AchR in the visual cortex of mice (Wang, 1994). Red fluorescent Bodipy 
558/568 was chosen as a fluorophore because of the similarity in wavelength to rhBTX. 
Bodipy pirenzepine showed a clear binding to muscarinic receptors in S. mansoni and this 
was unaffected by NTZ, indicating that NTZ does not inhibit binding of agents to 
neurotransmitter receptors generally. Although NTZ quenched the fluorescence of rhBTX 
significantly in vitro, it also quenched the fluorescence of BoP and, in spite of this, it did 
not prevent visualisation of the muscarinic receptors in S. mansoni adults. 
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4.13.6 NTZ protonophoric effect. 
NTZ and TIZ significantly reduced ATP levels in adult S. mansoni. This reduction was 
comparable to the reduction caused by FCCP and niclosamide, and again suggests that NTZ 
has similar mechanism of action to these drugs. This reduction in ATP could explain the 
similarity in paralysis between these drugs as a decrease of ATP in the worm would affect 
nerve signal transduction via Ca / Na ATPase, hence causing rapid paralysis. This has 
already been suggested as the cause of paralysis seen in Dipylidium caninum by 
niclosamide (Sano et al, 1982). PRAZ at 10µg/ml did not significantly alter ATP levels in 
S. mansoni, however at the lower concentration of 1µg/ml, a significant decrease was seen. 
This again highlights the differences in action of NTZ and PRAZ. 
4.13.7 NTZ as a molluscicide. 
Comparison of NTZ and bayluscide (niclosamide) showed no molluscicidal activity 
against B. glabrata with the Romark compound. Previous studies with BZNT (Dreyfuss et 
al, 1996) have shown this compound to be effective against Lymnaea glabra, again 
suggesting a differing mechanism between the two compounds. NTZ however may perhaps 
have molluscicidal activity against this other species due to its structural similarity to 
BZNT. 
4.13.8 Conclusions. 
With trematodes, it appears a few mechanisms of action of NTZ/TIZ are in effect, 
including an effect at the nicotinic receptor, reduction of ATP levels caused by a possible 
protonophoric effect and an effect on nutrient uptake. Both drugs cause a rapid paralysis 
and killing effect similar to that seen with the known uncouplers FCCP, CCCP and 
niclosamide, but different to that seen with PRAZ suggesting a protonophoric mechanism. 
This is further supported with NTZ significantly reducing ATP levels in the fluke. NTZ 
also causes clear tegumental damage which probably serves to lower the amount of glucose 
uptake of the fluke. However this is unlikely to be the primary mechanism of action owing 
to the speed in paralysis and mortality of the worm being too fast to be directly induced by 
lack of nutrients. Some effect at nicotinic receptors in schistosomes was observed where 
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NTZ was seen to clearly inhibit BTX binding to the receptor. Comparison with the known 
uncoupler CCCP, showed no inhibition of rhBTX binding suggesting that NTZ-induced 
paralysis in schistosomes is due to drug interaction at the nicotinic receptors. However, 
uncoupling could still be a factor of paralysis (and reduction of glucose uptake, which 
needs ATP), as an ATP drop in the worm would affect nerve signal transduction via Ca / 
Na ATPase and would cause rapid paralysis this way. This would explain the similarity in 
paralytic effects seen with FCCP, CCCP and niclosamide. NTZ demonstrated no 
molluscicidal activity. BZNT showed some activity against schistosomes, but type and 
speed of paralysis and lack of mortality suggests a different mechanism to that of NTZ. The 
reason for this is that BZNT lacks a substituent on the aromatic ring rendering it more 
likely to be metabolised differently. Hydrolysis of the amide would yield the highly toxic 
amino nitrothiazole which is not formed from NTZ / TIZ. 
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5.1 Introduction. 
Cestodicidal activity of NTZ against human parasites was first described in a clinical 
study (Rossignol and Maisonneuve, 1984). More recently, further clinical trials have 
shown good efficacy of NTZ against cestodes with an 82% cure rate of hymenolepiasis 
and a 98% reduction in egg production found in Peruvian children (Juan et al, 2002). In 
vitro, nitazoxanide (l0µg/ml) caused rapid damage to the ultrastructure and cellular 
destruction of metacestodes of Echinococcus multilocularis (Stettler et al, 2003). In the 
present project, studies were carried out in vitro, using adult and cysticercoid stages of 
Hymenolepis diminuta and cysticercoid stages of Hymenolepis microstoma. Effects of 
NTZ on motility and morphology were compared with those on nematodes and 
trematodes. Cestodes were very susceptible to NTZ demonstrating rapid paralysis and 
death. Oxygen uptake in mitochondria was stimulated in the presence of NTZ and 
severe tegumental damage was observed. BZNT as observed with trematodes caused 
paralysis and tegumental damage in Hymenolepis, though effects were less severe than 
with NTZ. DNNTZ, unlike with nematodes and trematodes caused slight paralysis and 
some tegumental damage. 
5.2 Activity of Romark drugs and control drugs against H. diminuta. 
5.2.1 NTZ and TIZ: Effects on adult H. diminuta. 
Single, freshly isolated adult H. diminuta were placed into 15m1 of Earle's balanced 
salt solution, in a plastic Petri dish. NTZ or TIZ in DMSO were added at concentrations 
of l Ogg/ml or 1 pg/ml and the effects observed at ambient temperature for 4 hours 
using initially a bench dissecting microscope and then an inverted microscope (20x 
magnification). NTZ or TIZ at either 10 or 1 pg/ml immediately increased the motility 
of the adult tapeworms, followed by visible spastic contractions starting from the 
scolex, running through the neck and then along the entire length of the strobila. After 
approximately 20 minutes the contractions ceased and the worms 
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began to curl up and became paralysed in a similar way to that observed with S. 
mansoni (Chapter 4). 
Paralysis was tonic with no worm movement evident, and after 1 hour, tegumental 
damage (characterised by blebbing) to the neck and proglottid segments was observed 
under an inverted microscope. Scolex integrity was also clearly affected and 
characterised by swelling. Worms appeared dead after 3-4 hours. 
If worms were exposed to 10µg/ml NTZ or TIZ for 1 hour and then the drug was 
removed, death still occurred within 4 hours showing that drug effect was irreversible at 
this concentration and time. Unfortunately, concentrations of NTZ below 1 gg/ml were 
not tested (and hence LD50's not found) due to a lack of tapeworms. The diluent DMSO 
(0.2%) had no effect on worm motility or viability and no visible effect on worm 
tegument up to the assay end point of 4 hours. 
5.2.2 Effect of other Romark compounds with adult H. diminuta. 
On addition of 10µg/ml DNNTZ or 10µg/ml BZNT, effects were initially similar to 
those seen with 1 or 10µg/ml NTZ, and adult worms within 5 minutes were 
demonstrating slight spastic contractions running along the length of the worm's body. 
However, the contractions, were not as severe as those seen with NTZ/ TIZ and only 
lasted for 5-10 minutes. After 10 minutes the contractions ceased and worms in either 
DNNTZ or BZNT partially recovered. No tegument damage was observed with either 
drug, and movement (though sluggish) was still evident after 4 hours. Concentrations of 
1 µg/ml DNNTZ and 1 µg/ml BZNT showed some slight contraction of the worm body, 
but paralytic effects were not clearly observed. TIZg had no effect on the motility or 
morphology of adult H. diminuta at 1 µg/ml or 1O tg/ml. 
5.2.3 Effect of praziquantel with adult H. diminuta. 
Addition of 10µg/m1 PRAZ to adult H. diminuta caused paralysis and contraction was 
observed after 10 minutes. The contraction was tonic, but was not as severe as the 
spastic - contractions observed with NTZ and TIZ. After 4 hours worms were still 
paralysed but no mortality was observed. After 4 hours no damaging effect on worm 
tegument was observed and the worm scolex appeared unaffected. 
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Table 5.1 Visual effects of NTZ and other compounds on 
adult H. diminuta after 4 hours. 
Compound Paralysis Death Tegument damage Scolex damage 
(10µg/ml) 
NTZ Yes Yes Yes Yes 
TIZ Yes Yes Yes Yes 
PRAZ Yes No No No 
BZNT Yes No No No 
DNNTZ Yes No No No 
TIZg No No No No 
Table 5.1: Adult H. diminuta were placed into 15m1 of Earle's balance salt solution, in a plastic petri dish 
and drug added to a final concentration of lOµg/ml. Effects were monitored at ambient temperature and 
included paralysis, tegument damage scolex damage and death. Effects with NTZ and TIZ were the most 
severe causing paralysis and death. PRAZ, DNNTZ and BZNT caused paralysis but did not cause death. 
TIZg had no effect. Molar concentrations used for each drug were as follows: NTZ (33µM), TIZ (38µM), 
PRAZ (32µM), BZNT (40µM), DNNTZ (38µM) and TIZg (23µM) 
5.3 Effect of drugs on excvsted protoscolices of H. diminuta and H. microstoma. 
In order to examine NTZ related effects on the larval stages of Hymenolepis spp, 
cysticercoids of either H. diminuta or H. microstoma were excysted and a suspension in 
Dulbecco's Modified Eagle's medium (DMEM) divided into wells of a 96 well plate 
(l00µl) then drug was added in triplicate assays from 0.1 µg/ml to 30gg/ml. Worms 
were incubated at 37°C and monitored microscopically using an inverted microscope 
(40x magnification) for a period of 4 hours. 
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5.3.1 Effects with H. microstoma. 
5.3.1.1 Effects with NTZ and TIZ. 
Excysted cysticercoids were fully motile in DMEM and demonstrated scolex 
elongation and sucker movement. Addition of lOgg/ml NTZ or TIZ to excysted 
cysticercoids of H. microstoma caused an immediate reaction, characterised by paralysis 
of the scolex causing motility and sucker movement to cease. Within a few seconds 
blebbing started to occur, the suckers retracted and the rostellum opened revealing 
damage in the formation of the hooks. This was followed by an enlargement of the 
scolex until integrity was lost and total collapse occurred within 5-10minutes (see figure 
5.1b). This form of disintegration was seen in 67% of excysted cysticercoids at this 
concentration, with the remainder becoming paralysed and showing no movement or 
other activity within 30 minutes. At 1 gg/ml the effect of either drug was slower and 
only 20% of scolices showed disintegration within 30 minutes. After 30 minutes all 
non-disintegrated scolices were paralysed but still alive, but after 1 hour all scolices 
were moribund. No recovery from exposure to 1 pg/ml NTZ or TIZ was observed. After 
24 hours, all cysticercoids exposed to 1 gg/ml NTZ or TIZ had disintegrated. No 
difference in paralysis or speed of effect was observed between NTZ and TIZ at any 
concentration tested. Addition of 0.1 pg/ml NTZ or TIZ had no effect on cysticercoid 
motility or morphology: 100% of worms were alive and fully active after 24 hours. 
Equal concentrations of the drug diluent DMSO had no effect on scolex motility or 
integrity. Table 5.2 shows the activity of varying concentrations of NTZ on the motility 
of H. microstoma excysted cysticercoids during a 24 hour period. 
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Table 5.2 NTZ induced effects on the motility/activity of excvsted cysticercoids 
of H. microstoma over time. 
Conc/time 10 mins 30 mins 1 hour 2 hours 4 hours 24 hours 
10µg/m1 0(67) 0(100) 0(100) 0(100) 0(100) 0(100) 
33 M 
5µg/ml 0(50) 0(100) 0(100) 0(100) 0(100) 0(100) 
16 M 
1µg/m1 3 2 (20) 1 (20) 1 (20) 1 (20) 0 (100) 
(3.3 µM) 
0.8µg/ml 4 3 3 2 2 0(100) 
2.6 M 
0.4µg/ml 4 4 3 3 2 0(100) 
1.3 M 
0.1 µg/m1 4 4 4 4 4 4 
0.33 M 
Key to table 5.2 
Activity of cysticercoid. Parentheses show percentage mortality. 
4= Good activity 
3= Sluggish 
2= paralysed 
1= Moribund 
0= Dead 
Table 5.2: Effect of varying concentrations on the motility of cysticercoids of H. microstoma over 24 
hours. Examination was carried out using an inverted microscope at 40x magnification. Between 
microscopic examinations, cysticercoids were placed in a 37°C incubator in 95%air/5% CO2, 
Excysted scolices exposed to 10µg/m1 NTZ or TIZ were also removed from drug and 
placed in fresh media after 30 minutes. No recovery however was observed and worms 
became moribund and died as above. 
5.3.1.2 Effect of other Romark compounds on excysted protoscolices of 
H. microstoma. 
Addition of IOµg/ml DNNTZ and BZNT to excysted cysticercoids caused a similar but 
less severe effect to that observed with NTZ and TIZ. Scolices on exposure to either 
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compound became paralysed within 5 minutes and sucker movement was reduced. 
However, the extreme disruption observed with NTZ or TIZ, was not evident. After 30 
minutes exposure to DNNTZ, scolices showed some recovery (though motility was not 
back to the level of the control) and no death was observed. Scolices exposed to BZNT 
did not show any recovery and all cysticercoids were moribund after 1 hour. Scolices 
exposed to 1 pg/ml DNNTZ showed no drug effect, whereas 1 gg/ml BZNT did cause 
motility impairment though much reduced from that observed in the higher 
concentration, with paralysis taking several hours to occur. Death was not observed 
with DNNTZ at either concentration up to 24 hours, whereas with BZNT scolex 
disintegration was observed at either 1 or lOug/ml. TIZg had no effect on cysticercoid 
motility or morphology up to 30gg/ml after 24 hours. 
5.3.1.3 Effect of other drugs on exc sy ted protoscolices of H. microstoma. 
Addition of 10µg/ml NIC, FCCP or CCCP, caused rapid paralysis in the exposed 
cysticercoids similar to that observed with NTZ. After 1 hour all sucker movement had 
ceased and clear damage to the tegumental integrity was observed characterised by 
collapse. At 1 pg/ml onset of paralysis with each drug occurred much more slowly, 
taking up to 1 hour to become evident. At four hours post drug addition all cysticercoids 
demonstrated damage to the scolex and all three drugs at 1 gg/ml caused complete 
scolex disintegration by 24 hours post-exposure. 
Addition of 10µg/ml praziquantel caused paralysis, but at a much slower rate than 
observed with NTZ, NIC, FCCP or CCCP. However all cysticercoids were paralysed 
within 4 hours, though no damage to the scolex was observed. After 24 hours all 
cysticercoids were alive but clear granulation and scolex damage was evident. At 
1 pg/ml, PRAZ failed to cause paralysis of cysticercoids after 4 hours. After 24 hours 
all cysticercoids were alive and motile, however some scolex damage and granulation 
was again evident. Addition of 109g/ml MET or LEV had no effect on worm motility or 
morphology. 
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Figure 5.1 Infective excvsted scolices of H my enolepis microstoma in the presence of 
a) DMSO and b) 10µg/ml NTZ. 
a) 
b) 
2' 
*ýr 
, ý. 
a' 
-0 
Fig 5.1: C}"sticercoids of H microstonta were exposed to lOgg/ml of NTZ for 10 minutes in 
DMEM at 37°C. After 5 minutes cysticercoids became paralysed and scolex integrity failed fig 
5.1 b). causing it to burst. An equal concentration of the drug solvent DMSO had no effect on 
cvsticercoid motility or scolex integrity. fig 5.1 a). 
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5.3.1.4 Quantitative comparison of sensitivity of H. microstoma cysticercoids 
to NTZ and other compounds in DMEM in the absence of FCS. 
Since larger numbers of H. microstoma cysticercoids were available, the effects of 
NTZ on motility was tested at several concentrations for 4 hours and the M150 
(concentration to affect motility in 50% of worms) determined. It was not possible to 
quantitate the cestodicidal activity owing to difficulty in discerning parasite death. 
Table 5.3 Effect of Romark compounds and control drugs on 
H. microstoma motility: quantitative data. 
Compound MI50 ± S. E. (µM) 
NTZ 0.55 ± 0.2 
TIZ 0.58±0.1 
DNNTZ < 19.0 > 3.8 
BZNT < 8.0 > 4.0 
TIZg (No effect at 68µM) 
PRAZ 2.9±0.7 
NIC 0.61±0.5 
FCCP 0.7 ± 0.3 
CCCP 0.44: L 0.1 
MI50 = Concentration of drug which results in motility inhibition in 
50% of the worm population in 4 hours. 
Table 5.3: Cysticercoids of H. microstoma were exposed to 10µg/ml of drug for 4 hours in 
DMEM (without FCS) at 37°C. After 4 hours, effects on motility characterised mainly by 
cessation of sucker movement were noted and M150's calculated using Sigmaplot 2000. An equal 
concentration of the drug solvent DMSO had no effect on cysticercoid motility within 4 hours. 
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5.3.1.5 Effects of drugs on H. microstoma cysticercoids in the presence of serum. 
Addition of 10% FCS dramatically lowered the potency of NTZ/TIZ against H. 
microstoma cysticercoids. Addition of IOgg/ml NTZ/TIZ caused sluggishness within 10 
minutes, followed by paralysis, but scolex integrity was unaffected, and all 
cysticercoids were alive after 4 hours. In 1 µg/ml NTZ/TIZ all cysticercoids were fully 
motile, demonstrating normal sucker movement compared with the solvent control even 
after 24 hours. The MI50's of NTZ and TIZ were increased more than 10-fold to 7.0 ± 
0.6µM and 8.4 ± 1.1µM respectively. Addition of serum had no effect on the potency 
of PRAZ, CCCP, FCCP or niclosamide: M150's did not differ significantly from those 
observed when serum was absent. 
5.3.2 Effect of NTZ on cysticercoids of H. diminuta. 
5.3.2.1 Effects with NTZ and TIZ. 
With addition of IOµg/ml NTZ or TIZ to H. diminuta complete paralysis was observed 
in 100% of cysticercoids within 5 minutes, characterised by lack of motility and 
cessation of sucker movement. Drug effects however, were not as severe as those 
observed with H. microstoma cysticercoids and rapid loss of scolex integrity was not a 
factor. However, H. diminuta cysticercoids appeared dead within one hour of drug 
exposure and no recovery was observed. After 24 hours scolex disintegration had 
occurred in 100% of exposed cysticercoids. In 1µg/ml of NTZ/TIZ, paralysis took 
approximately one hour to occur and all cysticercoids became moribund within four 
hours. Again after 24 hours, all cysticercoids exposed to ljtg/ml NTZ or TIZ had 
disintegrated. With additions of NTZ and TIZ at 0.1 gg/m1 concentration, no effect on 
motility, sucker movement or morphology was observed, and all cysticercoids showed 
normal movement after 24 hours. Equal concentrations of the DMSO solvent control to 
those found in the drugged wells had no effect on scolex motility or morphology. All 
cysticercoids displayed normal motility after 24 hours. 
5.3.2.2 Effect of other Romark compounds on excysted protoscolices of H. diminuta. 
Addition of 10µg/ml DNNTZ or BZNT caused paralysis as rapidly as a similar 
concentration of NTZ/TIZ but was less severe, with some movement of suckers still 
evident. After 4 hours drug exposure, BZNT-treated worms were moribund, whereas 
those exposed to DNNTZ continued to show limited sucker movement. After 24 hours 
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BZNT exposed worms had disintegrated whereas those exposed to DNNTZ still showed 
signs of life. Addition of 1 pg/ml BZNT again caused paralysis of cysticercoids though 
speed of paralysis was slower and scolices did not become moribund within 4 hours. 
Death was again observed after 24 hours. Addition of 1 µg/ml DNNTZ merely induced a 
slowing of motility with cysticercoids appearing sluggish and no mortality was 
observed after 24 hours. TIZg, similarly to equal concentrations of the drug diluent 
DMSO had no effect on cysticercoid motility or morphology. 
5.3.2.3 Effect of known anthelmintics and other compounds. 
Addition of 10µg/ml NIC, CCCP or FCCP caused rapid paralysis of cysticercoids, 
indistinguishable from that observed with NTZ or TIZ, characterised by lack of motility 
and cessation of sucker movement. All cysticercoids appeared dead lhour after drug 
exposure. All cysticercoids were dead and showed disintegration after 24 hours drug 
exposure. With 1 µg/m1 the same effects were observed except that onset of paralysis 
occurred after between 2-3 hours for each drug. 
Praziquantel (IOµg/ml and Ipg/ml) showed lesser effects exactly as observed with H. 
microstoma. Similarly, addition of 10µg/ml MET or LEV had no effect on motility or 
morphology of H. diminuta cysticercoids. 
MI50's for NTZ/TIZ effect on H. diminuta cysticercoid motility were the same as 
observed with H. microstoma. Similarly MI50's with FCCP, PRAZ and NIC were the 
same for both species. Again addition of FCS (10%), reduced NTZ/TIZ activity. 
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Figure 5.2 Comparison of activity of Romark compounds and known 
anthelmintics against H. diminuta and H. microstoma cysticercoids. 
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DRUG 
Drug activity is defined as: 0 Not Effective. 1 Slight Effect. 
2 Moderate Effect. 3 Strong Effect (Killing effect within 4 hours) 
4 Very Strong Effect (Killing effect within 1 hour) 
Fig: 5.2: Ten cysticercoids of H. din inuta or H. microstonia were exposed to 10gg/ml of drug in DMEM 
in vitro for 4 hours at 37°C in the absence of serum. NTZ/TIZ showed very strong activity against the 
cysticercoids and caused 100% mortality within 4 hours. The initial effect on H microsionta was more 
severe than that observed with H. din inuta and involved rapid disintegration of the scolex. NIC and 
CCCP showed very strong activity and 100% of worms were moribund within 4 hours. PRAZ and BZNT 
had a moderate effect causing lack of motility. Unlike with nematodes and trematodes. DNNTZ induced 
some paralysis in both species. TIZg. metrifonate and the anti-nematodal drug LEV had no effect on 
cysticercoids of either species. The solvent control DMSO had no effect on cysticercoid motility or 
integrity. 
5.4 Examination of morphological effects on cestodes. 
Previous studies have shown that anthelmintics can cause drug-induced 
pathomorphological changes in the tegument of tapeworm species e. g. taenifugin with 
Hymenolepis fralerna (Stoitsova ei al, 1992) and praziquantel with Boihriocephahis 
acheilognaihi (Pool, 1985). SEM studies were therefore carried out on samples of 
NTZ-treated rat tapeworm, H. dimimita. Treatments with DNNTZ or BZNT were also 
carried out for comparison. 
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5.4.1 Solvent control 
Foreman & Oaks (1991) showed that DMSO above 1% (v/v) caused tegumental 
degradation and vesiculation of H. diminuta after 20 hours in vitro culture, whereas 
concentrations below 1% (v/v) have no effect. In this study for drug effect analyses, a 
maximum of 0.2% (v/v) of DMSO was used so that tegumental damage was not 
induced. After tapeworms were incubated in 0.2% DMSO for 30 minutes at 37°C, they 
were fixed and prepared for SEM. SEM examination revealed the tegument was free of 
blebbing or fracturing (Figure 5.3 a, b) and at high magnification, the tegumental brush 
border showed no sign of smoothing or abrasion (Figure 5.3c). 
Figure 5.3 SEM analysis of solvent control-treated tegumental surface of 
H. diminuta. 
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a) At magnification x70, no blebbing is evident and the worm segments seem less 
swollen than those that were drug-treated. This suggests that addition of drug causes some 
stretching of the worm. 
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No fracturing of the tapeworm tegument is observed. Magnification x 700. 
C) 
Tegumental brush border appears intact with no sign of smoothing or abrasion. 
Magnification x 15000. 
Figure 5.3: Adult H. diminuta were exposed to 0.2 % DMSO for 30 min at 37°C and effect 
on tegument examined using SEM. Magnification 70x , 
700x and 15000x in a-c 
respectively. 
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5.4.2 Effect of NTZ. 
NTZ caused clear damage to the tegument of H. diminuta. On the tegumental surface, 
there was blebbing as well as some accumulation of membrane fragments over the 
microthrix tips (figure 5.4 a, b, c and d) and a slight erosion of the tegumental brush 
border (Figure 5.4 f). The ultra structure of the tegument appeared swollen possibly due 
to drug-induced stretching, and fractures of variable depth were also visible (Figure 
5.4c). This damage would probably produce an altered tegumental integrity and would 
cause disruption of the selective permeability barrier created by the normal tegument. 
Figure 5.4 NTZ induced damage of H. diminuta tegumental surface. 
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a) Magnification x70. Webbing and accumulation of membrane fragments arc 
clearly evident on the tapeworm surface due to presence of NTZ. 
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b) Magnification x200 and c) & dt Mapni Iiý: mion x700 show clear cracking and abrasion of 
the tegument surface due to NTZ. Segments are enlarged and swollen and damage to the ultra 
structure is seen. Blebs are evident. 
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e) Magnification x4500 shows cracking in the proglottid. f) 
magnification x 15000 shows smoothing of the tegumental brush 
border. 
Figure 5.4: Adult H. diminuta were exposed to 10µg/ml NTZ for 30 min at 37°C' and 
drug-effect on tegument examined using SEM. Magnifications are 70x, 200x, 700x, 
700x, 4500x and 15000x for a), b), c), d), e) and f) respectively. 
5.4.3 Effect of BZNT. 
Addition of 10µg/ml BZNT did not cause any visible blebbing though some 
accumulation of membrane fragments on the tegument was observed (figure 5.5a). 
However, as with NTZ, some swellings due to possible worm expansion were present. 
Fractures on the tegumental surface were also observed (figure 5.5 b), which in some 
cases appeared more severe than those due to NTZ treatment. BZNT did not cause 
smoothing of the brush border. 
. ;'j ^`1 
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Figure 5.5 BZNT induced damage of H. diminuta teaumental surface. 
a) 
b) 
i' 
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Figure 5.5: Adult H. diminuta were exposed to 10µg/ml BZNT for 30 min at 37°C and effects on the 
tegument examined using SEM. Addition of BZNT showed clear tegumental effect characterised by 
a) swelling and some membrane fragment accumulation at 70x magnification and h) extensive 
cracking at 700x magnification. Blebbing was not apparent, and the brush border was unaffected by 
the compound according to analysis at 15000x magnification (not shown). 
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5.4.4 Effect of DNNTZ. 
Unlike S. mansoni, H. diminuta was affected significantly by DNNTZ when analysed 
by SEM. Slight stretching caused the worm to appear swollen (figure 5.6 a) with some 
fractures of the tegument (figure 5.6 b) although not as severe as those observed with 
NTZ or BZNT. Blebbing and smoothing of the tegumental brush border were not seen 
with DNNTZ exposure. 
Figure 5.6 DNNTZ induced damage of H. diminuta teeumental surface. 
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Figure 5.6: H. diminuta adults were exposed to 10µg/ml DNNTZ for 30 minutes 
and examined by SEM. Slight swelling but no sign of blebbing was observed at 
70x magnification in a). Drug-induced fractures were seen at 700x magnification 
in b), though not to the extent as those seen with NTZ and BZNT. (The brush 
border examined at 15000x magnification was unaffected by DNNTZ, not 
shown) 
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5.5 Effects of NTZ/TIZ and selected uncouplers on the oxygen uptake 
of H. diminuta mitochondria. 
In order to test whether NTZ was acting as a protonophoric uncoupler in H. diminuta, 
mitochondria were prepared, and effects on respiration examined using an oxygen 
electrode. The methodology was the same as that used to discern uncoupling by 
niclosamide and other compounds in this organism (Yorke et al, 1974). 
Using 7.5mM succinate as respiratory substrate, addition of 200µM ADP showed a 
modest respiratory control in the H. diminuta mitochondria (Table 5.4). The respiration 
rates obtained were very similar to those reported by Yorke et al (1974). Addition of 
l Oug/ml of NTZ caused a rapid apparent uncoupling of respiration (Figure 5.7), which 
was also seen with FCCP and or Niclosamide (Table 5.4). Addition of LEV or an equal 
concentration of the solvent DMSO to that used in the drugs did not affect the uptake of 
oxygen. 
Figure 5.7 Oxy2en traces illustrating respiratory control. 
a) 
7.5mM 200µM 
Succinate ADP 
b) 
5 mins 
10 µmoles OZ 
Fig 5.7: Typical oxygen electrode traces illustrating respiratory control, and the effect of 
a)ADP and b) NTZ on the respiration of H. diminuta mitochondria. Arrows indicate the 
additions and final concentrations. Respiration rates are in ng-atom of oxygen/min/mg 
protein. 
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Table 5.4 Effect of NTZ on Oxygen uptake of H. diminuta 
mitochondria. 
Substrate 02 uptake Respiratory 
(ng-atom/min/mg protein) control ratio. 
- ADP + ADP + NTZ + TIZ + FCCP + NIC 
Succinate 20.4 30.6 (1.5) 
Succinate 30.6 61.1 (2.0) 
Succinate 34.6 55.0 (1.6) 
Succinate 40.7 71.3 (1.8) 
Succinate 18.3 30.6 (1.7) 
Table 5.4: Mitochondria were prepared from 5g (wet weight) of adult H. diminuta and respiration 
examined in the presence of 7.5mM sodium succinate in a lml stirred cell fitted with an oxygen electrode 
as described by Yorke et al (1974). Respiratory control was determined by addition of 200µM ADP, and 
uncouplers were added in DMSO, which had no effect on respiration when added alone. Results are the 
mean of 2 assays (due to limited material). Variability in succinate rate is due to the low rate measured 
which is more affected by oxygen leakage into the cell. 
5.6 Discussion. 
The mechanism of action on cestodes of NTZ, TIZ and other Romark compounds was 
examined using Hymenolepis diminuta and Hymenolepis microstoma. The results are 
fairly similar to those obtained with the trematodes characterised mainly by rapid 
paralysis and generally more obvious and lethal effects than those seen with nematodes. 
NTZ, BZNT and DNNTZ were found to have a damaging effect on the tegument of the 
tapeworm, suggesting a direct tegumental mechanism of action. NTZ also stimulated 
oxygen uptake in H. diminuta mitochondria, supporting its proposed protonophore 
activity (D. C. Warhurst & D. J. Meyer, 2000, Unpublished data) 
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5.6.1 Paralytic effects. 
NTZ caused a very rapid (< 5 mins) and severe paralytic reaction in Hymenolepis 
leading to death. This effect was similar in appearance and occurred with similar 
potency to that associated with FCCP, CCCP or niclosamide, suggesting that it is due 
to a protonophoric mechanism. Praziquantel, though also inducing paralysis had a 
much lesser cestodicidal effect than NTZ/TIZ or the other protonophores suggesting 
that, as with trematodes, NTZ has a different mechanism to PRAZ. NTZ-induced 
paralysis may also involve a specific neurotoxic effect, and further studies are required 
to examine this possibility. 
BZNT caused paralysis in cestodes with less potency than NTZ, similar to its effect in 
trematodes. 
DNNTZ in contrast to its lack of effect in nematodes and trematodes, did cause 
paralysis in the cestodes. The effect was not particularly severe but does show the 
compound to have some anthelmintic effect. 
As seen with the schistosomes, the paralytic effects of NTZ on cestodes were 
substantially reduced by FCS. However, for adult cestodes this is relatively unimportant 
since the majority of species occur in the gastro-intestinal tract and are therefore easily 
targeted by NTZ unbound to albumin. 
5.6.2 Tegumental effect. 
Within 30 minutes, NTZ caused considerable damage to the tegument of adult H. 
diminuta including blebbing, tegumental brush border abrasion and fissure formation. 
This suggests a tegumental targeting mechanism of action of the drug leading to 
impairment of structural integrity and contributing presumably to the eventual death. 
However, the speed in which paralysis occurred in the tapeworm was even more rapid 
(<5mins), than the tegumental damage suggesting that this is a secondary effect. Owing 
to the importance of the tegument for cestodes in nutrient absorption, the observed 
damage must affect nutrient uptake in a similar way to that observed with trematodes. 
However, death of the cestode due to impaired nutrient uptake would take significantly 
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longer than the time death was observed with addition of 10µg/ml (< 4 hours). Hence 
this is unlikely to be a primary cestodicidal mechanism of NTZ. 
BZNT also caused tegument damage, characterised by the presence of deep fissures. 
However blebbing was not present which again distinguishes its mechanism of action 
from that of NTZ. 
DNNTZ also caused tegumental damage, marked by slight cracking which again 
shows an anthelmintic effect of the compound not seen in nematodes or trematodes. As 
for NTZ the rapid speed in which paralysis developed with DNNTZ suggests that 
tegumental disruption is not the primary mechanism. 
5.6.3 Protonophoric effect. 
Previous work by Yorke et al, (1974) has demonstrated that mitochondria of H. 
diminuta are susceptible to uncoupling by protonophores. This study repeated this 
experiment and demonstrated significant increases in oxygen uptake by the 
mitochondria upon addition of 10µg/ml NTZ, TIZ, FCCP or NIC suggesting that NTZ 
is able to act as a protonophoric uncoupler in this system. The similarity in speed and 
type of paralysis amongst these compounds, further strengthens this suggestion. 
However, a further test should be carried out to check that the increased oxygen uptake 
caused by NTZ is inhibitable by the ATP synthase inhibitor, antimycin A, and could 
not be due to superoxide / peroxide formation. However if NTZ and TIZ are acting as 
protonophores against the cestodes by uncoupling oxidative phosphorylation, it remains 
unclear how this is directly related to a `spastic' type paralysis, when loss of ATP 
would tend to prevent neurotransmission and cause a more flaccid paralysis. The 
possibility remains that NTZ/TIZ have direct agonist effects on cestode neuro- 
receptors. This could be investigated further, for instance with bungarotoxin. 
5.6.4 Conclusions. 
From this study cestodes are clearly very susceptible to NTZ and TIZ. Owing to the 
rapidity of paralysis and effect on oxygen uptake in mitochondria being similar to that 
of the known protonophores CCCP, FCCP and NIC, it seems likely that the primary 
mechanism of NTZ/TIZ is as a protonophore. NTZ also affects the cestode tegument. 
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Although this effect in itself would lead to death by either direct loss of worm structural 
integrity or by starvation owing to lack of nutrient absorption, it is unlikely that this is 
the primary mechanism of action owing to the rapidity that NTZ-induced mortality 
occurred. 
BZNT also affected cestodes, but the effects were different to those observed with 
NTZ. This compound, like NTZ caused paralysis and tegumental disruption, though 
effects were not as severe as those observed with NTZ. This suggests that BZNT has 
either a different mechanism or has less potency against the tapeworm. DNNTZ also 
affected the tapeworm, however the potency was again weaker than that observed with 
NTZ. It is possible that this compound is acting as a protonophore (structure suggests 
this is a possibility), and is more active against cestodes than nematodes or trematodes 
perhaps due to it being more readily able to enter the tapeworm. Damage to the 
tapeworm tegument demonstrates a DNNTZ tegument interaction. 
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The 5- nitrothiazole, nitazoxanide (NTZ) has anti-protozoal, anti-bacterial and anti- 
helmintic activity (Diaz et al, 2003; Cedillo-Rivera et al, 2002; McVay & Rolfe, 2000). 
However, the mechanisms of action of the drug are not yet fully understood. It is thought to 
act on bacteria and protozoa in a similar way to metronidazole, a nitroimidazole, which has 
an extremely broad spectrum of activity against anaerobic and microaerophilic protozoa 
and bacteria (Upcroft et al, 1999; Hardman & Limbird, 1996). Metronidazole has a low 
midpoint redox potential (Eo') of S- 400mV and is selectively toxic for organisms capable 
of reducing its nitro group intracellularly to a toxic nitro anion free radical, which reacts 
with oxygen to produce a superoxide. This can lead to the production of peroxides and the 
highly toxic hydroxyl radical OHS, which can cause major damage to synthetic machinery 
and DNA (Halliwell & Gutteridge, 1999). NTZ also has a low midpoint redox potential 
(Eo' - -35OmV) and is thought to act on anaerobic and microaerophilic bacteria and 
protozoa in a similar way to metronidazole (Sisson et al, 2002). This mechanism however, 
does not readily explain toxicity or therapeutic ability against helminths, since they may 
not be able to reduce the drug. The aim of this project was to look for an alternative 
mechanism, which is functioning in helminths. 
From this study NTZ and TIZ have shown effects on the larval and adult stages of the free- 
living nematode C. elegans, and adult A. suum and H. contortus. The effects on these 
nematodes were slight, characterised by varying degrees of paralysis with a wide range of 
potency in different species, and were not lethal. NTZ and TIZ showed no effect on the L3 
infective stage of the trichostrongylid nematodes H. contortus and N. spathiger. However, 
the effect of these two Romark compounds (at lOpg/ml) on trematodes (S. mansoni and S. 
japonicum) and cestodes (H. diminuta and H. microstoma) were more marked, 
characterised by rapid paralysis, tegumental damage and 100% mortality within 24 hours. 
Cestodes were most susceptible showing the most rapid and violent effects. Both drugs 
affected all life cycle stages of the trematode (except eggs) and cestodes tested, and in 
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comparison to known anti-trematodal and anti-cestodal drugs showed equal or greater 
potency in vitro (Table 6.1). 
Table 6.1 Summary of anthelmintic activity of a) Romark compounds 
and b) control drugs. 
al 
ORGANISM / COMPOUND NTZ TIZ DNNTZ DNTIZ TIZ BZNT 
Ascaris suum t t - - - - 
Caenorhabditis elegans + + - - - - 
Haemonchus contortus f f - - - - 
Nematodirus s athi er - - - - - - 
H menole is diminuta ++ ++ f f - f 
H menole is microstoma ++ ++ f f - t 
Schistosoma a onicum ++ ++ - - - + 
Schistosoma mansoni ++ ++ - - - + 
hl 
ORGANISM / DRUG LEV MEB NIC FCCP CCCP PRAZ MET 
Ascaris suum ++ N N N N N N 
Caenorhabditis elegans ++ - - ++ ++ - - 
Haemonchus contortus ++ - - + f N N 
Nematodirus spat hi er ++ - - + + N N 
H menole is diminuta - N ++ ++ ++ + - 
H menole is microstoma - N ++ + + + - 
Schistosoma a onicum - N N N N ++ N 
Schistosoma mansoni - + ++ ++ ++ ++ f 
Table 6.1: Effects on worms are taken from concentrations of all drugs at 1Ogg/ml (Ascaris at 30µg/ml) after 4 
hours exposure. 
KEY for table 6.1 
++ Highly effective + Moderately effective 
± Low efficacy- - Not effective 
N Not tested " Not effective against larval stage. 
NTZ and TIZ are clearly most effective against trematodes and cestodes, with both 
showing potency equal to and sometimes greater than that seen with praziquantel. Effects 
with FCCP, CCCP and NIC with trematodes and cestodes are similar to those observed 
with NTZ/TIZ. Effect ' against nematodes was less severe, and in all cases levamisole 
220 
Chanter 6- Conclusions. 
showed much higher activity. However, even a weak paralytic effect may be of great 
importance clinically, since this may result in worm expulsion. Of the other Romark 
compounds TIZg had no effect against any worms, DNNTZ and DNTIZ had slight effect 
against cestodes and BZNT had some effect against cestodes and trematodes but showed no 
anti-nematodal effect. 
Several mechanisms of action are recognised for established anthelmintics. For example, 
levamisole acts specifically on the nematode nicotinic receptor (James & Gilles, 1985); 
Niclosamide is a protonophoric uncoupler (Vanden Bossche, 1985) and is also metabolised 
to a reductively activated nitro-compound; Mebendazole specifically inhibits the 
polymerisation of tubulin (Lacey et al, 1988). NTZ may have one or more of these 
mechanisms of action. The use of C. elegans as a convenient test system allowed the 
characterization of effects of NTZ upon motility. The model however, lacked the special 
qualities of a parasitic organism, particularly with regard to drug and nutrient uptake 
mechanisms. The availability of schistosomes, A. suum and Hymenolepis spp thus allowed 
a comparison of parasitic helminths with the C. elegans system, and with regards to the 
cestodes and the trematodes more obvious effects were seen. 
6.1 NTZ as a possible neurotoxicological agent. 
Initially in this study, using C. elegans, NTZ and TIZ, were observed to have a direct 
mode of action on the nematode. On addition of 10µg/ml NTZ or TIZ to C. elegans a 
primary effect characterised by spastic paralysis in 90% of the worms was observed. The 
paralysis took an average of 20 min to occur and was located more towards the posterior 
portion of the worm, characterised by increasing rigidity (characteristic of `transient spastic 
paralysis' (Hardman, 1996)). This paralysis was temporary and in all cases the worms 
made a full recovery. 
Analysis of the effects as `transient spastic paralysis', allowed comparison with other 
anthelmintics which have these effects: levamisole and pyrantel. With levamisole, a known 
neuromuscular agent, on addition to C. elegans, a rapid spastic paralysis was observed. In 
the host, this would lead to expulsion of a parasitic nematode by gut peristalsis (James & 
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Gilles, 1985). Nitazoxanide clinical trials, have already demonstrated worm expulsion of 
cestodes (Romark, unpublished data), consistent with a paralytic mechanism. Examination 
of effects of NTZ on contraction of Ascaris muscle showed that NTZ, like levamisole, is an 
agonist for the parasite nicotinic receptors. However, the agonism is much weaker than that 
observed with levamisole presumably due to a relatively high dissociation constant for 
binding of NTZ to the Ascaris receptor. However even a weak agonist effect at receptors of 
a gastrointestinal worm in vivo could result in worm expulsion, as a high concentration of 
NTZ should occur in the small intestine following a 500mg or lg dose. 
The target site of levamisole and pyrantel is the nicotinic acetylcholine receptor in 
nematodes (Martin, 1993), a target shared by a number of anthelmintics including morantel 
and bephenium. Since levamisole and pyrantel specifically affect neurotransmission at 
nicotinic, acetylcholine receptors, these mechanisms were investigated directly. With 
levamisole the nicotinic antagonists, pempidine and mecamylamine have been used to 
demonstrate the specificity of this drug to the acetylcholine nicotinic receptor in the 
nematode (Hardman & Limbird, 1996). In the presence of these antagonists, the paralytic 
effect of levamisole is abolished (James & Gilles, 1985). The hypothesis tested here was 
that if these antagonists blocked NTZ effects in C. elegans the mechanism of the drug 
might be similar to that of levamisole. Since the nicotinic antagonists pempidine and 
mecamylamine, indeed blocked the effect of nitazoxanide in C. elegans, the hypothesis is 
so far supported. 
The detailed mechanism of action, however, still remained uncertain, as neuromuscular 
anthelmintics can act in different ways at the nicotinic receptor: By neuromuscular 
blockage, which sends waves of depolarization along the neuron to the effector organ (in 
this case nematode muscle) which results in a paralysis; alternatively the drugs can directly 
inhibit acetylcholinesterases (like one mechanism of pyrantel), which causes an 
accumulation of acetylcholine at the receptor, again leading to paralysis (Hardman & 
Limbird, 1996). Experiments performed in this study show that unlike metrifonate, NTZ 
does not inhibit acetylcholinesterase of Electrophorus electricus (although it may do so in 
the helminths). This suggests that NTZ is more likely to be binding to the receptor itself. 
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Experiments with specific mutants of C. elegans, insensitive to levamisole were therefore 
carried out to investigate nicotinic receptor activity further. Drug assays using the mutants 
1072 (Unc29), 904 (Unc38) and lev 1 (nicotinic mutants and levamisole resistant) in the 
presence of NTZ, showed no sign of paralysis in nitazoxanide concentrations that affected 
100% of the wild type, indicating the nicotinic receptor mutated in Unc38, Unc29 and lev 1 
is involved in the sensitivity to NTZ. These experiments are supported using the GABA 
receptor mutant of C. elegans (407 Unc49), which, although it also had altered motility in 
the absence of drugs, still gave a typical response to NTZ. These results suggest that NTZ 
can act as an agonist at the nicotinic receptor in C. elegans, identical to the mechanism of 
action of levamisole. However, further confirmation of specific agonism should be sought 
using patch clamp techniques as previously demonstrated for levamisole by Martin el al, 
(1988). 
Comparison of the drug structures of NTZ, nicotine and levamisole (fig 6.1), show a 
similarity in position of positive charges and hydrophobic area which further support the 
possibility that NTZ and TIZ have features similar to specific nicotinic agonists. 
Figure 6.1 Comparison of structures of NTZ and 2 known nicotinic receptor a2onists. 
ýýý 
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In trematodes NTZ/TIZ effects at the nicotinic receptor were examined using the nicotinic 
receptor agonist BTX (Tornoe et al, 1995) which has previously been shown by Camacho 
et al, 1995 to bind at 4° C to the nicotinic receptors on the surface of S. haematobium. In 
this study clear binding of rhBTX after incubation at 37°C was seen to the nicotinic 
receptors in schistosomula and adult schistosomes. Pre-treatment and post treatment with 
I Opg/ml NTZ/TIZ abolished or prevented this binding, suggesting direct competition at the 
nicotinic receptor. Alternatively, this effect could be due to alterations in receptor 
distribution / availability associated with changes in the tegument. Inhibition of binding 
however, could be due to uncoupling, where reduction of energy in the worm might 
prevent the uptake of rhBTX therefore preventing binding. This however seems unlikely 
due to the protonophore CCCP not inhibiting rhBTX binding. In such a case, energy would 
be reduced but rhBTX may be able to enter the schistosome passively. Clearly there is 
scope for more experiments involving temperature and energy related effects at the 
nicotinic receptors. 
In cestodes direct interaction of NTZ at nicotinic receptors was not examined. However, 
addition of 1Oµg/ml NTZ to adult H. diminuta immediately resulted in spastic contractions 
of the worm suggesting a nicotinic receptor type effect. Studies need to be further extended 
to examine NTZ neurotoxicological effect in cestodes, for example by use of rhBTX. 
6.2 NTZ as a protonophore. 
In order to distinguish protonophore-dependent effects of NTZ / TIZ (D. J. Meyer and D. 
C. Warhurst, unpublished data) from other mechanisms, parallel experiments were 
generally carried out with FCCP and CCCP (and NIC - although protonophore action may 
not be its sole mechanism). Paradoxically, the effects of protonophores were distinct from 
NTZ/TIZ in C. elegans since they caused a rapid flaccid and tonic paralysis, but in S. 
mansoni and cestodes, protonophore action was markedly similar to that of NTZ/TIZ. 
Moreover, NTZ / TIZ, FCCP or CCCP dramatically reduced ATP levels in the nematode 
and trematode, consistent with a protonophoric effect in both cases. However attempts to 
examine mitochondrial oxygen uptake with both species failed probably due to insufficient 
material for testing. Although analysis of effects of NTZ on ATP levels was not carried `out 
224 
Chanter 6- Conclusions. 
with H. diminuta, an increase in oxygen uptake by isolated mitochondria was observed 
comparable to that seen with FCCP and NIC suggesting that uncoupling of oxidative 
phosphorylation occurs in this cestode. Mitochondria are abundant in the surface syncytium 
of cestodes (Chowdhury & Tada, 2001) especially along the basal membrane. This would 
allow an easy drug-induced action of NTZ and could explain the rapidity in which an effect 
in Hymenolepis spp was observed. 
However the host intestinal lumen is anaerobic, suggesting that although mitochondrial 
electron transport and phosphorylation may still be important, one would not expect 
oxygen uptake to be marked. In Ascaris, mitochondrial electron transfer proceeds through 
an NADH-linked reduction of fumarate resulting in the formation of succinate (Köhler & 
Bachmann, 1980). This system is insensitive to cyanide and protonophores. NTZ does not 
inhibit fumarate reductase, but any protonophoric activity of the drug is still likely to 
disrupt mechanisms the organism may use to maintain cellular pH. 
One discrepancy with uncoupling, is that if NTZ was acting as a protonophore it would 
cause a flaccid and tonic paralysis similar to that observed with FCCP and CCCP against 
C. elegans. However, NTZ caused spastic paralysis in nematodes and also caused spastic 
contractions in H. diminuta and contractions in S. mansoni suggesting the presence of a 
neurotoxicological based mechanism. However FCCP and CCCP also cause spastic and 
rigid paralysis in schistosomes, suggesting that they may also be targeting nicotinic 
receptors. One possibility is that FCCP and CCCP are being used at such high 
concentrations to demonstrate a weak agonistic effect for nicotinic receptors. However 
CCCP did not inhibit binding of rhBTX to schistosome nicotinic receptors suggesting 
rigidity is caused by another mechanism. One possibility is that the ATP depression due to 
NTZ, FCCP and CCCP, could be targeting purinergic neurotransmission which uses ATP 
instead of acetylcholine as a neurotransmitter (Bowman & Rand, 1990). This would 
explain why changes in ATP levels cause contraction and helps explain the similarity in 
paralysis in S. mansoni observed with NTZ and the protonophores (NB the ATP reduction 
is as predicted if there is a protonophore effect). Another factor that questions a 
protonophoric mechanism of NTZ, is the lack of lethal toxicity against nematodes. If a 
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protonophoric mechanism of action is present, death of the target organism should ensue. If 
NTZ is acting as a protonophore, this lack of lethal effect in nematodes could perhaps be 
due to antagonism by the other mechanism, for example, during paralysis there may be a 
much lower requirement for ATP to survive. More likely, the poor trans-cuticular entry of 
NTZ in nematodes (see below) presumably results in slow exposure via the digestive tract 
which increases the likelihood of drug metabolism / detoxication. 
6.3 NTZ mode of entry. 
One notable difference however, between the effect of NTZ and levamisole with C. 
elegans, is the speed in which the paralysis occurs. With levamisole, paralysis is total and 
occurs within a few minutes. With NTZ however, the paralysis takes longer to occur and is 
most evident at the posterior part of the worm. In schistosomes and cestodes the action of 
NTZ is very rapid. The delay in onset of paralysis in C. elegans may be due to the contrast 
between the impermeable cuticle of the nematode and the permeable absorptive tegument 
of the schistosome and cestode (Chowdhury & Tada, 2001) in which passive diffusion is a 
major mechanism of drug penetration (e. g. benzimidazoles). Thus in cestodes, lipid 
solubility is a major determinant factor influencing the diffusion of these anthelmintic 
molecules through the parasite tegument (Mottier et al, 2003). Presumably NTZ and TIZ 
are sufficiently lipophilic to be passively absorbed by the tapeworm tegument (and able to 
discharge directly any proton gradient which might be present). Since NTZ is less 
lipophilic than levamisole, it may fail to traverse the nematode cuticle and have to be 
ingested before any activity is observed. The rapid effects of levamisole suggest a trans- 
cuticular mode of entry. Further studies are required to determine the mode of entry and 
metabolism of NTZ in helminths. This would be facilitated by use of radioactively-labelled 
drug. 
6.4 Damage to the tegument. 
As discussed in chapter 4 and chapter 5, NTZ induces severe damage to the tegument of 
schistosomes and cestodes. In vivo, this may lead to either a lack of structural integrity, 
resulting in invasion by the host immune system, or more likely, a decrease in active 
226 
Chanter 6- Conclusions. 
nutrient uptake leading to starvation of the worm. Lack of nutrient uptake was 
demonstrated here in S. mansoni with less glucose absorbed by the worm compared to the 
DMSO treated controls. It is also likely that this (though not tested) would affect nutrient 
uptake in Hymenolepis species as Wastling & Chappell, (1994) have already demonstrated 
reduced glucose uptake of H. microstoma after treatment with Cyclosporin A. However 
owing to the presence of mitochondria on the surface of cestodes (and possibly on the 
surface of trematodes) (Chowdhury & Tada, 2001), the tegument is undoubtedly a site of 
energy transduction involved in the active uptake processes. Uncoupling of these 
mitochondria therefore would prevent active uptake of nutrients owing to lack of energy, 
and it is a possibility that NTZ prevented uptake of glucose in schistosomes due to 
protonophoric action rather than direct tegumental disruption. However, though tegumental 
disruption and inhibition of nutrient uptake is a mechanism of action it might cause death to 
occur less rapidly than observed with the trematodes and cestodes in this study and it is 
therefore unlikely to be the primary mechanism. 
6.5 Possible drug reduction. 
In this study no evidence of NTZ reduction was observed. It was not possible to 
demonstrate reduction of NTZ by nitroreductases present in C. elegans and schistosomes. 
This suggests that drug-induced paralysis in these worms is not due to drug reduction, but 
another mechanism of action is present. However, because the organisms and the assays 
were not completely anaerobic and because the reduction products of NTZ have not been 
well-characterised, looking for a NTZ radical by loss of absorbance at a given wavelength 
may not have been a proper assay. Drug reduction in helminths could be looked at using 
electron spin resonance spectroscopy (which detects free radicals). This would require snap 
freezing of worms treated or untreated with NTZ and carrying out spectra in liquid 
nitrogen. The radical could perhaps also be characterised in an oxygen electrode using NTZ 
+ NADPH ferredoxin reductase from spinach, + Ferredoxin + NADPH. 
Drug reduction as a mechanism of activation of drug to a toxic free radical could still be a 
possibility in worms in vivo, due to the anaerobic environment in which they live being 
more likely to aid in NTZ reduction. This drug reduction has recently been supported by 
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Mansour-Ghanaei et al, (2003) where Fasciola hepatica treatment with metronidazole in 
Iran resulted in promising cure rates. NTZ is more easily reduced than metronidazole, and 
it remains a possibility that this is the mechanism of action against Fasciola. 
6.6 Effects with other Romark compounds. 
6.6.1 Denitro compounds. 
It was hoped initially that use of the DNNTZ with negative results would allow proof that 
a nitro-group was involved in a particular toxic mechanism. However, it does not allow the 
conclusion of whether the nitro-group has to be reduced, or whether it is involved in 
neuroreceptor binding, or protonophore formation. In fact DNNTZ is likely to be a weak 
protonophore even though it lacks the nitro-group. Thus, only when it does have an effect 
on worms can useful conclusions be made: i. e. if the effect of DNNTZ is similar to that of 
NTZ, it cannot involve nitro-reduction. This applies to a weak paralytic effect of DNNTZ 
in cestodes, but its lack of lethality still leaves open the question of nitro-reduction 
involvement for NTZ in lethality. 
6.6.2 Tizoxanide glucuronide. 
No drug effect was observed with tizoxanide glucuronide in C. elegans, schistosomes or 
cestodes at concentrations used. However NTZ has a marked effect in vivo on F. hepatica 
infections (Romark data, unpublished), which may be due to the high accumulation of the 
metabolite in the bile, >1144M, which contains no NTZ and only low concentrations of 
TIZ (Broeckhuysen et al, 2000). TIZg retains the nitro group, hence could be reductively 
activated if exposed to a suitable reductase, however it would be unable to traverse 
membranes passively because of the hydrophilic glucuronide group, and it could not have 
protonophore activity. There is a possibility that F. hepatica is ingesting TIZg and 
hydrolysing it back to TIZ, which would explain the presence of an effect in this parasite in 
vivo. However recent findings by Mansour-Ghanaei, et al, (2003) suggest that Fasciola can 
reduce metronidazole. If true, this suggests that the reductive power of the parasite in vivo 
would be capable of acting directly on TIZg. 
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6.6.3 BZNT. 
2-benzamido-5-nitrothiazole, BZNT, showed no effect on C. elegans. However, in 
schistosomula, BZNT caused a rapid paralysis followed by death, and in adult 
schistosomes, it induced paralysis and caused tegumental damage, though no death of 
worms was observed over 120 hours. BZNT also showed activity against cestodes causing 
paralysis and death in the larvae, and paralysis and tegument damage in adults. In all cases, 
the effects, though clear, were distinct from those of NTZ. These differences must be 
attributable to their different chemical properties: BZNT, lacking an oxygen substituent on 
the aromatic ring should be less effective as a protonophore, and may be more liable to 
attack by amidases/peptidases which would yield the very toxic amino-nitrothiazole 
moiety, which is readily activated by reduction to reactive electrophilic intermediates. 
Furthermore, lack of the aromatic substituent would also alter any specific interaction at, 
for instance, the nicotinic receptor. Thus, speculatively, the likely toxicity of BZNT may be 
due mainly to its hydrolysis and formation of reactive electrophiles. Paralytic and 
protonophoric effects should be of less importance. The differences between NTZ and 
BZNT effects further support the conclusions of neurotoxicity and protonophore action for 
NTZ. 
6.7 Summary. 
From this study it seems likely that the mechanism of action of NTZ in nematodes is 
predominantly neuromuscular toxicity via specific receptor action. However, drug 
accessibility, metabolism and potency at different receptors yields great variability in 
actions on different nematodes and this would explain the differences observed in this 
study. In cestodes it appears likely that uncoupling of oxidative phosphorylation is 
occurring as a primary mechanism, though neuro-receptor drug-interaction and tegumental 
disruption are also occurring. Reductive activation has not been ruled out, particularly in 
relation to lethality. In schistosomes again a protonophoric effect is important, associated 
with rapid death of the worm. Studies with rhBTX clearly indicate a specific 
neuromuscular toxicity of NTZ, and the observed effect on the schistosome tegument and 
effect on nutrient absorption would serve as secondary mechanisms or even secondary 
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consequences of the protonophoric and neuromuscular effects. Trematodes and cestodes 
are most susceptible to NTZ because of the large area of absorptive tegument exposed to 
the external medium, in the absence of a cuticle. 
The ineffectiveness of NTZ against schistosomes in vivo (Q. D. Bickle, Personal 
communication, 2000) is probably due to its high affinity for albumin (99% protein bound) 
and this may restrict the usefulness of NTZ to organisms which occur in relatively protein - 
poor compartments outside the blood, such as the gut lumen. The extent of NTZ/TIZ 
binding to food proteins in the gut is probably reduced on breakdown of these proteins 
during digestion. Investigations need to be carried out, using radioactive drug, to determine 
whether concentrative uptake into parasites is of importance. This may be of great 
significance for the in vivo effectiveness of any anthelmintic treatment with NTZ. 
As a final statement, it can be assumed that NTZ could be demonstrating more than one 
mechanism of action, all aiding in its anthelmintic activity. NTZ as a protonophore would 
prevent energy production through electron transport and oxidative phosphorylation. 
During anaerobic metabolism, drug activation by nitro-reduction (not yet confirmed for this 
drug in helminths) might also have an impact. Finally, nicotinic receptor antagonism of 
NTZ, which is persistently suggested in the foregoing studies, could be an important factor 
in motility alteration, leading to expulsion or death of gut worms. 
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APPENDIX I. 
Medium 169. (Basch, 1981). 
Preperation of medium 169 minus phenol red for Schistosome culture with 
fluorophores. 
Using double strength BME 50m1(Gibco BRL) add: 
0.1 g lactalbumin hydrolysate 
0. lg glucose 
5Oµ1 hypoxanthine stock 
l00µ1 serotonin stock 
100µl insulin stock 
10011 hydrocortisone stock 
10011 T3 stock 
0.5m1 MEM vitamins 
5ml Schneiders insect medium 
240mg HEPES 
220mg NaHCO3 
mQ water to about 90m1 
5N NaOH to pH 7.4 
Filter sterilize into the original BME bottle, make up to 100ml with sterile mQ 
water. 
E/LAC (Earle's/Lactalbumin). 
Earle's Balanced Salt and Lactalbumin Enzymatic hydrolysate. 
8.64g Earle's balanced salt (Sigma). 
0.85g NaHCO3 
5g Lactalbumin enzymatic hydtolsate (Sigma). 
Made up to 1 litre with sterile mQ water (pH 7.4). 
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Artificial Perienteric fluid. (A. P. F). 
27. Og NaCl 
16. Og MgC12 
3. Og CaC12 
3. Og KC1 
5. Og Tris 
5.49g Na acetate 
Make up to 1 litre with de-ionised distilled water. 
Warm to 37°C and make to pH 7.6 using ethanoic acid. 
Add 1 teaspoon (per litre) of glucose. 
LB medium. 
log Bacto-tryptone (Difco) 
5g Bacto-yeast extract (Oxoid) 
log NaCl 
Made up to 1 litre with deionised H2O and autoclaved. 
RPMI (Gibco) 
With 25mM HEPES buffer. 
Without L. Glutamine. 
Hank's saline solution. 
8. Og NaCI 
0.4g KCl 
0.14g CaC12 
O. lg MgSO4.7H20 
0-19 MgC12.6H20 
0.06g Na2HPO4.2H20 
0.06g KH2PO4 
1. Og Glucose 
0.35g NaHCO3 
100mg phenol red indicator. 
Make up to 1 litre with de-ionised water. 
Sterilize by filtration through a bacteriological filter. 
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Tyrode's saline. 
8. Og NaCI 
0.20g KCl 
0.20g CaC12 
0- 109 MgC12 
0.05g NaH2PO4 
1. Og Glucose 
1. Og NaHCO3 
Make up to 1 litre with de-ionised water. 
Insect Ringer Solution. 
6.5g NaC1 
0.14g KC1 
0.12g CaC12 
0.1 g NaHCO3 
0.01 g Na2HPO4 
Make up to 1 litre with de-ionised water. 
Earle's Balanced Salt solution. 
NaCl - 116.4mM 
KCl - 5.4mM 
CaCl2 -1.8mM 
MgSO4 - 0.4mM 
NaH2P04 - 0.9mM 
NaHCO3 -11.9mM 
Mops - 50mM 
Adjust to pH 7.2 with 5M NaOH. 
Made to 1 litre with deionised water. 
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APPENDIX II (a) Ascariasis. 
Ascaris lumbricoides is the most frequent human intestinal nematode (Georgiev, 
2001). It is the causative agent of ascariasis, with an estimated worldwide prevalence of 
1300-1400 million people (23% of the world population) (Muller, 2003). In humans, 
transmission is usually due to the hand-to-mouth route (faecal-oral) by way of 
contaminated agricultural products and food, or from dirty hands. It is cosmopolitan in 
distribution being common in both temperate and tropical countries where there are 
both adequate moisture and low standards of hygiene and sanitation. Although 
ascariasis is characterised with low morbidity and mortality rates, the global prevalence 
of ascariasis still results in approximately 60,000-100,000 deaths annually (Muller, 
2003), primarily as a consequence of intestinal obstruction (Cook, 1998). Infection with 
Ascaris is generally asymptomatic, however, heavy infestation can sometimes cause 
serious pulmonary disease, or partial or complete obstruction of biliary or intestinal 
tracts. 
Life cycle. 
The adult worms (1 see digram) normally live in the lumen of the small intestine, but 
do not attach to the mucosa. The females (200-400mm x 3-6mm in length) are slightly 
larger than the males (150-300mm x 2-4mm) but may show great variation in size, 
depending on age and worm load (Muller, 2003). A female produces approximately 
200,000 eggs (broadly ovoid and measure 45-70 µm x 35-50 µm) per day (Muller, 
2003), which are passed with the faeces (2). Unfertilized eggs may be ingested but are 
not infective. Fertilised eggs embryonate and become infective after 18 days to several 
weeks (3), depending on the environmental conditions with optimal conditions being 
moist, warm and shaded soil. After infective eggs are swallowed (4) the larvae hatch (5) 
and invade the intestinal mucosa, and are carried via the portal then systemic system to 
the lungs (6). The larvae mature further in the lungs (10-14 days), penetrate the alveolar 
walls, ascend the bronchial tree to the throat and are swallowed (7). Upon reaching the 
small intestine, they develop into adult worms (1). Between 2-3 months are required 
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from ingestion of infective eggs to oviposition by the adult female. Adult worms can 
live I to 2 years. 
Lifecycle of Ascaris lumbricoides/ Ascaris suum. 
Ferhlited egg 0 
Life cycle diagram obtained from Image Library :- 
A= Infective Stage 
A= Diagnostic Stage 
Unfertilized egg 
will not undergo 
e 
biological development 
http: /Hww. dpd. cdc. gov%dpdx lTML/ImageLibrarvAscariasis_il. asp? body=A-F'Ascariasis%bodyAscariasisilll. htm 
The parasitic round worm Ascaris . scum 
is very similar to A. scari. s humbricoides, 
causing some debate as to whether they are indeed separate species (Crompton, 2001). 
A. smum is a parasite of pigs but has been known under unusual circumstances to cause 
disease in humans (Georgiev, 2001). Drug treatment of Ascariasis involves using either 
albendazole, mebendazole, pyrantel pamoate or levamisole (Cook, 1998). 
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APPENDIX 11 (b) Schistosomiasis. 
Schistosomiasis is caused by digenetic blood trematodes. The three main species 
infecting humans are Schistosoma haematobium, S. japonicum, and S. mansoni. Two 
other species, more localized geographically, are S. mekongi and S. intercalatum. In 
addition, other species of schistosomes, which parasitize birds and mammals, can cause 
cercarial dermatitis in humans (Cook, 1998). Schistosoma mansoni is found in parts of 
South America and the Caribbean, Africa, and the Middle East; S. haematobium in Africa 
and the Middle East; and S. japonicum in the Far East. Schistosoma mekongi and S. 
intercalatum are found focally in Southeast Asia and central West Africa, respectively. 
Unlike all other pathologically important trematodes, schistosomes are dioecious (rather 
than hermaphroditic). The adult worms are about 10-20mm long and the male has a deep 
ventral groove or schist (hence the name schistosome) in which the female resides 
permanently in copulo (WHO, 1994). Worms of each sex have a mouth at the exterior 
end, which also serves as an anus since there is only one gut opening. Around the mouth 
is the oral sucker, while a little further back is the ventral sucker, which is better 
developed in the male. The suckers are used mainly for hanging on to the venous 
epithelium of the host and for locomotion of the worm pair. The adult worms ingest red 
blood cells in order to obtain amino acids for protein synthesis and they break down 
haemoglobin with haemoglobinase (WHO, 1994). Small molecules including glucose, 
amino acids, purines and pyrimidines are taken up via transtegumentary absorption. 
There is evidence that the female derives much of her nutrition via transtegumentary 
absorption from the male worm (Basch, 1991). The metabolism of adult schistosomes is 
largely anaerobic, by glycolysis. Adult worms live for up to 30 years with a mean life 
span of 3-6 years. They produce large numbers of eggs, 300 eggs per day for S. mansoni 
and S. haematobium and ten times this for S. japonicum. About one half of the eggs 
transit to the lumen of the urinary bladder or the intestine and leave the body in the urine 
or the faeces. However a substantial number of eggs are retained in the tissues where they 
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can survive for around 3 weeks (WHO, 1994). It is these eggs which are responsible for 
inducing most of the pathological manifestations of disease. 
Life cycle of Schistosoma spp 
Cercanae released by snail © 
into water and free-swimming 
Sporocysts in snail 
0A 
(successive generations) 
" Penetrate 
^ý- ` skin 
(41 q ý- © Muacidia penetrate 
snail tissue 
in feces 
A 
in urine c 
J%- .. 
A= Infective Stage 
A= Diagnostic Stage 
O 
Cercanae lose tails during 
penetration and become 
schsstosomulae 
O Circulation 
Migrate to portal blood 
J in liver and mature fý Cr into adults 
Eggs hatch 
releasing mrraadýa Jý ' '" ; ýi 
ýý- ý", . ;, ; i; ' ý; r Paired adult worms migrate to 
S !ý\ ýr 
Q mesenteric venules of aow ectum 
(laying eggs that that circulate to o the 
S mansom S haemafobrum liver and shed in stools) 
ýý_ CC venous plexus of bladder 
Image obtained from: 
http: ,,,,,, dpd. eac. gov dpdx images Parasiteimages S-Z Schistosomiasis, Schistomes_LifeCycle. gif 
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Eggs are passed out with the faeces or urine' and under optimal conditions the eggs 
hatch and release miracidia2, which swim and penetrate specific snail intermediate hosts3 
(e. g. Biomphalaria glabrata for S. mansoni and Oncomelania hupensis for S. japonicum. 
The stages in the snail include 2 generations of sporocysts 4 and the production of 
cercariae5. Upon release from the snail, the infective cercariae swim, penetrate the skin of 
the human host6, shed their forked tail, becoming schistosomula7. Once in the host, the 
schistosomula migrate through several tissues and stages to their residence in the veins 
(8,9). Adult worms in humans reside in the mesenteric venules in various locations, 
which at times seem to be specific for each species1°. S. japonicum is most frequently 
found in the superior mesenteric veins draining the small intestineA, and S. mansoni 
occurs more often in the superior mesenteric veins draining the large intestine". Both 
species however can occupy either location, and they are capable of moving between 
sites. S. haematobium most often occurs in the venous plexus of the bladders, but it can 
also be found in the rectal venules. The females deposit eggs in the small venules of the 
portal and perivesical systems. The eggs are moved progressively toward the lumen of 
the intestine (S. mansoni and S. japonicum) and of the bladder and ureters (S. 
haematobium), and are eliminated with faeces or urine, respectively'. 
Pathology of S. mansoni and S. japonicum schistosomiasis includes: Katayama fever, 
hepatic perisinusoidal egg granulomas, Symmers' pipe stem periportal fibrosis, portal 
hypertension, and occasional embolic egg granulomas in brain or spinal cord. Pathology 
of S. haematobium schistosomiasis includes: haematuria, scarring, calcification, 
squamous cell carcinoma, and occasional embolic egg granulomas in brain or spinal cord 
(Cook, 1998; Muller, 2003). 
In order for infection with schistosomiasis to occur, human contact with water is 
necessary for infection. Some schistosome infections are zoonoses, with various animals 
serving as reservoirs of infection, e. g. dogs, cats, rodents, pigs, horses and goats, for S. 
japonicum, and dogs for S. mekongi. 
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APPENDIX 11 (c) Hymenolepiasis. 
Hymenolepiasis is caused by two cestodes (tapeworm) species, Hymenolepis nana and 
Hymenolepis diminuta. H. nana (the dwarf tapeworm) is the most common cause of all 
cestode infections, and is of cosmopolitan distribution. In temperate areas its incidence 
is higher in children and institutionalized groups. Hymenolepis diminuta or the rat 
tapeworm while less frequent is a cosmopolitan parasite of rats, mice and other rodents 
with most cases of human infection, like H. nana, being reported in children (Vanden 
Bossche, 1985). H. diminuta, normally measures between 300 x 600 mm x 4mm in 
length and has 800-1000 proglottids. The scolex (0.2-0.4mm in diameter) is spherical 
and has four small suckers and a retractable rostellum; but no hooks (Muller, 2003). H. 
nana is smaller than H. diminuta, measuring 15-40 mm x 0.5-1.0mm and has a 
spherical scolex with a short retractile rostellum with a single row of 20-30 hooks and 
four round suckers or acetabula. There may be many thousands of tapeworms present in 
a heavy infection of H. nana (Muller, 2003). 
Adults of both species are usually found in the upper three-quarters of the ileum, with 
the scolex usually embedded in the mucosa (Muller, 2003). However, in rats it has been 
shown that the tapeworm moves backwards and forwards in the intestine and this may 
be generally true of this and other tapeworms in humans (Muller, 2003). The egg of H. 
diminuta is slightly ovoid and has a thick yellow outer shell and a thin colourless inner 
membrane (embryophore), with a granular intermediate layer. Eggs measure from 60- 
80 µm in diameter). With H. nana, infection with many worms (2000+) results in 
enteritis, diarrhoea loss of appetite, vomiting and dizziness. With H. diminuta, infection 
in children appears to cause no clinical symptoms apart from diarrhoea. A single dose 
of 500mg niclosamide has been used as treatment (Muller, 2003). 
Although H. diminuta has little direct medical importance, it is of great scientific 
interest as a laboratory model and is used in many research studies on the physiology, 
biochemistry and immunology of cestodes and for chemotherapeutic screening tests 
(Muller, 2003). One other tapeworm Rodentolepis microstoma (also known as 
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Hº'nrenolepis n icrostoma) is also useful as a model for chemotherapeutic screening 
tests. H. nricrostonia is similar to H. diminuta but instead of a rat, matures in a mouse 
and has not been known to infect humans, though a recent report by Macnish et al, 
(2003) suggest the emergence of the first human case in Western Australia. Both 
species utilise the flour beetle, 7ribolium confitsnm, as the intermediate host. 
Life cycle of Hymenoleyis diminuta / Hi'meno%nis microstoma. . 
A= Infective Stage 
A= Diagnostic Stage 
0 Cysticerci in body cavity 
of insect ingested by 
VAI rodent or human 
Oncospheres hatch and 
penetrate intestinal wall 
10 
Ingested by an arthropod © 
intermediate host 
Eggs passed in feces 
scolex 
O Adults in small intestine 
0 gravid proglottids 
Life cycle diagram obtained from Image Library: - 
http: //www. dpdcdc. gov dpdx imagesParasitclmages/G-L! HymenolepiasisýH_diminuta_LifeCycle. gif 
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Eggs of Hymenolepis diminuta are passed out in the faeces of the infected definitive 
host (rodents or man) (1). The mature eggs are ingested by an intermediate host, which 
can be various arthropod adults or larvae (2). Species from the genus Tribolium are 
common intermediate hosts for H. diminuta. The cysticercoid larvae persist through 
the arthropod's morphogenesis to adulthood. Once ingested, oncospheres are released 
from the eggs which penetrate the intestinal wall of the host (3), eventually developing 
into cysticercoid larvae. H. diminuta infection is acquired by the mammalian host after 
ingestion of an intermediate host carrying the cysticercoid larvae (4). Humans can be 
accidentally infected through the ingestion of insects in precooked cereals, or other 
food items, and directly from the environment (e. g., oral exploration of the environment 
by children). After ingestion, the tissue of the infected arthropod is digested releasing 
the cysticercoid larvae in the stomach and small intestine. Eversion of the scoleces (5) 
occurs shortly after the cysticercoid larvae are released. Using the four suckers on the 
scolex, the parasite attaches to the small intestine wall. Maturation of the parasites 
occurs within 20 days and the adult worms can reach an average of 30 cm in length (6). 
Eggs are released in the small intestine from gravid proglottids (7) that disintegrate 
after breaking off from the adult worms. The eggs are expelled to the environment in 
the mammalian host's faeces (1). 
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APPENDIX II (d) Haemonchus contortus, 
Nematodirus spathiger. 
Haemonchus contortus (the barber pole worm) and Nematodirus spathiger belong to the 
family Trichostrongylidae. They are of cosmopolitan distribution, though they are more 
prevalent in warm moist regions than in cold, dry ones. The males of both species are 10 to 
20 mm and the females 18 to 30 mm long. Sheep are the usual host for H. contortus and 
hosts for Nematodirus spp include goats, cattle and wild ruminants. 
Life Cycle of H. contortus. 
Adult male and female worms live in the abomasum (or true stomach) of ruminant animals 
and no intermediate host is required. The female deposits 5,000 to 10,000 eggs per day 
which pass out of the host with the faeces. Before the eggs of trichostrongylid nematodes 
are capable of infecting another host, they must develop through three stages (Vanden 
Bossche et al, 1985). The first and second stages of H. contortus are free-living and feed on 
coliform bacteria in the faeces. After varying periods of development owing to 
environmental factors, the infective third stage larvae (L3) is formed. This stage retains the 
second stage cuticle as a sheath, does not feed and is regarded as a resting stage. These 
larvae are also more resistant than other stages to extremes of temperature and desiccation. 
Once L3 development is complete, in order for the infective larvae to be accessible to the 
grazing animal, they must migrate from the faeces to the herbage (Vanden Bossche et al, 
1985). This again is dependent on environmental factors and also faecal mass. Enormous 
numbers of juveniles may accumulate on heavily grazed pastures. 
The ruminant becomes infected while grazing by ingestion of the third-stage juveniles. 
Once in the host, exsheathment occurs in the rumen, anterior to the abomasum, and the 
young worms pass into the abomasum where they burrow into the mucosa. Here they 
undergo another moult, and the fourth-stage juveniles come back into the paramucosal 
lumen of the abomasum. They begin to feed and undergo a final moult before reaching 
adulthood. Mating of adults occurs and egg production commences. Some infections may 
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also occur through the skin. Infection with H. contortus can result in emaciation, anaemia 
and in certain cases death. 
Figure 5 Life cycle of Haeneonchus contortus. 
Egg 
lWomasum/small intestine 
"i : 
ý", / (L3-+L4-+Aduhs) 
1 Prepalenl period - 23 weeln 
L9 C. ' 
TRICHOSTRONGYLES - LIFE CYCLE 
'f I lýl / L1 
L2 
http: Ww4R. Vetsci. rsu. edu coursedese %-sc402 slideshows'25Trichostrongyles. pdf 
Life cycle of Nematodirus spathiger. 
The life cycle of N. spathiger is very similar to that of H. contortus and other 
trichostrongylids, but with some important differences. The free-living development of 
Nematodirus spp differs from that of other trichostrongylids in that it is completed within 
the eggshell and development from egg through to the infective L3 takes approximately one 
month. They are thus very resilient on the ground and able to survive winter in large 
numbers. Cold weather seems to prime them for spring development when the temperature 
exceeds 10°C and they hatch together in the spring (Vanden Bossche, 1985) . 
Sheep etc are 
infected as with H. conforms by ingestion of the infective larvae whilst grazing. Following 
ingestion of LL's, exsheathment occurs in the abomasum and subsequent developing stages 
are found on the mucosal surface of the small intestine. The parasitic phase is non- 
migratory and the pre-patent period is 15 days. 
Nemalodirrus is not usually a primary pathogen in ruminants in North America and its 
importance derives from an additive effect in mixed infections of nematodes causing 
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Appendix II d). 
parasitic gastroenteritis. However, Nematodirus does cause significant disease in lambs in 
Britain. This is because its unusual hatching requirements may result in heavy 
contamination of pastures with newly hatched L3's just as lambs are close to weaning and 
are beginning to graze pastures more in late spring (May and early June in Britain). 
Diarrhoea followed rapidly by dehydration are the primary clinical signs. Adult ewes have 
developed a strong immunity to Nemaiodinrs and are usually unaffected. The damage to 
the lamb is caused by the large numbers of infected larvae burrowing into the lining of the 
gut simultaneously. In severe cases death is very rapid, whilst other lambs may take several 
days to die. 
Figure 6 Life cycle of Nematodirus spathiger. 
Nematodirus - Life Cycle 
14, 
L3 
tve 
E99 
1i II 
Egg + L3 7 Egg + L7 
Egg + L2 
http: cal. nlx.. upenn. edu merialTriehos, images nemdir_c. gif 
Presently trichostrongylid infection represents a major economic scourge. Control is by 
drug therapy typically included in the animals feed. Resistance however, is a problem with 
documented cases of anthelmintic resistance reported in benzimidazole compounds and 
ivermectin (Prichard, 1994). 
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APPENDIX III - Drug Structures. 
Denitro-nitazoxanide 
(DNNTZ) 
A derivative of 
nitazoxanide, without 
the nitro-group. 
Denitro-tizoxanide 
(DNTIZ) 
A derivative of 
tizoxanide, without the 
nitro-group. 
2-benzamido-5-nitrothiazole 
(BZNT) 
A derivative of tizoxanide. 
benzamido nitro thiazole 
' 0 
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Levamisole. 
(LEV) 
Anti-nematodal drug. Acts on 
helminth nicotinic receptors. 
OYY 
Mebendazole. 
(MEB) H N Anti"nematodal benzimidazole NN 
drug. Acts by inhibiting tubulin N 
polymerisation. 
Metrifonate. 
(MET) O/CH3 
Anti-schistosomal drug. Inhibits I OH 
acetylcholinesterase 0= CI I 
/O 
H3C CI 
CI 
Niclosamide. ci 
(NIC) 
Anti-cestodal drug. 
! N+ 
NH 
Protonophore. Uncouples °o 
mitochondrial oxidative ci off 
phosphorylation. 
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Pyrantel. 
Anti-nematodal drug. Acts 
on helminth nicotinic 
receptors. Also inhibits 
acetylcholinesterase. 
Avermectin a 
Anti-nematodal drug. 
Acts on helminth GABA 
receptors. 
Niridazole. 
(NIRI) 
Anti-schistosomal drug. No 
longer in use due to 
mutagenic properties. 
Nitrofurazone 
(NF) 
Antibiotic. Anti- 
trypanosomal drug. 
Ö 
I+ 
/N 
Oý 
N/ý-NH 
0 
O 
-ý( NH 
_N 
\NH2 
O 
N 
11 
0 
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Praziquantel. 
(PRAZ) 
Anti-trematodal drug. Drug 
of choice for treatment of 
schistosomiasis. Also has 
anti-cestodal activity. 
CCCP. 
Protonophore. Uncouples 
oxidative phosphorylation. 
FCCP. 
Protonophore. Uncouples 
oxidative phosphorylation. 
N 
H ýN ýN 
H 
CI 
I 
N 14 
H 
H 
F$CIO 
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A crvstallo raphic study of tizoxanide carried out by Dr. John Lisgarten 
and Prof Rex Palmer of Birkbeck College. University of London. 
The above crystallographic study shows the two rings of tizoxanide are completely 
coplanar, and linked by an H-bond between >N-JXand the phenolic -OH effectively giving 
a 3-ring structure. 
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APPENDIX IV 
Molecular weight / Molarity Data on Romark Test Compounds 
& Related Drugs 
Compound Other name Mol 
Wt 
Molarity (µM) 
of 1 µg/ml 
soln 
Molarity (mM) 
of 10mg/ml 
stock 
Nitazoxanide 307.3 3.25 32.5 
p-Nitazoxanide 307.3 3.25 32.5 
m-Nitazoxanide 307.3 3.25 32.5 
Tizoxanide Deacetyl- 
Nitazoxanide 
265.2 3.77 37.7 
p-Tizoxanide Deacetyl-p- 
Nitazoxanide 
265.2 3.77 37.7 
m-Tizoxanide Deacetyl-m- 
Nitazoxanide 
265.2 3.77 37.7 
Tizoxanide-glucuronide 441.4 2.27 22.7 
2-Benzamido-5- 
Nitrothiazole 
Deoxy-Tizoxanide 249.2 4.01 40.1 
Denitro-Nitazoxanide 261.3 3.83 38.3 
Denitro-Tizoxanide 219.2 4.57 45.7 
Metronidazole 171 5.84 58.4 
Niclosamide 327 3.06 30.6 
Mebendazole 295 3.86 38.6 
Prazi uantel 312.4 3.2 32.0 
FCCP Carbonyl cyanide p-i(mfluoronicithoxy) 254.2 3.93 39.34 
CCCP 
Carbonylcysnide m-rophenylhydnuone 
204.6 4.89 48.88 
Ivermectin 269.8 3.71 37.06 
Oxamni uine 279.3 3.58 35.8 
Metrifonate 257.4 3.89 38.85 
Lucanthone 340.5 2.94 29.37 
Hycanthone 356.5 2.81 28.05 
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APPENDIX V. 
From the Caenorhabditis elegans genome, a member of the oxygen-insensitive 
nitroreductases which strongly resembles the FMN linked nitroreductase from Enterobacter 
cloacae was found by (Bryant & DeLuca J Biol Chem 1991 5; 266: 4119-25). It is possible 
that this enzyme may be able to reduce NTZ causing a toxic effect in C. elegans. 
A consensus sequence was obtained from sequences of nitroreductase from various species 
using ExPASy (lit tp: //ca. expas . oran 
(D. C. Warhurst, unpublished data) 
10 20 30 40 50 60 
.... *.... .... *.... .... *.... .... *.... .... *.... .... *.... consensus 1 DVLELITTRRSIRKFD-DKPVSEEELEEILEAARLAPSSGNLQPWHFIVVEDEELKEKLA 59 
C. elegans 146 iFYEEMKMRRSCRQFS-SRDVPLKVIQNLLKTAGTSPSVGNLQPWTFCVVSSDSIKTMIR 204 
70 80 90 100 110 120 
.... *.... I.... *.... I .... *.... I .... *.... I.... *.... I.... *.... I Consensus 60 ELAGG----- QRQVESASAVIWCADTNRAQSALKLYG---------- GRVEEILDAARD 104 
C. elegans 205 KILEAd---eRDNYVSRKKGASWVVDVSQLQDTWRRPY--------------- ITDAPYL 246 
130 140 150 160 170 180 
.... *.... I.... *.... I.... *.... I .... *.... I.... *.... I.... *. -I consensus 105 LSIAAVNAAVAAESLGRGFDWESKQSY-IAVGNLLLAARALGLDSCPISGFDLGKPAERL 163 
C. elegans 247 LIVCHEIFRDVHSKTERVFHYNQISTS-IAVGILLAAIQNVGLSTVVTSPLNAGPDISRi 305 
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